: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Influenza

Free Subscription

Articles published in Vaccine
Retrieve available abstracts of 1413 articles:
HTML format

Single Articles

September 2023

CASSARINO N, Ahnger-Pier KK, Wurcel A
Trends in COVID-19 and influenza vaccine ordering and distribution in Massachusetts jails.
Vaccine. 2023 Sep 25:S0264-410X(23)01115-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GOLOVKINA MI, Ertz SC, Lechnir SS, Hayney MS, et al
Providing influenza vaccines at endoscopy visits increases influenza vaccine uptake.
Vaccine. 2023 Sep 23:S0264-410X(23)01108-8. doi: 10.1016/j.vaccine.2023.
PubMed

RAISER F, Davis M, Adelglass J, Cai MR, et al
Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults.
Vaccine. 2023;41:5965-5973.
PubMed Abstract available

HAO F, Shao W
Social network, political climate, income inequality, and Americans uptake of monovalent COVID-19 booster.
Vaccine. 2023;41:6077-6082.
PubMed Abstract available

HOMAIRA N, He WQ, McRae J, Macartney K, et al
Coverage and predictors of influenza and pertussis vaccination during pregnancy: a whole of population-based study.
Vaccine. 2023 Sep 21:S0264-410X(23)01062-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NELSON CB, Brady BL, Richards M, Lew CR, et al
Optimal site of care for administration of extended half-life respiratory syncytial virus (RSV) antibodies to infants in the United States (US).
Vaccine. 2023;41:5820-5824.
PubMed Abstract available

POTT H, Andrew MK, Shaffelburg Z, Nichols MK, et al
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canad
Vaccine. 2023 Sep 9:S0264-410X(23)01026-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YU J, Sreenivasan C, Sheng Z, Zhai SL, et al
A recombinant chimeric influenza virus vaccine expressing the consensus H3 hemagglutinin elicits broad hemagglutination inhibition antibodies against divergent swine H3N2 influenza viruses.
Vaccine. 2023 Sep 7:S0264-410X(23)01060-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MONTEIRO HS, Lima Neto AS, Kahn R, Sousa GS, et al
Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study.
Vaccine. 2023;41:5742-5751.
PubMed Abstract available

ALSAIF F, Twigg M, Scott S, Blyth A, et al
A systematic review of barriers and enablers associated with uptake of influenza vaccine among care home staff.
Vaccine. 2023 Sep 4:S0264-410X(23)01048-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WILLIS DE, Moore R, Andersen JA, Li J, et al
Correlates of COVID-19 vaccine coverage in Arkansas: Results from a weighted random sample survey.
Vaccine. 2023 Sep 1:S0264-410X(23)01039-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PORRAS-RAMIREZ A, Sanchez-Paris R, Lopez-Devia W, Moreno-Perilla Z, et al
Confirmed cases of COVID-19 after vaccination against COVID in health personnel in Bogota, Colombia.
Vaccine. 2023 Sep 1:S0264-410X(23)00924-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

August 2023

SAKALA IG, Honda-Okubo Y, Petrovsky N
Developmental and reproductive safety of Advax-CpG55.2 adjuvanted COVID-19 and influenza vaccines in mice.
Vaccine. 2023 Aug 31:S0264-410X(23)01007-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GRILLS LA, Wagner AL
The impact of the COVID-19 pandemic on parental vaccine hesitancy: A cross-sectional survey.
Vaccine. 2023 Aug 31:S0264-410X(23)00977-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUDLEY HM, O'Mara M, Auma A, Gong J, et al
Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine.
Vaccine. 2023 Aug 31:S0264-410X(23)00965-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

REGAN AK, Fell DB, Wise LA, Vazquez-Benitez G, et al
Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy.
Vaccine. 2023 Aug 31:S0264-410X(23)00964-7. doi: 10.1016/j.vaccine.2023.
PubMed

PHIRIYASART F, Aimyong N, Jirapongsuwan A, Roseh N, et al
COVID-19 vaccine hesitancy among older adult Thai Muslim people: A case-control study.
Vaccine. 2023 Aug 27:S0264-410X(23)00994-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANG J, Li B, Yang D, Wu J, et al
The immunogenicity of Alum+CpG adjuvant SARS-CoV-2 inactivated vaccine in mice.
Vaccine. 2023 Aug 26:S0264-410X(23)01017-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JANSSEN ERC, van Montfoort AZ, Hollman F, Lambers Heerspink FO, et al
The prevalence and clinical course of shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccines in Dutch hospital workers.
Vaccine. 2023 Aug 25:S0264-410X(23)00975-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHIBA S, Halfmann PJ, Iida S, Hirata Y, et al
Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2.
Vaccine. 2023 Aug 25:S0264-410X(23)01008-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHEN IR, Wang GJ, Hsueh PR, Chou CH, et al
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan.
Vaccine. 2023 Aug 25:S0264-410X(23)00952-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WATERLOW NR, Procter SR, van Leeuwen E, Radhakrishnan S, et al
The potential cost-effectiveness of next generation influenza vaccines in England and Wales: A modelling analysis.
Vaccine. 2023 Aug 24:S0264-410X(23)00963-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOHAMMED IS, Widome R, Searle KM
COVID-19 vaccine decision-making among Black women: A qualitative study.
Vaccine. 2023 Aug 24:S0264-410X(23)00920-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DENG L, Tapper K, Thosar D, Goeman E, et al
Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study.
Vaccine. 2023 Aug 24:S0264-410X(23)00956-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GOULD S, Wrzesinski C, Stebbings R, Segal L, et al
Report from an ICT 2022 workshop on toxicology for Covid19 vaccines: Industry, regulatory and CRO perspectives.
Vaccine. 2023 Aug 24:S0264-410X(23)00972-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

STRUYF F, Hardt K, Van Rampelbergh R, Shukarev G, et al
Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S.
Vaccine. 2023;41:5351-5359.
PubMed Abstract available

SU Y, Guo Z, Gu X, Sun S, et al
Influenza vaccine effectiveness against influenza A during the delayed 2022/23 epidemic in Shihezi, China.
Vaccine. 2023 Aug 19:S0264-410X(23)00971-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YAO T, Guo Y, Xu X, Zhang X, et al
Predictors of immune persistence induced by two-dose BBIBP-CorV vaccine in high-risk occupational population.
Vaccine. 2023 Aug 19:S0264-410X(23)00974-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KENIGSBERG TA, Goddard K, Hanson KE, Lewis N, et al
Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines.
Vaccine. 2023 Aug 18:S0264-410X(23)00955-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHAIWONG W, Takheaw N, Pata S, Laopajon W, et al
Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease.
Vaccine. 2023 Aug 18:S0264-410X(23)00966-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PALACHE A, Billingsley JK, MacLaren K, Morgan L, et al
Lessons learned from the COVID-19 pandemic for improved influenza control.
Vaccine. 2023 Aug 17:S0264-410X(23)00960-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MORRISON K, Cullen L, James AB, Chua V, et al
Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose.
Vaccine. 2023 Aug 17:S0264-410X(23)00916-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZUR M, Shelef L, Glassberg E, Fink N, et al
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles.
Vaccine. 2023 Aug 15:S0264-410X(23)00951-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SARNA M, Gebremedhin A, Richmond P, Levy A, et al
Determining the true incidence of seasonal respiratory syncytial virus-confirmed hospitalizations in preterm and term infants in Western Australia.
Vaccine. 2023;41:5216-5220.
PubMed Abstract available

TOYAMA K, Eto T, Takazawa K, Shimizu S, et al
DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study.
Vaccine. 2023 Aug 14:S0264-410X(23)00824-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WITTAWATMONGKOL O, Bunjoungmanee P, Kosalaraksa P, Laoprasopwattana K, et al
Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.
Vaccine. 2023 Aug 14:S0264-410X(23)00953-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BERTHELEMY C, Bouche P, Lamiral Z, Boivin JM, et al
Parental acceptability of vaccinating young children against influenza and COVID-19.
Vaccine. 2023 Aug 12:S0264-410X(23)00929-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HONDA-OKUBO Y, Bart Tarbet E, Hurst BL, Petrovsky N, et al
An Advax-CpG adjuvanted recombinant H5 hemagglutinin vaccine protects mice against lethal influenza infection.
Vaccine. 2023 Aug 9:S0264-410X(23)00941-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAGLIVO F, Magri M, De Angelis L, Aprile V, et al
Performance comparison between heterologous and homologous COVID19 vaccine schedules on Omicron variant incidence: A real-world retrospective cohort study in Southern Italy.
Vaccine. 2023 Aug 9:S0264-410X(23)00886-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MAC S, Shi S, Millson B, Tehrani A, et al
Burden of illness associated with Respiratory Syncytial Virus (RSV)-related hospitalizations among adults in Ontario, Canada: A retrospective population-based study.
Vaccine. 2023;41:5141-5149.
PubMed Abstract available

CHICOYE A, Crepey P, Nguyen VH, Marquez-Pelaez S, et al
Contributions of cost-effectiveness analyses (CEA) to influenza vaccination policy for older adults in Europe.
Vaccine. 2023 Aug 5:S0264-410X(23)00919-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SIMMS AJ, King KD, Tsui N, Edwards SA, et al
COVID-19 vaccine behaviour among citizens of the Metis Nation of Ontario: A qualitative study.
Vaccine. 2023 Aug 5:S0264-410X(23)00891-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VERJOVSKY M, Barreto MP, Carmo I, Coutinho B, et al
Political quarrel overshadows vaccination advocacy: How the vaccine debate on Brazilian Twitter was framed by anti-vaxxers during Bolsonaro administration.
Vaccine. 2023 Aug 5:S0264-410X(23)00921-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CAMPBELL J, Kaur A, Gamino D, Benoit E, et al
Individual and structural determinants of COVID-19 vaccine uptake in a marginalized community in the United States.
Vaccine. 2023 Aug 5:S0264-410X(23)00923-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOSCARA L, Venerito V, Martinelli A, Di Lorenzo A, et al
Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.
Vaccine. 2023 Aug 4:S0264-410X(23)00874-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

XU S, Yu H, Cheng X, Wu J, et al
Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves' disease: An observational cohort study.
Vaccine. 2023 Aug 4:S0264-410X(23)00884-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AUVIGNE V, Tamandjou Tchuem CR, Schaeffer J, Vaux S, et al
Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France.
Vaccine. 2023 Aug 2:S0264-410X(23)00917-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MO J, Spackman E, Swayne DE
Prediction of highly pathogenic avian influenza vaccine efficacy in chickens by comparison of in vitro and in vivo data: A meta-analysis and systematic review.
Vaccine. 2023 Aug 1:S0264-410X(23)00922-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

July 2023

HONDA-OKUBO Y, Sakala IG, Andre G, Tarbet EB, et al
An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice.
Vaccine. 2023 Jul 31:S0264-410X(23)00892-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIU B, Stepien S, Qian J, Gidding H, et al
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection.
Vaccine. 2023 Jul 29:S0264-410X(23)00881-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AMANI A, Njoh AA, Atuhebwe P, Ndoula S, et al
Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses.
Vaccine. 2023 Jul 29:S0264-410X(23)00905-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GREEN-MCKENZIE J, Shofer FS, Kruse G, Momplaisir F, et al
COVID-19 vaccine uptake before and after a vaccine mandate at a major academic hospital: Trends by race/ethnicity and level of patient contact.
Vaccine. 2023 Jul 28:S0264-410X(23)00853-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LAVENDER B, Hooker C, Frampton C, Williams M, et al
Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naive New Zealand cohort.
Vaccine. 2023 Jul 27:S0264-410X(23)00882-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROSA RG, Falavigna M, Manfio JL, de Araujo CLP, et al
BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study.
Vaccine. 2023 Jul 26:S0264-410X(23)00869-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM DH, Lee J, Youk S, Jeong JH, et al
Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection.
Vaccine. 2023;41:4787-4797.
PubMed Abstract available

TAMADA Y, Takeuchi K, Kusama T, Maeda M, et al
Effectiveness of COVID-19 vaccines against infection in Japan: A test-negative study from the VENUS study.
Vaccine. 2023 Jul 22:S0264-410X(23)00856-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GHAZY RM, Ibrahim SA, Taha SHN, Elshabrawy A, et al
Attitudes of parents towards influenza vaccine in the Eastern Mediterranean Region: A multilevel analysis.
Vaccine. 2023 Jul 20:S0264-410X(23)00808-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ARAUJO-CHAVERON L, Sicsic J, Moffroid H, Diaz Luevano C, et al
Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adults.
Vaccine. 2023 Jul 20:S0264-410X(23)00805-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KATHERINE YIH W, Daley MF, Duffy J, Fireman B, et al
Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink.
Vaccine. 2023 Jul 19:S0264-410X(23)00823-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PISL V, Vevera J
COVID-19 vaccine uptake in mental healthcare users: Czech nationwide register study.
Vaccine. 2023 Jul 19:S0264-410X(23)00840-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZIMMERMAN RK, Patricia Nowalk M, Dauer K, Clarke L, et al
Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design.
Vaccine. 2023 Jul 18:S0264-410X(23)00741-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SABAT I, Neumann-Bohme S, Barros PP, Torbica A, et al
Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to vaccinate against COVID-19 from seven European countries.
Vaccine. 2023 Jul 15:S0264-410X(23)00829-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOROS A, Prenafeta A, Barreiro A, Perozo E, et al
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.
Vaccine. 2023 Jul 15:S0264-410X(23)00820-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CLOUSTON SAP, Hanes DW, Link BG
Social inequalities and the early provision and dispersal of COVID-19 vaccinations in the United States: A population trends study.
Vaccine. 2023 Jul 15:S0264-410X(23)00833-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TALOTTA R
COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in silico analysis, considerations and perspectives.
Vaccine. 2023 Jul 13:S0264-410X(23)00819-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALABANZA C, Gavrilov V, Scott T, Yang RS, et al
Quantitation of strain-specific hemagglutinin trimers in mosaic quadrivalent influenza nanoparticle vaccine by ELISA.
Vaccine. 2023 Jul 12:S0264-410X(23)00821-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BEYERS KCL, Rbeihat MNM, S Vasconcelos D, Pasmans D, et al
Preclinical evaluation of performance, safety and usability of VAX-ID(R), a novel intradermal injection device.
Vaccine. 2023;41:4609-4615.
PubMed Abstract available

AGRAWAL P, Damania D, Cseh A, Grab J, et al
Impact of COVID vaccine and comorbidities in patients receiving casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta) surge: A real-world study.
Vaccine. 2023 Jul 12:S0264-410X(23)00822-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MINCHIN J, Harris GH, Baumann S, Smith ER, et al
Exclusion of pregnant people from emergency vaccine clinical trials: A systematic review of clinical trial protocols and reporting from 2009 to 2019.
Vaccine. 2023 Jul 11:S0264-410X(23)00776-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WILLIS DE, Reece S, Gurel-Headley M, Selig JP, et al
Social processes, practical issues, and COVID-19 vaccination among hesitant adults.
Vaccine. 2023 Jul 7:S0264-410X(23)00809-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZHANG X, Shen P, Liu J, Ji X, et al
Evaluating the effectiveness and cost-effectiveness of free influenza vaccination policy for older adults in Yinzhou, China: Study protocol of a real-world analyses.
Vaccine. 2023 Jul 5:S0264-410X(23)00790-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WAGNER A, Juvalta S, Speranza C, Suggs LS, et al
Let's talk about COVID-19 vaccination: Relevance of conversations about COVID-19 vaccination and information sources on vaccination intention in Switzerland.
Vaccine. 2023 Jul 5:S0264-410X(23)00807-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LE H, de Klerk N, Blyth CC, Gidding H, et al
Non-specific benefit of seasonal influenza vaccine on respiratory syncytial virus-hospitalisations in children: An instrumental variable approach using population-based data.
Vaccine. 2023 Jul 3:S0264-410X(23)00788-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PATEL UC, Schultz T, Schmidt J
Veteran influenza vaccination acceptance rates after completion of the COVID-19 vaccination series among historical influenza vaccine refusers.
Vaccine. 2023 Jul 3:S0264-410X(23)00803-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROSHCHINA Y, Rozhkova K, Roshchin S
Between nudges and mandates: The drivers of COVID-19 vaccination intentions and subsequent uptake in Russia.
Vaccine. 2023 Jul 3:S0264-410X(23)00756-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TUCKERMAN J, Kaufman J, Overmars I, Holland P, et al
Barriers to COVID-19 vaccination of migrant populations: A qualitative interview study of immunisation providers in Victoria, Australia.
Vaccine. 2023 Jul 3:S0264-410X(23)00804-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TROGSTAD L, Laake I, Robertson AH, Mjaaland S, et al
Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination.
Vaccine. 2023 Jul 3:S0264-410X(23)00801-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

June 2023

LIU Z, Pang C, Deng Y, Guo C, et al
Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults.
Vaccine. 2023 Jun 30:S0264-410X(23)00616-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHINJOH M, Furuichi M, Tsuzuki S, Iqbal A, et al
Effectiveness of inactivated influenza and COVID-19 vaccines in hospitalized children in 2022/23 season in Japan - The first season of co-circulation of influenza and COVID-19.
Vaccine. 2023 Jun 30:S0264-410X(23)00785-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIU Y, Zhang A, Wang Y, Yang J, et al
Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques.
Vaccine. 2023 Jun 30:S0264-410X(23)00789-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KU JH, Sy LS, Qian L, Ackerson BK, et al
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study.
Vaccine. 2023;41:4212-4219.
PubMed Abstract available

VAN DER BOOR SC, Schmitz-de Vries ETJ, Smits D, Scholl JHG, et al
Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.
Vaccine. 2023;41:4319-4326.
PubMed Abstract available

ALVES K, Plested JS, Galbiati S, Chau G, et al
Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373.
Vaccine. 2023;41:4280-4286.
PubMed Abstract available

ISHIKAWA K, Nascimento MC, Asano M, Hirata H, et al
One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan.
Vaccine. 2023;41:4199-4205.
PubMed Abstract available

LEE KS, Rader NA, Miller-Stump OA, Cooper M, et al
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice.
Vaccine. 2023 Jun 28:S0264-410X(23)00783-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHENG Y, Li Z, Lin X, Ma Y, et al
The position of Spy Tag/Catcher system in hepatitis B core protein particles affects the immunogenicity and stability of the synthetic vaccine.
Vaccine. 2023 Jun 28:S0264-410X(23)00759-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DOMNICH A, Orsi A, Ogliastro M, Trombetta CS, et al
Influenza vaccine effectiveness in preventing hospital encounters for laboratory-confirmed infection among Italian adults, 2022/23 season.
Vaccine. 2023 Jun 27:S0264-410X(23)00775-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM S, Ko M, Heo Y, Lee YK, et al
Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over.
Vaccine. 2023 Jun 27:S0264-410X(23)00780-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BARRIENTOS M, Vasquez-Lavin F, Rosales C, Bratti L, et al
Understanding the role of personal experiences and contextual variables in shaping risk reduction preferences.
Vaccine. 2023;41:4092-4105.
PubMed Abstract available

TORP HANSEN K, Kusk Povlsen F, Hammer Bech B, Nygaard Hansen S, et al
Immediate adverse reactions following COVID-19 vaccination among 16-65-year-old Danish citizens.
Vaccine. 2023 Jun 23:S0264-410X(23)00758-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TURLEY CB, Tables L, Fuller T, Sanders LJ, et al
Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials.
Vaccine. 2023 Jun 23:S0264-410X(23)00755-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SALEH SN, McDonald SA, Basit MA, Kumar S, et al
Public perception of COVID-19 vaccines through analysis of Twitter content and users.
Vaccine. 2023 Jun 23:S0264-410X(23)00743-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HOWARD MC
Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates and vaccination outcomes.
Vaccine. 2023 Jun 23:S0264-410X(23)00742-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHAUDHARY A, Madhavan R, Babji S, Raju R, et al
Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India.
Vaccine. 2023 Jun 23:S0264-410X(23)00744-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AUGUSTYNIAK A, Szymanski T, Porzucek F, Mieloch AA, et al
A cohort study reveals different dynamics of SARS-CoV-2-specific antibody formation after Comirnaty and Vaxzevria vaccination.
Vaccine. 2023 Jun 21:S0264-410X(23)00665-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LUANGASANATIP N, Painter C, Pan-Ngum W, Saralamba S, et al
How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic.
Vaccine. 2023 Jun 20:S0264-410X(23)00740-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

EKIMOV A, Arunachalam AB, Blake T, Bodle J, et al
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine.
Vaccine. 2023 Jun 19:S0264-410X(23)00726-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HONDA-OKUBO Y, Li L, Andre G, Leong KH, et al
An Advax-CpG55.2 adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge.
Vaccine. 2023 Jun 19:S0264-410X(23)00748-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MASOUD D, Pierz A, Rauh L, Cruz AK, et al
Vaccine Trust Gauge: Mixed methods research to measure and understand vaccine trust.
Vaccine. 2023 Jun 17:S0264-410X(23)00690-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DOYON-PLOURDE P, Przepiorkowski J, Young K, Zhao L, et al
Intraseasonal waning immunity of seasonal influenza vaccine - A systematic review and meta-analysis.
Vaccine. 2023 Jun 16:S0264-410X(23)00713-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUNN DT, Gilson R, McCormack S, McCoy LE, et al
Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials.
Vaccine. 2023 Jun 16:S0264-410X(23)00712-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BISWAS RK, Afiaz A, Huq S, Farzana M, et al
Public opinion on COVID-19 vaccine prioritization in Bangladesh: Who gets the vaccine and whom do you leave out?
Vaccine. 2023 Jun 16:S0264-410X(23)00725-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NISHIYAMA A, Adachi Y, Tonouchi K, Moriyama S, et al
Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses.
Vaccine. 2023 Jun 15:S0264-410X(23)00685-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PIGNATTI P, Ramirez GA, Russo M, Marraccini P, et al
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.
Vaccine. 2023 Jun 15:S0264-410X(23)00714-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MUANGNOICHAROEN S, Wiangcharoen R, Nanthapisal S, Kamolratakul S, et al
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial.
Vaccine. 2023 Jun 15:S0264-410X(23)00718-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KENIGSBERG TA, Hanson KE, Klein NP, Zerbo O, et al
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink.
Vaccine. 2023 Jun 15:S0264-410X(23)00717-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PUTHANAKIT T, Chokephaibulkit K, Chaithongwongwatthana S, Bhat N, et al
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women.
Vaccine. 2023 Jun 15:S0264-410X(23)00657-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHOAIBI A, Lloyd PC, Wong HL, Clarke TC, et al
Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.
Vaccine. 2023 Jun 14:S0264-410X(23)00682-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CIEMINS EL, Gillen A, Tallam M
RSV: A vaccine is coming, time to educate providers.
Vaccine. 2023 Jun 14:S0264-410X(23)00695-3. doi: 10.1016/j.vaccine.2023.
PubMed

SAADATIAN-ELAHI M, Henaff L, Elias C, Nunes MC, et al
Patient influenza vaccination reduces the risk of hospital-acquired influenza: An incident test negative-case control study in Lyon university hospital, France (2004-2020).
Vaccine. 2023 Jun 13:S0264-410X(23)00621-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SALMANTON-GARCIA J, Wipfler P, Valle-Simon P, Merakou C, et al
VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.
Vaccine. 2023;41:3915-3922.
PubMed Abstract available

WOO EJ, Gee J, Marquez P, Baggs J, et al
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022.
Vaccine. 2023 Jun 13:S0264-410X(23)00687-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MUNOZ FM, Posavad CM, Richardson BA, Badell ML, et al
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn.
Vaccine. 2023 Jun 13:S0264-410X(23)00698-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WATESKA AR, Nowalk MP, Lin CJ, Harrison LH, et al
Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults.
Vaccine. 2023 Jun 12:S0264-410X(23)00669-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MA D, Tian S, Qin Q, Yu Y, et al
Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model.
Vaccine. 2023 Jun 10:S0264-410X(23)00655-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MADRAN B, Kayi I, Beser A, Ergonul O, et al
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study.
Vaccine. 2023 Jun 9:S0264-410X(23)00688-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

UI M, Hirama T, Akiba M, Honda M, et al
Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan.
Vaccine. 2023 Jun 9:S0264-410X(23)00663-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MARTINEZ MR, Gao J, Wan H, Kang H, et al
Inactivated influenza virions are a flexible vaccine platform for eliciting protective antibody responses against neuraminidase.
Vaccine. 2023 Jun 8:S0264-410X(23)00629-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NOGAREDA F, Gharpure R, Contreras M, Velandia M, et al
Seasonal influenza vaccination in the Americas: Progress and challenges during the COVID-19 pandemic.
Vaccine. 2023 Jun 8:S0264-410X(23)00689-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DE GIER B, van Asten L, Boere TM, van Roon A, et al
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021-January 2022.
Vaccine. 2023 Jun 8:S0264-410X(23)00660-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROY A, Polazzi S, Ploin D, Gillet Y, et al
The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs.
Vaccine. 2023;41:3796-3800.
PubMed Abstract available

SHAW RJ, Doyle AJ, Millen EA, Stowe J, et al
Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria.
Vaccine. 2023 Jun 7:S0264-410X(23)00662-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KATO H, Hozawa T, Fukushima W, Nobusawa E, et al
Influenza vaccine viruses and the development of seasonal vaccines: A Japanese perspective.
Vaccine. 2023 Jun 6:S0264-410X(23)00640-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM DELUCA E, Gebremariam A, Rose A, Biggerstaff M, et al
Cost-effectiveness of routine annual influenza vaccination by age and risk status.
Vaccine. 2023 Jun 6:S0264-410X(23)00495-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM WJ, Roberts CC, Song JY, Yoon JG, et al
Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost.
Vaccine. 2023 Jun 6:S0264-410X(23)00683-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PELLETIER C, Labbe F, Bettinger JA, Curran J, et al
From high hopes to disenchantment: A qualitative analysis of editorial cartoons on COVID-19 vaccines in Canadian newspapers.
Vaccine. 2023 Jun 6:S0264-410X(23)00658-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ELDER E, Bangalore Revanna C, Johansson C, Wallin RPA, et al
Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine.
Vaccine. 2023 Jun 6:S0264-410X(23)00684-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MAKANUT S, Wangteeraprasert A, Jitpewngam W, Ngoenkam J, et al
Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University.
Vaccine. 2023 Jun 5:S0264-410X(23)00666-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WESSELINK AK, Lovett SM, Weinberg J, Geller RJ, et al
COVID-19 vaccination and menstrual cycle characteristics: A prospective cohort study.
Vaccine. 2023 Jun 5:S0264-410X(23)00681-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KOZMA GT, Meszaros T, Berenyi P, Facsko R, et al
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG.
Vaccine. 2023 Jun 5:S0264-410X(23)00667-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ERGUN T, Hosgoren Tekin S, Apti Sengun O, Akin Cakici O, et al
Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study.
Vaccine. 2023 Jun 3:S0264-410X(23)00615-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FEDDEMA JJ, Fernald KDS, Schikan HGCP, van de Burgwal LHM, et al
Upscaling vaccine manufacturing capacity - Kkey bottlenecks and lessons learned.
Vaccine. 2023 Jun 3:S0264-410X(23)00554-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

May 2023

WANG LJ, Tsai CS, Chou WJ, Li CJ, et al
Medical outcomes of children with neurodevelopmental disorders after SARS-CoV-2 vaccination: A six-month follow-up study.
Vaccine. 2023 May 29:S0264-410X(23)00628-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ARROSPIDE A, Sagardui MG, Larizgoitia I, Iturralde A, et al
Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study.
Vaccine. 2023 May 29:S0264-410X(23)00622-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HU S, Xiong C, Zhao Y, Yuan X, et al
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS-Cov-2 B.1.1.529 (Omicron) variant.
Vaccine. 2023 May 29:S0264-410X(23)00617-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MILLER ER, Moro PL, Shimabukuro TT, Carlock G, et al
COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office.
Vaccine. 2023 May 24:S0264-410X(23)00613-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HORI D, Keneda Y, Ozaki A, Tabuchi T, et al
Sexual orientation was associated with intention to be vaccinated with a smallpox vaccine against mpox: A cross-sectional preliminary survey in Japan.
Vaccine. 2023 May 24:S0264-410X(23)00611-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NUGENT C, Abul Y, White EM, Shehadeh F, et al
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers.
Vaccine. 2023;41:3403-3409.
PubMed Abstract available

JOUDEH AI, Lutf AQ, Mahdi S, Tran G, et al
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review.
Vaccine. 2023 May 22:S0264-410X(23)00609-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALICANDRO G, Orena BS, Rosazza C, Cariani L, et al
Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis.
Vaccine. 2023 May 22:S0264-410X(23)00590-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GHAZNAVI C, Eguchi A, Suu Lwin K, Yoneoka D, et al
Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020-2021.
Vaccine. 2023 May 22:S0264-410X(23)00583-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GUO BQ, Li HB, Yang LQ
Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12-17 years.
Vaccine. 2023 May 22:S0264-410X(23)00610-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BOLSEWICZ KT, Steffens MS, King C, Abdi I, et al
A qualitative study on COVID-19 pandemic impacts on parental attitudes and intentions for routine adolescent vaccinations: The role of trust.
Vaccine. 2023 May 22:S0264-410X(23)00586-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

EGER J, Kaplan LC, Sternberg H
How to reduce vaccination hesitancy? The relevance of evidence and its communicator.
Vaccine. 2023 May 22:S0264-410X(23)00298-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

EMBI PJ, Levy ME, Patel P, DeSilva MB, et al
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021.
Vaccine. 2023 May 22:S0264-410X(23)00588-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BOING AF, Boing AC, Barberia L, Borges ME, et al
Uncovering inequities in Covid-19 vaccine coverage for adults and elderly in Brazil: A multilevel study of 2021-2022 data.
Vaccine. 2023 May 17:S0264-410X(23)00569-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZHOU ZH, Cortese MM, Fang JL, Wood R, et al
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
Vaccine. 2023 May 16:S0264-410X(23)00568-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BLACK SB, Chandler RE, Edwards KM, Sturkenboom MCJM, et al
Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.
Vaccine. 2023 May 15:S0264-410X(23)00468-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIMAYE RJ, Singh P, Paul A, Fesshaye B, et al
COVID-19 vaccine decision-making among pregnant and lactating women in Bangladesh.
Vaccine. 2023 May 15:S0264-410X(23)00551-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SURIE D, Bonnell LN, DeCuir J, Gaglani M, et al
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022.
Vaccine. 2023 May 15:S0264-410X(23)00567-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GEORGE TK, Nair NP, Singh AK, Dilesh Kumar A, et al
Development of a Choice-framework for Covid vaccines in India using a multi-criteria decision analysis approach.
Vaccine. 2023 May 12:S0264-410X(23)00486-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KEHAGIA E, Papakyriakopoulou P, Valsami G
Advances in intranasal vaccine delivery: A promising non-invasive route of immunization.
Vaccine. 2023 May 11:S0264-410X(23)00529-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROBERTS-MCCARTHY E, Buck PO, Smith-Ray RL, Van de Velde N, et al
Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic.
Vaccine. 2023 May 11:S0264-410X(23)00383-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LANGLETE P, Tesli M, Veneti L, Starrfelt J, et al
Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022.
Vaccine. 2023 May 10:S0264-410X(23)00549-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SMITH K, Hegazy K, Cai MR, McKnight I, et al
Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials.
Vaccine. 2023 May 10:S0264-410X(23)00543-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VAN IERSEL SCJL, McDonald SA, de Gier B, Knol MJ, et al
Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022.
Vaccine. 2023 May 10:S0264-410X(23)00545-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RUBIN THOMPSON LJ, Grubo M, Veller M, Badenhorst RH, et al
Building global vaccine manufacturing capacity: Spotlight on Africa.
Vaccine. 2023 May 10:S0264-410X(23)00527-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHIAVENNA C, Leone LP, Melegaro A, Rotesi T, et al
Personal risk or societal benefit? Investigating adults' support for COVID-19 childhood vaccination.
Vaccine. 2023 May 9:S0264-410X(23)00544-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KURIYAMA K, Murakami K, Masuda T, Sugiura K, et al
Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial.
Vaccine. 2023 May 8:S0264-410X(23)00519-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SUTTON WJH, Branham PJ, Williamson YM, Cooper HC, et al
Quantification of SARS-CoV-2 spike protein expression from mRNA vaccines using isotope dilution mass spectrometry.
Vaccine. 2023 May 8:S0264-410X(23)00458-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BORDALO FERREIRA F, Rafael MA, Coimbra L, Boavida N, et al
Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease.
Vaccine. 2023 May 8:S0264-410X(23)00530-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FITZ-PATRICK D, Young M, Yacisin K, McElwee K, et al
Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults >/=65 years old.
Vaccine. 2023 May 8:S0264-410X(23)00520-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KPOZEHOUEN EB, Heywood AE, Menzies R, Seale H, et al
Informing the design of a whole of life immunisation register for Australia.
Vaccine. 2023;41:3011-3018.
PubMed Abstract available

RODRIGUEZ DM, Major CG, Sanchez-Gonzalez L, Jones E, et al
Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico.
Vaccine. 2023 May 5:S0264-410X(23)00516-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KU JH, Sy LS, Qian L, Ackerson BK, et al
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study.
Vaccine. 2023 May 3:S0264-410X(23)00498-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FUKUNAGA R, Kaplan ZE, Rodriguez T, Hagan L, et al
Attitudes towards COVID-19 vaccination among incarcerated persons in the Federal Bureau of Prisons, June-July 2021.
Vaccine. 2023 May 2:S0264-410X(23)00512-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LEFFERTS B, Bruden D, Plumb ID, Hodges E, et al
Effectiveness of the COVID-19 vaccines on preventing symptomatic SARS-CoV-2 infections and hospitalizations in Southwestern Alaska, January-December 2021.
Vaccine. 2023 May 1:S0264-410X(23)00496-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MESINA FZ, Sapinoso FAD, De Castro JAV, Vaswani PPM, et al
Hematologic adverse events reported after COVID-19 vaccination in the Philippines: A national database study.
Vaccine. 2023 May 1:S0264-410X(23)00490-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HUSSAINI L, Labberton AS, Winje BA, Kraft KB, et al
COVID-19 vaccination rates among adolescents (12-17 years) by immigrant background and sociodemographic factors: A nationwide registry study in Norway.
Vaccine. 2023 May 1:S0264-410X(23)00514-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KUHLBRANDT C, McGowan CR, Stuart R, Grenfell P, et al
COVID-19 vaccination decisions among Gypsy, Roma, and Traveller communities: A qualitative study moving beyond "vaccine hesitancy".
Vaccine. 2023 May 1:S0264-410X(23)00515-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

April 2023

MARCHESE AM, Zhou X, Kinol J, Underwood E, et al
NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial.
Vaccine. 2023 Apr 29:S0264-410X(23)00467-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VANNI T, da Graca Salomao M, Viscondi JYK, Braga PE, et al
A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults.
Vaccine. 2023 Apr 28:S0264-410X(23)00464-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KOEN AL, Izu A, Baillie V, Kwatra G, et al
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005).
Vaccine. 2023 Apr 27:S0264-410X(23)00483-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM C, Aminawung JA, Brinkley-Rubinstein L, Wang EA, et al
COVID-19 vaccine deliberation in individuals directly impacted by incarceration.
Vaccine. 2023 Apr 26:S0264-410X(23)00492-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALSUHEBANY N, Alowais SA, Aldairem A, Almohareb SN, et al
Identifying gaps in vaccination perception after mandating the COVID-19 vaccine in Saudi Arabia.
Vaccine. 2023 Apr 26:S0264-410X(23)00481-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LU X, Masuda S, Horlad H, Katoh T, et al
Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population.
Vaccine. 2023 Apr 26:S0264-410X(23)00469-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM SJ, Kwon SL, Lee JY, Oh J, et al
Why school is crucial to increase vaccination coverage for children: Evaluation of school vaccination check program in South Korea 2021-2022.
Vaccine. 2023 Apr 25:S0264-410X(23)00430-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JIANG M, Vaisanen E, Kolehmainen P, Huttunen M, et al
COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs.
Vaccine. 2023 Apr 25:S0264-410X(23)00463-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WALTER D, Ophir Y, Ye H
Conspiracies, misinformation and resistance to public health measures during COVID-19 in white nationalist online communication.
Vaccine. 2023;41:2868-2877.
PubMed Abstract available

TAMANDJOU C, Auvigne V, Schaeffer J, Vaux S, et al
Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France.
Vaccine. 2023;41:2754-2760.
PubMed Abstract available

MA L, Brecher M, Soufal A, Gaiotto T, et al
Structural interrogation of a trimeric prefusion RSV fusion protein vaccine candidate by a camelid nanobody.
Vaccine. 2023 Apr 19:S0264-410X(23)00413-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAO Y, He L, Miao B, Zhong Z, et al
BBIBP-CorV vaccination accelerates anti-viral antibody responses in heterologous Omicron infection: A retrospective observation study in Shanghai.
Vaccine. 2023 Apr 19:S0264-410X(23)00377-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PILLSBURY A, Phillips A, Deng L, Quinn H, et al
Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines.
Vaccine. 2023 Apr 18:S0264-410X(23)00441-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MAO Z, Li X, Dacosta-Urbieta A, Billard MN, et al
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe.
Vaccine. 2023;41:2707-2715.
PubMed Abstract available

HOUTSMA C, Raines AM, Reggio A, Rushing LK, et al
COVID-19 vaccine distribution: A high reliability organization approach.
Vaccine. 2023 Apr 17:S0264-410X(23)00423-1. doi: 10.1016/j.vaccine.2023.
PubMed

GORDON SF, Lam J, Vasquez JT, Cercone R, et al
A tailored COVID-19 vaccination pathway for children 5-11 years in Victoria, Australia.
Vaccine. 2023 Apr 17:S0264-410X(23)00424-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LUDWIKOWSKA KM, Popiel A, Matkowska-Kocjan A, Biela M, et al
COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS).
Vaccine. 2023 Apr 14:S0264-410X(23)00427-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FREITAG TL, Fagerlund R, Karam NL, Leppanen VM, et al
Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models.
Vaccine. 2023 Apr 14:S0264-410X(23)00403-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ANDRAUD M, Herve S, Gorin S, Barbier N, et al
Evaluation of early single dose vaccination on swine influenza A virus transmission in piglets: From experimental data to mechanistic modelling.
Vaccine. 2023 Apr 13:S0264-410X(23)00401-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ESTEPHAN L, Lin YC, Lin YT, Chen YH, et al
Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial.
Vaccine. 2023 Apr 12:S0264-410X(23)00421-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

UEMURA K, Ono S, Michihata N, Yamana H, et al
Duration of influenza vaccine effectiveness in the elderly in Japan: A retrospective cohort study using large-scale population-based registry data.
Vaccine. 2023 Apr 10:S0264-410X(23)00373-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RATHORE APS, St John AL
Promises and challenges of mucosal COVID-19 vaccines.
Vaccine. 2023 Apr 10:S0264-410X(23)00396-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HARRIS C, Cottrell S, Perry M, Meaden R, et al
A pilot intervention to improve uptake and equality of childhood influenza vaccination in an area of Wales, through the introduction of a mixed delivery model including nursery school immunisation sessions.
Vaccine. 2023 Apr 8:S0264-410X(23)00382-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LEIGH HOBBS J, Paul LA, Buchan SA, Harris T, et al
Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada.
Vaccine. 2023 Apr 7:S0264-410X(23)00389-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HARRIS JN, Mauro CM, Morgan TL, de Roche A, et al
Factors impacting parental uptake of COVID-19 vaccination for U.S. Children ages 5-17.
Vaccine. 2023 Apr 7:S0264-410X(23)00384-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALMAHASIS SO, Fox B, Ha D, Qian J, et al
Pharmacy-based immunization in rural USA during the COVID-19 pandemic: A survey of community pharmacists from five southeastern states.
Vaccine. 2023;41:2503-2513.
PubMed Abstract available

SMITS PD, Gratzl S, Simonov M, Nachimuthu SK, et al
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities.
Vaccine. 2023;41:2447-2455.
PubMed Abstract available

GOLD MS, Amarasinghe A, Greenhawt M, Kelso JM, et al
Anaphylaxis: Revision of the Brighton collaboration case definition.
Vaccine. 2023;41:2605-2614.
PubMed Abstract available

BURKHOLDER B, Wadood Z, Kassem AM, Ehrhardt D, et al
The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities.
Vaccine. 2023;41 Suppl 1:A2-A11.
PubMed Abstract available

KALKOWSKA DA, Pallansch MA, Wassilak SGF, Cochi SL, et al
Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
Vaccine. 2023;41 Suppl 1:A136-A141.
PubMed Abstract available

KALKOWSKA DA, Voorman A, Pallansch MA, Wassilak SGF, et al
The impact of disruptions caused by the COVID-19 pandemic on global polio eradication.
Vaccine. 2023;41 Suppl 1:A12-A18.
PubMed Abstract available

PAYNE JR, Bose S, Kubiak RW, Nolen LD, et al
Evaluation of mortality risk after COVID-19 vaccination, Utah 2021.
Vaccine. 2023 Apr 5:S0264-410X(23)00380-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BRAEYE T, Catteau L, Brondeel R, van Loenhout JAF, et al
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021-2022.
Vaccine. 2023 Apr 5:S0264-410X(23)00376-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM H, Cho HK, Kang YM, Sagong M, et al
Protective efficacy of a bivalent H5 influenza vaccine candidate against both clades 2.3.2.1 and 2.3.4.4 high pathogenic avian influenza viruses in SPF chickens.
Vaccine. 2023 Apr 4:S0264-410X(23)00311-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PRADA E, Langbecker A, Catalan-Matamoros D
Public discourse and debate about vaccines in the midst of the covid-19 pandemic: A qualitative content analysis of Twitter.
Vaccine. 2023 Apr 4:S0264-410X(23)00375-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FRODLUND M, Nived P, Chatzidionysiou A, Sodergren A, et al
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA).
Vaccine. 2023 Apr 4:S0264-410X(23)00372-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TOSHKOV D
What accounts for the variation in COVID-19 vaccine hesitancy in Eastern, Southern and Western Europe?
Vaccine. 2023 Apr 4:S0264-410X(23)00314-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALI Y, Piche-Renaud PP, Karimi-Shahrbabak E, Farrar DS, et al
Pediatricians' perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada.
Vaccine. 2023 Apr 3:S0264-410X(23)00335-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

URQUIDI C, Santelices E, Lagomarcino AJ, Teresa Valenzuela M, et al
The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study.
Vaccine. 2023 Apr 3:S0264-410X(23)00354-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MAQUILING A, Jeevakanthan A, Ho Mi Fane B
The effect of vaccine mandate announcements on vaccine uptake in Canada: An interrupted time series analysis.
Vaccine. 2023 Apr 3:S0264-410X(23)00334-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CRIADO MF, Kassa A, Bertran K, Kwon JH, et al
Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses.
Vaccine. 2023 Apr 1:S0264-410X(23)00349-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LYTRAS T, Athanasiadou M, Demetriou A, Stylianou D, et al
Lack of association between vaccination rates and excess mortality in Cyprus during the COVID-19 pandemic.
Vaccine. 2023 Apr 1:S0264-410X(23)00316-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

March 2023

XU S, Zhang B, Yao J, Ruan W, et al
A new H9 influenza virus mRNA vaccine elicits robust protective immunity against infection.
Vaccine. 2023 Mar 31:S0264-410X(23)00343-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DATAR RS, Fette LM, Hinkelman AN, Hammershaimb EA, et al
Factors associated with COVID-19 vaccination during June-October 2021: A multi-site prospective study.
Vaccine. 2023 Mar 31:S0264-410X(23)00352-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HU Y, Wang Y, Shao T, Tang W, et al
Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes.
Vaccine. 2023 Mar 30:S0264-410X(23)00350-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FUKUDA H, Maeda M, Murata F
Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study.
Vaccine. 2023 Mar 29:S0264-410X(23)00353-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SU WJ, Arnold Chan K, Chuang JH, Wang TA, et al
Acute reactions after a homologous primary COVID-19 vaccination series: Analysis of Taiwan V-Watch data.
Vaccine. 2023 Mar 28:S0264-410X(23)00336-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SANTI LAURINI G, Montanaro N, Broccoli M, Bonaldo G, et al
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database.
Vaccine. 2023 Mar 28:S0264-410X(23)00348-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GIDENGIL CA, Parker AM, Markowitz LE, Gedlinske AM, et al
Health care provider knowledge around shared clinical decision-making regarding HPV vaccination of adults aged 27-45 years in the United States.
Vaccine. 2023 Mar 27:S0264-410X(23)00186-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HU B, Yang W, Bouanchaud P, Chongo Y, et al
Determinants of COVID-19 vaccine acceptance in Mozambique: The role of institutional trust.
Vaccine. 2023 Mar 27:S0264-410X(23)00347-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KANG SW, Park H, Yeun Kim J, Bae JY, et al
Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study.
Vaccine. 2023 Mar 27:S0264-410X(23)00339-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CESUR F, Atasever Z, Ozoran Y
Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial.
Vaccine. 2023 Mar 27:S0264-410X(23)00341-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUGOVICH AM, Cox TH, Weeda ER, Garner SS, et al
First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic.
Vaccine. 2023 Mar 27:S0264-410X(23)00333-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PANNUS P, Depickere S, Kemlin D, Georges D, et al
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naive nursing home residents and healthy adults.
Vaccine. 2023 Mar 27:S0264-410X(23)00340-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CIAPPONI A, Berrueta M, P K Parker E, Bardach A, et al
Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis.
Vaccine. 2023 Mar 27:S0264-410X(23)00332-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VAN KESSEL R, Forman R, Milstein R, Mastylak A, et al
Divergent COVID-19 vaccine policies: Policy mapping of ten European countries.
Vaccine. 2023 Mar 22:S0264-410X(23)00320-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANG J, Huo X, Jiang Q, Liao Y, et al
Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques.
Vaccine. 2023 Mar 21:S0264-410X(23)00317-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PHOOLCHAROEN W, Shanmugaraj B, Khorattanakulchai N, Sunyakumthorn P, et al
Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant.
Vaccine. 2023 Mar 21:S0264-410X(23)00312-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SATO R
Vaccine hesitancy against COVID-19 vaccine over time in Nigeria.
Vaccine. 2023 Mar 21:S0264-410X(23)00313-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ATMAR RL, Bernstein DI, Winokur P, Frey SE, et al
Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trial.
Vaccine. 2023 Mar 18:S0264-410X(23)00285-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHEN AK, Browne S, Srivastava T, Kornides ML, et al
Trusted messengers and trusted messages: The role for community-based organizations in promoting COVID-19 and routine immunizations.
Vaccine. 2023;41:1994-2002.
PubMed Abstract available

PEREZ MA, Hsiao HM, Chen X, Kunkel A, et al
Serologic responses to COVID-19 vaccination in children with history of multisystem inflammatory syndrome (MIS-C).
Vaccine. 2023 Mar 15:S0264-410X(23)00283-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIN JH, Huang YT, Yu JC, Chan KA, et al
Mediation and instrumental variable analyses for vaccine-induced antibody titer against influenza B.
Vaccine. 2023 Mar 14:S0264-410X(23)00261-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LAMUDA PA, Azar A, Taylor BG, Balawajder EF, et al
Latent class analysis of medical mistrust and COVID-19 vaccine hesitancy among adults in the United States just prior to FDA emergency use authorization.
Vaccine. 2023 Mar 13:S0264-410X(23)00263-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KELLY D, O'Donnell K, Marron L, Dwyer R, et al
Immunocompromise among vaccinated versus unvaccinated COVID-19 cases admitted to critical care in Ireland, July to October 2021.
Vaccine. 2023 Mar 13:S0264-410X(23)00258-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KWAK HW, Park HJ, Jung SY, Oh EY, et al
Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants.
Vaccine. 2023;41:1892-1901.
PubMed Abstract available

LIU YC, Munoz FM, Izurieta HS, Tamborska AA, et al
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2023;41:1902-1910.
PubMed Abstract available

SRIVASTAV A, Lu PJ, Amaya A, Dever JA, et al
Prevalence of influenza-specific vaccination hesitancy among adults in the United States, 2018.
Vaccine. 2023 Mar 10:S0264-410X(23)00255-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SANCHEZ L, Nakama T, Nagai H, Matsuoka O, et al
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults >/= 60 years of age: Results from a phase III, randomized clinical trial.
Vaccine. 2023 Mar 9:S0264-410X(23)00225-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PLUMB ID, Fette LM, Tjaden AH, Feldstein L, et al
Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.
Vaccine. 2023 Mar 9:S0264-410X(23)00253-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

IKEWAKI N, Kurosawa G, Levy GA, Preethy S, et al
Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management.
Vaccine. 2023 Mar 8:S0264-410X(23)00252-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HART RJ, Baumer-Mouradian S, Bone JN, Olson P, et al
Factors associated with US caregivers' uptake of pediatric COVID-19 vaccine by race and ethnicity.
Vaccine. 2023 Mar 6:S0264-410X(23)00242-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAEK YJ, Kim WJ, Ko JH, Lee YJ, et al
A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen.
Vaccine. 2023;41:1694-1702.
PubMed Abstract available

GRIGNOLIO CORSINI A, Zagarella RM, Adamo M, Caporale C, et al
From COVID-19 vaccine candidates to compulsory vaccination: The attitudes of Italian citizens in the key 7-month of vaccination campaign.
Vaccine. 2023 Mar 3:S0264-410X(23)00243-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ESTEPHAN L, Liu LT, Lien CE, Smith ER, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine.
Vaccine. 2023 Mar 3:S0264-410X(23)00245-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

XIE S, Monteiro K, Gjelsvik A
The association between maternal influenza vaccination during pregnancy and adverse birth outcomes in the United States: Pregnancy risk Assessment Monitoring System (PRAMS).
Vaccine. 2023 Mar 2:S0264-410X(23)00228-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LUDWIKOWSKA KM, Popiel A, Matkowska-Kocjan A, Olbromski MJ, et al
COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study.
Vaccine. 2023 Mar 2:S0264-410X(23)00227-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HURSTAK EE, Paasche-Orlow MK, Hahn EA, Henault LE, et al
The mediating effect of health literacy on COVID-19 vaccine confidence among a diverse sample of urban adults in Boston and Chicago.
Vaccine. 2023 Mar 2:S0264-410X(23)00202-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GOLDMAN RD, Hart RJ, Bone JN, Seiler M, et al
Willingness to vaccinate children against COVID-19 declined during the pandemic.
Vaccine. 2023 Mar 2:S0264-410X(23)00223-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NA L, Banks S, Wang PP
Racial and ethnic disparities in COVID-19 vaccine uptake: A mediation framework.
Vaccine. 2023 Mar 1:S0264-410X(23)00241-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

February 2023

MALTEZOU HC, Hatziantoniou S, Theodoridou K, Vasileiou K, et al
Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance.
Vaccine. 2023 Feb 27:S0264-410X(23)00221-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TAMANDJOU TCHUEM CR, Auvigne V, Vaux S, Montagnat C, et al
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.
Vaccine. 2023 Feb 27:S0264-410X(23)00216-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

O'KENNEDY MM, Abolnik C, Smith T, Motlou T, et al
Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits.
Vaccine. 2023 Feb 27:S0264-410X(23)00185-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ITAMOCHI M, Yazawa S, Inasaki N, Saga Y, et al
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort.
Vaccine. 2023 Feb 27:S0264-410X(23)00222-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GETANEH AM, Li X, Mao Z, Johannesen CK, et al
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries.
Vaccine. 2023;41:1623-1631.
PubMed Abstract available

FEITSMA EA, Janssen YF, Boersma HH, van Sleen Y, et al
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452.
Vaccine. 2023 Feb 23:S0264-410X(23)00200-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KABIR SULAIMAN S, Sale Musa M, Isma'il Tsiga-Ahmed F, Muhammad Dayyab F, et al
COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons.
Vaccine. 2023 Feb 23:S0264-410X(23)00199-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CANNON K, Cardona JF, Yacisin K, Thompson A, et al
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial.
Vaccine. 2023 Feb 22:S0264-410X(22)01459-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MOORE KA, Leighton T, Ostrowsky JT, Anderson CJ, et al
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy.
Vaccine. 2023 Feb 21:S0264-410X(23)00167-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZHANG H, Chen L, Huang Z, Li D, et al
The effects of parent's health literacy and health beliefs on vaccine hesitancy.
Vaccine. 2023 Feb 21:S0264-410X(23)00161-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAMBURG M, Poland GA
The time is now for committed and comprehensive action to attain more broadly protective coronavirus vaccines: The coronavirus vaccines R&D roadmap.
Vaccine. 2023 Feb 21:S0264-410X(23)00196-2. doi: 10.1016/j.vaccine.2023.
PubMed

MOTTA M, Callaghan T, Lunz-Trujillo K, Lockman A, et al
Erroneous Consonance. How inaccurate beliefs about physician opinion influence COVID-19 vaccine hesitancy.
Vaccine. 2023 Feb 20:S0264-410X(23)00195-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

USTYUGOVA IV, Pougatcheva S, Farrell T, Strugnell T, et al
AF03 adjuvant improves anti-hemagglutinin and anti-neuraminidase immune responses induced by licensed seasonal quadrivalent influenza vaccines in mice.
Vaccine. 2023 Feb 18:S0264-410X(23)00169-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GEOGHEGAN S, Acosta F, Stephens LC, Gillan H, et al
Maternity care provider acceptance of a future Group B Streptococcus vaccine - A qualitative study in three countries.
Vaccine. 2023 Feb 18:S0264-410X(23)00172-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FORD A, Hwang A, Mo AX, Baqar S, et al
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.
Vaccine. 2023 Feb 18:S0264-410X(23)00163-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUDLEY MZ, Gerber JE, Budigan Ni H, Blunt M, et al
Vaccinomics: A scoping review.
Vaccine. 2023 Feb 18:S0264-410X(23)00135-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RANADE D, Jena R, Patil K, Dogar V, et al
A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent).
Vaccine. 2023 Feb 17:S0264-410X(23)00174-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PARODI A, Martini M
History of vaccine and immunization: Vaccine-hesitancy discussion in Germany in XIX century.
Vaccine. 2023 Feb 17:S0264-410X(23)00164-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MEYER C, Goffe L, Antonopoulou V, Graham F, et al
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England.
Vaccine. 2023 Feb 17:S0264-410X(23)00182-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MORAIS A, Morais J, Felix M, Neto Z, et al
Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019-2020.
Vaccine. 2023 Feb 17:S0264-410X(23)00170-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZIMMERMANN BM, Paul KT, Araujo ER, Buyx A, et al
The social and socio-political embeddedness of COVID-19 vaccination decision-making: A five-country qualitative interview study from Europe.
Vaccine. 2023 Feb 16:S0264-410X(23)00139-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BENEDICT KPOZEHOUEN E, Arrudsivah B, Raina Macintyre C
Knowledge, attitudes and practices of health care workers in a cardiology department on influenza vaccination.
Vaccine. 2023 Feb 15:S0264-410X(23)00112-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CAMPMAN SL, van Rossem G, Boyd A, Coyer L, et al
Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study.
Vaccine. 2023 Feb 13:S0264-410X(23)00165-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BARNES K, Faasse K, Colagiuri B
The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample.
Vaccine. 2023 Feb 13:S0264-410X(23)00158-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SAELEE R, Chandra Murthy N, Patel Murthy B, Zell E, et al
Minority Health Social Vulnerability Index and COVID-19 vaccination coverage - The United States, December 14, 2020-January 31, 2022.
Vaccine. 2023 Feb 13:S0264-410X(23)00157-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WANKHEDE D, Grover S, Hofman P
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis.
Vaccine. 2023 Feb 13:S0264-410X(23)00115-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AFREH OK, Angwaawie P, Attivor E, Boateng LA, et al
Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana.
Vaccine. 2023 Feb 13:S0264-410X(23)00159-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FACCHIN G, Bella A, Del Manso M, Rota MC, et al
Decline in reported measles cases in Italy in the COVID-19 era, January 2020 - July 2022: The need to prevent a resurgence upon lifting non-pharmaceutical pandemic measures.
Vaccine. 2023;41:1286-1289.
PubMed Abstract available

SELL H, Raj Paudel Y, Voaklander D, MacDonald SE, et al
School immunization coverage in adolescents during the COVID-19 pandemic: A retrospective cohort study.
Vaccine. 2023;41:1333-1341.
PubMed Abstract available

DE VRIES M, Claassen L, Lambooij MS, Timen A, et al
Did the temporary suspension of Vaxzveria vaccinations influence COVID-19 vaccination intentions, vaccination perceptions and trust in the vaccination campaign? A repeated survey study in the Netherlands.
Vaccine. 2023 Feb 10:S0264-410X(23)00138-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HOSAIN R, Aquino P, Baccarini C, Smolenov I, et al
Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study.
Vaccine. 2023 Feb 10:S0264-410X(23)00144-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHEN AK, Browne S, Srivastava T, Kornides ML, et al
Persuading the "Movable Middle": Characteristics of effective messages to promote routine and COVID-19 vaccinations for adults and children - The impact of COVID-19 on beliefs and attitudes.
Vaccine. 2023 Feb 9:S0264-410X(23)00141-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SILVA VASCONCELOS G, da Conceicao Rodrigues Fernandes M, Cardoso Matsui T, Claudia Dos Santos Luciano M, et al
Persistent SARS-COV-2 infection in vaccinated individual with three doses of COVID-19 vaccine.
Vaccine. 2023 Feb 9:S0264-410X(23)00145-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BUNTINX E, Brochado L, Borja-Tabora C, Yu CY, et al
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naive and exposed individuals in a phase 2/3, double-blind, randomized study.
Vaccine. 2023 Feb 9:S0264-410X(23)00143-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FEIKIN DR, Higdon MM, Andrews N, Collie S, et al
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization.
Vaccine. 2023 Feb 9:S0264-410X(23)00146-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BUGHIN J, Cincera M, Peters K, Reykowska D, et al
Make it or break it: On-time vaccination intent at the time of Covid-19.
Vaccine. 2023 Feb 8:S0264-410X(23)00140-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WATANABE A, Iwagami M, Yasuhara J, Takagi H, et al
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis.
Vaccine. 2023 Feb 8:S0264-410X(23)00134-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FELL DB, Torok E, Sprague AE, Regan AK, et al
Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study.
Vaccine. 2023 Feb 3:S0264-410X(23)00114-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HASSAN RAZA S, Yousaf M, Zaman U, Waheed Khan S, et al
Unlocking infodemics and mysteries in COVID-19 vaccine hesitancy: Nexus of conspiracy beliefs, digital informational support, psychological Well-being, and religious fatalism.
Vaccine. 2023 Feb 3:S0264-410X(23)00079-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LI R, Liu H, Fairley CK, Ong JJ, et al
mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia.
Vaccine. 2023 Feb 3:S0264-410X(23)00126-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MALTEZOU HC, Basoulis D, Bonelis K, Gamaletsou MN, et al
Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece.
Vaccine. 2023 Feb 2:S0264-410X(23)00109-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAMADA H, Futamura M, Ito H, Yamamoto R, et al
Association of a third vaccination with antibody levels and side reactions in essential workers: A prospective cohort study.
Vaccine. 2023 Feb 1:S0264-410X(23)00082-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JOHNSON R, Djaafara B, Haw D, Doohan P, et al
The societal value of SARS-CoV-2 booster vaccination in Indonesia.
Vaccine. 2023 Feb 1:S0264-410X(23)00110-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ANDREJKO KL, Myers JF, Fukui N, Nelson L, et al
Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: A registry-linkage study.
Vaccine. 2023 Feb 1:S0264-410X(23)00108-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

January 2023

UWAMINO Y, Yokoyama T, Sato Y, Shibata A, et al
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine.
Vaccine. 2023 Jan 31:S0264-410X(23)00081-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GRESSENS SB, Wiedemann A, Dechenaud M, Dupuis J, et al
Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies.
Vaccine. 2023 Jan 30:S0264-410X(23)00095-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MATTA MG, Pulido L, Herrera-Paz JJ, Picco JM, et al
Influenza and pneumococcal vaccine prescription for adults during COVID-19 first wave in three regions of Argentina.
Vaccine. 2023 Jan 27:S0264-410X(23)00088-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RODRIGUEZ-APONTE SA, Dalvie NC, Wong TY, Johnston RS, et al
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants.
Vaccine. 2023;41:1108-1118.
PubMed Abstract available

PARODI JB, Indavere A, Bobadilla Jacob P, Toledo GC, et al
Impact of COVID-19 vaccination in post-COVID cardiac complications.
Vaccine. 2023 Jan 27:S0264-410X(23)00084-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HARBIN A, Laventhal N, Navin M
Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19.
Vaccine. 2023 Jan 27:S0264-410X(23)00087-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KRAUSE NM, Beets B, Howell EL, Tosteson H, et al
Collateral damage from debunking mRNA vaccine misinformation.
Vaccine. 2023;41:922-929.
PubMed Abstract available

RENNERT W, Hindiyeh M, Allahham M, Mercer LD, et al
Introducing ROTAVAC(R) to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition.
Vaccine. 2023;41:945-954.
PubMed Abstract available

KUZEL TG, Fu J, Anderson M, Stec M, et al
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naive and previously-infected individuals.
Vaccine. 2023;41:879-882.
PubMed Abstract available

FAIZULOEV E, Gracheva A, Korchevaya E, Smirnova D, et al
Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity.
Vaccine. 2023;41:892-902.
PubMed Abstract available

MYERS TR, Marquez PL, Gee JM, Hause AM, et al
The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC's COVID-19 pandemic response.
Vaccine. 2023 Jan 23:S0264-410X(22)01545-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

VATCHARAVONGVAN P, Boonyanitchayakul N, Khampachuea P, Sinturong I, et al
Health Belief Model and parents' acceptance of the Pfizer-BioNTech and Sinopharm COVID-19 vaccine for children aged 5-18 years Old: A national survey.
Vaccine. 2023 Jan 23:S0264-410X(23)00050-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TENG Y, Hanibuchi T, Machida M, Nakaya T, et al
Psychological determinants of COVID-19 vaccine acceptance: A comparison between immigrants and the host population in Japan.
Vaccine. 2023 Jan 23:S0264-410X(23)00056-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZOLOTAROVA T, Dussault C, Park H, Varsaneux O, et al
Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: The EDUCATE study.
Vaccine. 2023 Jan 23:S0264-410X(23)00061-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GROSSMAN-GIRON A, Tzur Bitan D, Shemesh S, Mayer Y, et al
COVID-19 vaccine hesitancy scale and its association with actual COVID-19 vaccine uptake in Israel.
Vaccine. 2023 Jan 23:S0264-410X(23)00065-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MALLAH SI, Alawadhi A, Jawad J, Wasif P, et al
Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals.
Vaccine. 2023 Jan 23:S0264-410X(23)00053-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

STRATHDEE SA, Abramovitz D, Vera CF, Artamonova I, et al
Predictors of COVID-19 vaccine uptake among people who inject drugs.
Vaccine. 2023 Jan 23:S0264-410X(23)00063-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KRAMER C, Song M, Sufrin CB, Eber GB, et al
COVID-19 vaccination hesitancy and uptake: Perspectives from people released from the Federal Bureau of Prisons.
Vaccine. 2023 Jan 21:S0264-410X(23)00060-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DARBY B, Alexander V, Murphy J
SARS-CoV-2 vaccine breakthrough infections in Virginia, January 17, 2021 - June 30, 2021.
Vaccine. 2023 Jan 20:S0264-410X(23)00062-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BIANCHI FP, Stefanizzi P, Martinelli A, Brescia N, et al
COVID-19 vaccination hesitancy in people affected by diabetes and strategies to increase vaccine compliance: A systematic narrative review and meta-analysis.
Vaccine. 2023 Jan 20:S0264-410X(23)00058-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUDLEY MZ, Schuh HB, Shaw J, Rimal RN, et al
COVID-19 vaccination among different types of US Healthcare Personnel.
Vaccine. 2023 Jan 20:S0264-410X(23)00051-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GHORBANI A, Ngunjiri JM, Edward C Abundo M, Pantin-Jackwood M, et al
Development of in Ovo-Compatible NS1-truncated live attenuated influenza vaccines by modulation of hemagglutinin cleavage and polymerase Acidic X Frameshifting sites.
Vaccine. 2023 Jan 18:S0264-410X(23)00029-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOINI A, Rabiei M, Pirjani R, Abiri A, et al
COVIDâ€‘19 vaccine hesitancy among pregnant women and their reported reasons for vaccine refusal - A prospective study in Tehran, Iran.
Vaccine. 2023 Jan 16:S0264-410X(23)00032-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BEDSTON S, Lowthian E, Jarvis CI, Akbari A, et al
COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study.
Vaccine. 2023 Jan 13:S0264-410X(23)00034-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANG H, Li Z, Zhang R, Guo S, et al
Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac(R)) among population aged 3 years and older in a large-scale use: A multi-center open-label study in China.
Vaccine. 2023 Jan 13:S0264-410X(23)00031-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KALRA S, Kalra D, Grafova I, Rubin JS, et al
Association of death or illness from COVID-19 among family and friends on vaccine uptake within four months of the Emergency Use Authorization. Findings from a national survey in the United States.
Vaccine. 2023 Jan 13:S0264-410X(23)00035-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KLUWER B, Margrethe Rydland K, Nybru Gleditsch R, Mamelund SE, et al
Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21.
Vaccine. 2023 Jan 11:S0264-410X(23)00013-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ELLISON TJ, Talbott GC, Henderson DR
Intradermal delivery of a quadrivalent cell-based seasonal influenza vaccine using an adjuvanted skin patch vaccination platform.
Vaccine. 2023;41:304-314.
PubMed Abstract available

ASLAM J, Khan FS, Talha Haris M, Hewadmal H, et al
Prior immunization status of COVID-19 patients and disease severity: A multicenter retrospective cohort study assessing the different types of immunity.
Vaccine. 2023;41:598-605.
PubMed

MOELLER-ARENDT M, van de Witte S, Nauta J, de Voogd H, et al
Enhanced passive safety surveillance of Influvac(R) and Influvac(R) Tetra: Results from seven consecutive seasons.
Vaccine. 2023;41:606-613.
PubMed Abstract available

KEVIN YIN J, Harris RC, Loiacono MM, Chit A, et al
Letter to editor regarding a review of MF59-adjuvanted influenza vaccine by Gartner et al.
Vaccine. 2023 Jan 9:S0264-410X(22)01559-6. doi: 10.1016/j.vaccine.2022.
PubMed

MORO PL, Zhang B, Ennulat C, Harris M, et al
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022.
Vaccine. 2023 Jan 9:S0264-410X(23)00016-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WHITEHEAD HS, French CE, Caldwell DM, Letley L, et al
A systematic review of communication interventions for countering vaccine misinformation.
Vaccine. 2023 Jan 9:S0264-410X(22)01593-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WAGNER AL, Moniz MH, Stout MJ, Townsel C, et al
Experiences, risk perceptions, and COVID-19 vaccination outcomes among hospital workers.
Vaccine. 2023 Jan 9:S0264-410X(23)00012-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MENON I, Kang SM, Braz Gomes K, Uddin MN, et al
Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response.
Vaccine. 2023 Jan 9:S0264-410X(23)00002-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHAWANPAIBOON S, Anuwutnawin S, Kanjanapongporn A, Pooliam J, et al
Breastfeeding women's attitudes towards and acceptance and rejection of COVID-19 vaccination: Implementation research.
Vaccine. 2023 Jan 9:S0264-410X(23)00015-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TULLOCH JSP, Lawrenson K, Gordon AL, Ghebrehewet S, et al
COVID-19 vaccine hesitancy in care home staff: A survey of Liverpool care homes.
Vaccine. 2023 Jan 9:S0264-410X(23)00009-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LONG Z, He J, Shuai Q, Zhang K, et al
Influenza vaccination-induced H3 stalk-reactive memory B-cell clone expansion.
Vaccine. 2023 Jan 6:S0264-410X(22)01603-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

EBRAHIMI N, Mazdak M, Shaygannejad V, Mirmosayyeb O, et al
CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: A case series.
Vaccine. 2023 Jan 6:S0264-410X(23)00004-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JANG Y, Cho H, Chun J, Park K, et al
Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice.
Vaccine. 2023 Jan 6:S0264-410X(22)01602-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TSUCHIYA Y, Tamura H, Fujii K, Numaguchi H, et al
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S: Results of a phase 1, randomized, double-blind, placebo-controlled COVID-19 vaccine trial in Japan.
Vaccine. 2023 Jan 5:S0264-410X(23)00006-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TORALES J, Cuenca-Torres O, Barrios L, Armoa-Garcia L, et al
An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay.
Vaccine. 2023;41:109-118.
PubMed Abstract available

MAERTZDORF KM, Rietman ML, Lambooij MS, Verschuren WMM, et al
Willingness to get vaccinated against influenza, pneumococcal disease, pertussis, and herpes zoster - A pre-COVID-19 exploration among the older adult population.
Vaccine. 2023 Jan 4:S0264-410X(23)00001-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAGGA S, Krishnan A, Dar L
Revisiting live attenuated influenza vaccine efficacy among children in developing countries.
Vaccine. 2023 Jan 3:S0264-410X(22)01594-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

REGO RT, Kenney B, Ngugi AK, Espira L, et al
COVID-19 vaccination refusal trends in Kenya over 2021.
Vaccine. 2023 Jan 3:S0264-410X(22)01601-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SHOOK NJ, Oosterhoff B, Sevi B
A longitudinal assessment of variability in COVID-19 vaccine hesitancy and psychosocial correlates in a national United States sample.
Vaccine. 2023 Jan 2:S0264-410X(22)01600-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

FORD JS, Rouleau SG, Wagner JL, Adams CB, et al
Assessment of a COVID-19 vaccination protocol for unhoused patients in the emergency department.
Vaccine. 2023 Jan 2:S0264-410X(22)01598-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

December 2022

GAMBLE A, Hastings TJ, Westrick SC, Smith M, et al
COVID-19 booster vaccination in rural community pharmacies.
Vaccine. 2022 Dec 26:S0264-410X(22)01576-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

XIE Z, Hamadi HY, Mainous AG, Hong YR, et al
Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity.
Vaccine. 2022 Dec 23:S0264-410X(22)01568-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ANDREJKO KL, Myers JF, Openshaw J, Fukui N, et al
Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season.
Vaccine. 2022 Dec 23:S0264-410X(22)01578-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SAIAG E, Alcalay Y, Marudi O, Orr-Urtreger A, et al
Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older.
Vaccine. 2022 Dec 21:S0264-410X(22)01560-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WAND O, Breslavsky A, Bar-Shai A, Levy C, et al
One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine.
Vaccine. 2022 Dec 21:S0264-410X(22)01567-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

XU S, Huang R, Sy LS, Hong V, et al
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination.
Vaccine. 2022 Dec 20:S0264-410X(22)01561-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

RANE MS, Robertson MM, Kulkarni SG, Frogel D, et al
Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting.
Vaccine. 2022 Dec 20:S0264-410X(22)01564-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WILLIAMS KV, Moehling Geffel K, Alcorn JF, Patricia Nowalk M, et al
Factors associated with humoral immune response in older adults who received egg-free influenza vaccine.
Vaccine. 2022 Dec 19:S0264-410X(22)01566-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

DUDLEY MZ, Barnett EE, Paulenich A, Omer SB, et al
Characterization of parental intention to vaccinate elementary school aged children in the state of California.
Vaccine. 2022 Dec 19:S0264-410X(22)01544-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BOISSON A, Morgan CE, Stover A, Ngimbi P, et al
Changes in hepatitis B vaccine perception in response to the COVID-19 pandemic: Development of the Shift in vaccine confidence (SVC) survey tool.
Vaccine. 2022 Dec 16:S0264-410X(22)01542-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

YIH WK, Daley MF, Duffy J, Fireman B, et al
A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink.
Vaccine. 2022 Dec 16:S0264-410X(22)01541-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SONOYAMA T, Iwata S, Shinkai M, Iwata-Yoshikawa N, et al
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults.
Vaccine. 2022 Dec 16:S0264-410X(22)01540-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

PAPAZACHARIOU A, Tsioutis C, Lytras T, Malikides O, et al
The impact of seasonal influenza vaccination uptake on COVID-19 vaccination attitudes in a rural area in Greece.
Vaccine. 2022 Dec 15:S0264-410X(22)01539-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

VAUX S, Fonteneau L, Pefau M, Venier AG, et al
Vaccination against influenza, measles, pertussis and varicella in workers in healthcare facilities in France: A national cross-sectional study in 2019.
Vaccine. 2022 Dec 15:S0264-410X(22)01537-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CHEN L, Levine MZ, Zhou S, Bai T, et al
Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza.
Vaccine. 2022 Dec 14:S0264-410X(22)01468-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

OHNO M, Sagata M, Sekiya T, Nomura N, et al
Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques.
Vaccine. 2022 Dec 14:S0264-410X(22)01534-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

IBROCI E, Liu X, Lieb W, Jessel R, et al
Impact of prenatal COVID-19 vaccination on delivery and neonatal outcomes: Results from a New York City cohort.
Vaccine. 2022 Dec 14:S0264-410X(22)01226-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SAINI SJ, Carle AC, Forsyth AR, Chi DL, et al
Association between caregiver opposition to topical fluoride and COVID-19 vaccines.
Vaccine. 2022 Dec 14:S0264-410X(22)01532-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SALVATORE PP, Lee CC, Sleweon S, McCormick DW, et al
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021.
Vaccine. 2022 Dec 13:S0264-410X(22)01458-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CHIBA S, Hatta M, Pattinson D, Yasuhara A, et al
Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses.
Vaccine. 2022 Dec 12:S0264-410X(22)01518-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CHO BH, Athar HM, Bates LG, Yarnoff BO, et al
Patient flow time data of COVID-19 vaccination clinics in 23 sites, United States, April and May 2021.
Vaccine. 2022 Dec 12:S0264-410X(22)01527-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TADDIO A, Ilersich ANT, Bucci L, McMurtry CM, et al
Letting kids play their CARDs (Comfort, Ask, Relax, Distract) to help cope with needle-related fear and pain: Results from user testing.
Vaccine. 2022;40:7667-7675.
PubMed Abstract available

HALL PA, Meng G, Boudreau C, Hudson A, et al
Social cognitive predictors of vaccination status, uptake and mitigation behaviors in the Canadian COVID-19 Experiences survey.
Vaccine. 2022 Dec 12:S0264-410X(22)01526-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CUDDIHY MT, Berger WL, Cummings PL, Keith R, et al
An organizational assessment of 101 Community-Based Adult Services centers to identify and address gaps in influenza vaccination among Medicare-Medicaid beneficiaries.
Vaccine. 2022 Dec 10:S0264-410X(22)01490-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

PEPIN S, Samson SI, Alvarez FP, Dupuy M, et al
Corrigendum to "Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III trial in the northern and southern Hemispheres" [Vaccin
Vaccine. 2022 Dec 9:S0264-410X(22)01483-9. doi: 10.1016/j.vaccine.2022.
PubMed

FERNANDES NEHAB M, Goncalves Camacho K, Teixeira Reis A, Junqueira-Marinho MF, et al
Willingness of Brazilian caregivers in having their children and adolescents vaccinated against Covid-19.
Vaccine. 2022 Dec 9:S0264-410X(22)01520-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ANDERSON-CHAVARRIA M, Turner J
Searching for the 'Trigger': An ethnographic analysis of parental beliefs regarding autism causation and vaccination in Puerto Rico.
Vaccine. 2022 Dec 7:S0264-410X(22)01488-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

LATKIN C, Dayton L, Miller J, Eschliman E, et al
Trusted information sources in the early months of the COVID-19 pandemic predict vaccination uptake over one year later.
Vaccine. 2022 Dec 6:S0264-410X(22)01510-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SERISIER A, Beale S, Boukari Y, Hoskins S, et al
A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and Wales.
Vaccine. 2022 Dec 5:S0264-410X(22)01497-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

IWAI-SAITO K, Sato K, Kondo K
Associations of influenza and pneumococcal vaccinations with burdens of older family caregivers: The Japan Gerontological Evaluation study (JAGES) cross-sectional study.
Vaccine. 2022 Dec 2:S0264-410X(22)01460-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CASPERSEN IH, Juvet LK, Feiring B, Laake I, et al
Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway.
Vaccine. 2022 Dec 2:S0264-410X(22)01492-X. doi: 10.1016/j.vaccine.2022.
PubMed

STOLIAROFF-PEPIN A, Peine C, Herath T, Lachmann J, et al
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022.
Vaccine. 2022 Dec 2:S0264-410X(22)01489-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

AL-KASSAB-CORDOVA A, Silva-Perez C, Mendez-Guerra C, Sangster-Carrasco L, et al
Inequalities in infant vaccination coverage during the COVID-19 pandemic: A population-based study in Peru.
Vaccine. 2022 Dec 2:S0264-410X(22)01491-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

INGRAM C, Roe M, Downey V, Phipps L, et al
Exploring key informants' perceptions of Covid-19 vaccine hesitancy in a disadvantaged urban community in Ireland: Emergence of a '4Cs' model.
Vaccine. 2022 Dec 2:S0264-410X(22)01496-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

UTTEKAR S, MacDonald N, Orenstein WA, Danchin M, et al
Empowering Health Workers to Build Public Trust in Vaccination: Experience from the International Pediatric Association's Online Vaccine Trust Course, 2020-2021.
Vaccine. 2022 Dec 2:S0264-410X(22)01485-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BENDER FL, Rief W, Wilhelm M
Really just a little prick? A meta-analysis on adverse events in placebo control groups of seasonal influenza vaccination RCTs.
Vaccine. 2022 Dec 1:S0264-410X(22)01431-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WONG HL, Tworkoski E, Ke Zhou C, Hu M, et al
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older.
Vaccine. 2022 Dec 1:S0264-410X(22)01493-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

November 2022

SUN Y, Huang SK, Arlikatti S, Lindell MK, et al
What attributes influence rural household's willingness to get vaccinated for COVID-19? Perspectives from six Chinese townships.
Vaccine. 2022 Nov 29:S0264-410X(22)01487-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TANG S, Liu X, Jia Y, Chen H, et al
Education level modifies parental hesitancy about COVID-19 vaccinations for their children.
Vaccine. 2022 Nov 29:S0264-410X(22)01484-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CHRISTOU-ERGOS M, Wiley KE, Leask J
Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Vaccine. 2022 Nov 26:S0264-410X(22)01447-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MICHELLE DRIEDGER S, Capurro G, Tustin J, Jardine CG, et al
"I won't be a guinea pig": Rethinking public health communication and vaccine hesitancy in the context of COVID-19.
Vaccine. 2022 Nov 25:S0264-410X(22)01469-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

STOCKER A, Hoffmann J, Mause L, Neufeind J, et al
What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector.
Vaccine. 2022 Nov 25:S0264-410X(22)01466-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ZARZECZNA N, Bertlich T, Veckalov B, Rutjens BT, et al
Spirituality is associated with Covid-19 vaccination scepticism.
Vaccine. 2022 Nov 25:S0264-410X(22)01463-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

RADER B, Chiang ME, Kriner DL, Weintraub RL, et al
Persistent drop in confidence following US recommended pause of Ad26.COV2.S vaccine administration.
Vaccine. 2022 Nov 25:S0264-410X(22)01448-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

LIP A, Pateman M, Fullerton MM, Chen HM, et al
Vaccine hesitancy educational tools for healthcare providers and trainees: A scoping review.
Vaccine. 2022 Nov 24:S0264-410X(22)01225-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KATHERINE YIH W, Daley MF, Duffy J, Fireman B, et al
Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink.
Vaccine. 2022 Nov 24:S0264-410X(22)01467-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

HUMBLE RM, Scott SD, Dube E, Olson J, et al
The impact of the COVID-19 pandemic on parents' perceptions and acceptance of routine childhood vaccination in Canada: A national longitudinal study.
Vaccine. 2022 Nov 24:S0264-410X(22)01465-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TANAKA H, Mukai J, Kushibiki K, Mizushima S, et al
Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers.
Vaccine. 2022 Nov 24:S0264-410X(22)01462-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CAETANO C, Morgado ML, Patricio P, Leite A, et al
Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal.
Vaccine. 2022;40:7115-7121.
PubMed Abstract available

KAUFMANN J, DeVoe JE, Angier H, Moreno L, et al
Association of parent influenza vaccination and early childhood vaccinations using linked electronic health record data.
Vaccine. 2022;40:7097-7107.
PubMed Abstract available

HASSAN YAM, Daud Ali M, Al-Eid RR, Al-Ghuraya FA, et al
A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
Vaccine. 2022;40:7087-7096.
PubMed Abstract available

FRANCO C, Herazo-Padilla N, Castaneda JA
A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia.
Vaccine. 2022;40:7073-7086.
PubMed Abstract available

HODGSON D, Koltai M, Krauer F, Flasche S, et al
Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales.
Vaccine. 2022;40:7151-7157.
PubMed Abstract available

ZHOU W, Tang B, Bai Y, Shao Y, et al
The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study.
Vaccine. 2022;40:7141-7150.
PubMed Abstract available

WILLAME C, Dodd C, Duran CE, Elbers R, et al
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study.
Vaccine. 2022 Nov 22:S0264-410X(22)01429-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

OZDARENDELI A, Sezer Z, Pavel STI, Inal A, et al
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.
Vaccine. 2022 Nov 22:S0264-410X(22)01380-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ELICABE RJ, Distel MN, Jofre BL, Leporati M, et al
Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina.
Vaccine. 2022 Nov 21:S0264-410X(22)01416-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

NIQUEUX E, Flodrops M, Allee C, Lebras MO, et al
Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks.
Vaccine. 2022 Nov 18:S0264-410X(22)01398-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

FEKETE M, Horvath A, Santa B, Tomisa G, et al
COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease - A cross-sectional study in Hungary.
Vaccine. 2022 Nov 18:S0264-410X(22)01415-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MCCORMICK DW, Hagan LM, Salvatore PP, Magleby R, et al
SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series.
Vaccine. 2022 Nov 18:S0264-410X(22)01428-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KAHN AL, Steffen CA, Henaff L, MacDonald NE, et al
COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).
Vaccine. 2022 Nov 17:S0264-410X(22)01427-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

PANICKAN S, Bhatia S, Bhat S, Bhandari N, et al
Reverse genetics based H5N2 vaccine provides clinical protection against H5N1, H5N8 and H9N2 avian influenza infection in chickens.
Vaccine. 2022;40:6998-7008.
PubMed Abstract available

ALFANO V, Ercolano S
Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination?
Vaccine. 2022;40:6987-6997.
PubMed Abstract available

TURBYFILL C, Adams K, Tenforde MW, Murray NL, et al
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
Vaccine. 2022;40:6979-6986.
PubMed Abstract available

KULKARNI AV, Jaggaiahgari S, Iyengar S, Simhadri V, et al
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients.
Vaccine. 2022;40:6971-6978.
PubMed Abstract available

HE H, Zhu Y, Jin M, Zhou Y, et al
The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study.
Vaccine. 2022;40:6956-6962.
PubMed Abstract available

ATTWELL K, Rizzi M, Paul KT
Consolidating a research agenda for vaccine mandates.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01384.
PubMed Abstract available

ZIMMERMAN T, Shiroma K, Fleischmann KR, Xie B, et al
Misinformation and COVID-19 vaccine hesitancy.
Vaccine. 2022 Nov 14:S0264-410X(22)01402-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

VANWORMER JJ, Alicea G, Weichelt BP, Berg RL, et al
COVID-19 vaccine coverage disparities in rural and farm children.
Vaccine. 2022 Nov 14:S0264-410X(22)01403-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

FABIANI M, Mateo-Urdiales A, Sacco C, Rota MC, et al
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study.
Vaccine. 2022 Nov 14:S0264-410X(22)01399-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MANANDHAR P, Wannemuehler K, Danovaro-Holliday MC, Nic Lochlainn L, et al
Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01301.
PubMed Abstract available

JACKSON ML, Phillips CH, Wellwood S, Kiniry E, et al
Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons.
Vaccine. 2022 Nov 12. pii: S0264-410X(22)01397.
PubMed Abstract available

KPOZEHOUEN EB, Tan T, Macintyre CR
Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation.
Vaccine. 2022 Nov 12. pii: S0264-410X(22)01377.
PubMed Abstract available

DE FIGUEIREDO A, Simas C, Larson HJ
COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: A multi-country cross-sectional study.
Vaccine. 2022 Nov 10:S0264-410X(22)01310-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

DENG T, Li T, Chen G, Zhu Y, et al
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation.
Vaccine. 2022;40:6839-6848.
PubMed Abstract available

REN H, Li H, Cao L, Wang Z, et al
Intranasal immunization with HRSV prefusion F protein and CpG adjuvant elicits robust protective effects in mice.
Vaccine. 2022;40:6830-6838.
PubMed Abstract available

HASHIMOTO M, Aoe S, Kawazu Y, Seki NM, et al
Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques.
Vaccine. 2022 Nov 8. pii: S0264-410X(22)01379.
PubMed Abstract available

MOLL K, Lufkin B, Fingar KR, Ke Zhou C, et al
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020.
Vaccine. 2022 Nov 8:S0264-410X(22)01373-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TAKEUCHI Y, Iwagami M, Ono S, Michihata N, et al
A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01370.
PubMed Abstract available

HAO XB, Anand M, Wang TR, Rao AR, et al
Reducing COVID vaccine hesitancy by inducing a comparative mindset.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01359.
PubMed Abstract available

GUERIN RJ, Naeim A, Baxter-King R, Okun AH, et al
Parental intentions to vaccinate children against COVID-19: Findings from a U.S. National Survey.
Vaccine. 2022 Nov 7:S0264-410X(22)01371-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BEALE S, Burns R, Braithwaite I, Byrne T, et al
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01362.
PubMed Abstract available

SKAWRAN S, Schiesser H, Maurer A, Sartoretti T, et al
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01376.
PubMed Abstract available

WU YY, Zhang W
Demographic disparities in COVID-19 vaccine hesitancy among U.S. adults: Analysis of household pulse survey data from Jul 21 to Oct 11 in 2021.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01381.
PubMed Abstract available

LOPEZ-DORIGA RUIZ P, Gunnes N, Michael Gran J, Karlstad O, et al
Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01367.
PubMed Abstract available

OSOWICKI J, Morgan HJ, Harris A, Clothier HJ, et al
Guillain-Barre syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01366.
PubMed Abstract available

LEUNG J, Gray EB, Anderson TC, Sharkey SM, et al
Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50-64 years in the United States.
Vaccine. 2022 Nov 5. pii: S0264-410X(22)01328.
PubMed Abstract available

MORSTEAD T, Zheng J, Sin NL, DeLongis A, et al
Perceived threat and coping responses during the COVID-19 pandemic: Prospective associations with vaccine hesitancy.
Vaccine. 2022 Nov 4. pii: S0264-410X(22)01363.
PubMed Abstract available

MALDEN DE, Gee J, Glenn S, Li Z, et al
Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system.
Vaccine. 2022 Nov 3. pii: S0264-410X(22)01361.
PubMed Abstract available

TOMPKINS LK, Baggs J, Myers TR, Gee JM, et al
Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01342.
PubMed Abstract available

CHANG CT, Lim XJ, Chew CC, Rajan P, et al
Preferences and willingness of accepting COVID-19 vaccine booster: Results from a middle-income country.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01334.
PubMed Abstract available

LUCINDE RK, Karia B, Ouma N, Amadi D, et al
The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study.
Vaccine. 2022 Nov 1:S0264-410X(22)01345-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

October 2022

KUNASEKARAN M, Moa A, Hooshmand E, Trent M, et al
Effectiveness estimates for enhanced trivalent influenza vaccines in an aged care summer outbreak.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)00766.
PubMed Abstract available

KUNASEKARAN M, Poulos CJ, Chughtai AA, Heslop DJ, et al
Factors associated with repeated influenza vaccine uptake among aged care staff in an Australian sample from 2017 to 2019.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)00981.
PubMed Abstract available

CRUZ MC, Nascimento-Carvalho CM
The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01335.
PubMed Abstract available

LIMAYE RJ, Paul A, Gur-Arie R, Zavala E, et al
A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01331.
PubMed Abstract available

CAPURRO G, Maier R, Tustin J, Jardine CG, et al
"They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01338.
PubMed Abstract available

SIANI A, Tranter A
Is vaccine confidence an unexpected victim of the COVID-19 pandemic?
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01337.
PubMed Abstract available

MARIE REINHART A, Tian Y, Lilly AE
The role of trust in COVID-19 vaccine hesitancy and acceptance among Black and White Americans.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01330.
PubMed Abstract available

THULUVA S, Paradkar V, Gunneri S, Yerroju V, et al
Safety, tolerability and immunogenicity of Biological E's CORBEVAX vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01308.
PubMed Abstract available

HEYERDAHL LW, Dielen S, Dodion H, Van Riet C, et al
Strategic silences, eroded trust: The impact of divergent COVID-19 vaccine sentiments on healthcare workers' relations with peers and patients.
Vaccine. 2022 Oct 27. pii: S0264-410X(22)01306.
PubMed Abstract available

SCHIFF J, Schmidt AR, Pham PK, Perez JB, et al
Parental attitudes in the pediatric emergency department about the COVID-19 vaccine.
Vaccine. 2022 Oct 26. pii: S0264-410X(22)01309.
PubMed Abstract available

MALTEZOU HC, Ledda C, Gagneux-Brunon A, Botelho-Nevers E, et al
Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants.
Vaccine. 2022 Oct 26. pii: S0264-410X(22)01313.
PubMed

MALTEZOU HC, Gamaletsou MN, Koukou DM, Giannouchos TV, et al
Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study.
Vaccine. 2022 Oct 26. pii: S0264-410X(22)01304.
PubMed Abstract available

PHOKSAWAT W, Nithichanon A, Lerdsamran H, Wongratanacheewin S, et al
Phenotypic and functional changes of T cell subsets after CoronaVac vaccination.
Vaccine. 2022 Oct 22. pii: S0264-410X(22)01265.
PubMed Abstract available

MADEWELL ZJ, Chacon-Fuentes R, Badilla-Vargas X, Ramirez C, et al
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01284.
PubMed Abstract available

SUN R, Budhwani H
Negative sentiments toward novel coronavirus (COVID-19) vaccines.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01297.
PubMed Abstract available

ARRIETA A, Garcia-Prado A, Sarmiento JP, Paz Castro C, et al
Identifying early adopters of COVID-19 vaccines in Latin America.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01294.
PubMed Abstract available

LAI L, Rouphael N, Xu Y, Kabbani S, et al
An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cTFH) cells and antibody responses.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01146.
PubMed Abstract available

BLANCO S, Spinsanti L, Javier Aguilar J, Diaz A, et al
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01283.
PubMed Abstract available

DUCLOS P, MacDonald NE, Dochez C, Thacker N, et al
Report of the 2nd workshop of the International Collaboration on advanced vaccinology training.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01222.
PubMed Abstract available

SANTIBANEZ TA, Black CL, Vogt TM, Chatham-Stephens K, et al
Where are children ages 5-17 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01282.
PubMed Abstract available

STONER MCD, Tweedy D, Comello MGL, Toval C, et al
Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01286.
PubMed Abstract available

ZHONG VW, Li X, Ran J, Hu G, et al
Vaccination, symptomatic infection and negative conversion of viral RNA by body mass index, diabetes, and age: An observational study.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01262.
PubMed Abstract available

HOSHI SL, Shono A, Seposo X, Okubo R, et al
Cost-effectiveness analyses of 15- and 20-valent pneumococcal conjugate vaccines for Japanese elderly.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01259.
PubMed Abstract available

HALL PA, Meng G, Sakib MN, Quah ACK, et al
Do the vaccinated perform less distancing, mask wearing and hand hygiene? A test of the risk compensation hypothesis in a representative sample during the COVID-19 pandemic.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01289.
PubMed Abstract available

GOLLAMUDI J, Sartain SE, Navaei AH, Aneja S, et al
Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2022;40:6431-6444.
PubMed Abstract available

LIAO SH, Chang WJ, Hsu CY, Ming-Fang Yen A, et al
Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01258.
PubMed Abstract available

TAKAHASHI Y, Ishitsuka K, Sampei M, Okawa S, et al
COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01227.
PubMed Abstract available

RHODES S, Smith N, Evans T, White R, et al
Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01260.
PubMed Abstract available

CREISHER PS, Campbell AD, Perry JL, Roznik K, et al
Influenza subtype-specific maternal antibodies protect offspring against infection but inhibit vaccine-induced immunity and protection in mice.
Vaccine. 2022 Oct 14. pii: S0264-410X(22)01241.
PubMed Abstract available

SAADE EA, Abul Y, McConeghy K, Edward Davidson H, et al
High-dose influenza vaccines for the prevention of hospitalization due to cardiovascular events in older adults in the nursing home: Post-hoc analysis of a cluster-randomized trial.
Vaccine. 2022 Oct 13. pii: S0264-410X(22)01215.
PubMed Abstract available

HUDSON A, Hall PA, Hitchman SC, Meng G, et al
Cognitive predictors of COVID-19 mitigation behaviors in vaccinated and unvaccinated general population members.
Vaccine. 2022 Oct 13. pii: S0264-410X(22)01242.
PubMed Abstract available

LIU S, Yang G, Li M, Sun F, et al
Transcutaneous immunization via dissolving microneedles protects mice from lethal influenza H7N9 virus challenge.
Vaccine. 2022 Oct 12. pii: S0264-410X(22)01102.
PubMed Abstract available

VOGELSANG EM, Polonijo AN
Scarier than the flu shot? : The social determinants of shingles and influenza vaccinations among U.S. older adults.
Vaccine. 2022 Oct 8. pii: S0264-410X(22)01183.
PubMed Abstract available

CHEN JY, Hsieh SM, Hwang SJ, Liu CS, et al
Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study.
Vaccine. 2022 Oct 7. pii: S0264-410X(22)01200.
PubMed Abstract available

ELHARAKE JA, Omer SB, Schwartz JL
Country immunization policies for refugees across 20 low-middle income and 20 high-income countries.
Vaccine. 2022;40:6017-6022.
PubMed Abstract available

EKTARE V, Lang J, Choi Y, Finelli L, et al
The clinical impact of multiple prevention strategies for respiratory syncytial virus infections in infants and high-risk toddlers in the United States.
Vaccine. 2022;40:6064-6073.
PubMed Abstract available

MARLOWE E, Pranikoff S, Borsheim B, Salafian K, et al
Pilot study to determine effect of an altruism intervention focusing on herd immunity to enhance influenza vaccination rates.
Vaccine. 2022 Oct 6. pii: S0264-410X(22)01194.
PubMed Abstract available

PAGUIO JA, Ojikutu BO, Alfonso PG, Yao JS, et al
Association of culturally competent care with influenza vaccination coverage in the United States.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01065.
PubMed Abstract available

CHUGHTAI AA, Mohammed S, Al Ariqi L, McCarron M, et al
Development of a road map to scale up the uptake and utilization of influenza vaccine in 22 countries of Eastern Mediterranean Region.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01159.
PubMed Abstract available

BYRNE A, Thompson LA, Filipp SL, Ryan K, et al
COVID-19 vaccine perceptions and hesitancy amongst parents of school-aged children during the pediatric vaccine rollout.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01221.
PubMed Abstract available

VAN EWIJK CE, Hazelhorst EI, Hahne SJM, Knol MJ, et al
COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaign.
Vaccine. 2022 Oct 4. pii: S0264-410X(22)01213.
PubMed Abstract available

CHAO CR, Xu L, Cannizzaro N, Bronstein D, et al
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California.
Vaccine. 2022 Oct 3. pii: S0264-410X(22)01195.
PubMed Abstract available

AL-SHAIKH A, Mahmoud RI, Boukerdenna H, Muthu N, et al
Counselling of non-communicable diseases' patients for COVID-19 vaccine uptake in Jordan: Evaluating the intervention.
Vaccine. 2022 Oct 3. pii: S0264-410X(22)01214.
PubMed Abstract available

FERREIRA LS, de Almeida GB, Borges ME, Simon LM, et al
Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil.
Vaccine. 2022 Oct 3. pii: S0264-410X(22)01216.
PubMed Abstract available

ODIO CD, Katzelnick LC
'Mix and Match' vaccination: Is dengue next?
Vaccine. 2022 Oct 1. pii: S0264-410X(22)01101.
PubMed Abstract available

September 2022

WILLIAMS E, Colson J, Valiathan R, Carreno JM, et al
Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2.
Vaccine. 2022;40:5868-5872.
PubMed Abstract available

SPETZ M, Lundberg L, Nwaru C, Li H, et al
An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01186.
PubMed Abstract available

HATHAWAY CA, Siegel EM, Gonzalez BD, Oswald LB, et al
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01184.
PubMed Abstract available

MARCHESE AM, Beyhaghi H, Orenstein WA
With established safe and effective use, protein vaccines offer another choice against COVID-19.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01185.
PubMed

SILVA-VALENCIA J, Soto-Becerra P, Escobar-Agreda S, Fernandez-Navarro M, et al
Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study usi
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01189.
PubMed Abstract available

TRAKARNVANICH T, Ngamvichchukorn T, Phumisantiphong U, Pholtawornkulchai K, et al
Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01187.
PubMed Abstract available

CERVANTES-TORRES J, Rosales-Mendoza S, Cabello C, Montero L, et al
Towards the development of an epitope-focused vaccine for SARS-CoV-2.
Vaccine. 2022 Sep 27. pii: S0264-410X(22)01168.
PubMed Abstract available

LLOYD PC, Hu M, Wong HL, Shoaibi A, et al
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years.
Vaccine. 2022 Sep 27. pii: S0264-410X(22)01167.
PubMed Abstract available

ZHU H, Li X, Ren X, Chen H, et al
Improving cross-protection against influenza virus in mice using a nanoparticle vaccine of mini-HA.
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01165.
PubMed Abstract available

OHTA M, Kambayashi Y, Mita H, Kuroda T, et al
Protective efficacy of a reverse genetics-derived inactivated vaccine against equine influenza virus in horses.
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01155.
PubMed Abstract available

TOLSTRUP WESTER C, Lybecker Scheel-Hincke L, Bovil T, Andersen-Ranberg K, et al
Prayer frequency and COVID-19 vaccine hesitancy among older adults in Europe.
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01153.
PubMed Abstract available

GATES DM, Cohen SA, Orr K, Caffrey AR, et al
Pediatric influenza vaccination rates lower than previous estimates in the United States.
Vaccine. 2022 Sep 24. pii: S0264-410X(22)01162.
PubMed Abstract available

MOHAMMED AH, Hassan BAR, Wayyes AM, Gadhban AQ, et al
Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East.
Vaccine. 2022 Sep 23. pii: S0264-410X(22)01161.
PubMed Abstract available

MUES KE, Kirk B, Patel DA, Gelman A, et al
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States.
Vaccine. 2022 Sep 23. pii: S0264-410X(22)01120.
PubMed Abstract available

RUCKSTUHL L, Czock A, Haile SR, Lang P, et al
Influence of cantonal health policy frameworks & activities on the influenza vaccination rate in patients with non-communicable diseases in Switzerland.
Vaccine. 2022 Sep 22. pii: S0264-410X(22)01148.
PubMed Abstract available

ROMER D, Winneg KM, Jamieson PE, Brensinger C, et al
Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5-11-year-olds in the United States.
Vaccine. 2022 Sep 22. pii: S0264-410X(22)01154.
PubMed Abstract available

LIU B, Gidding H, Stepien S, Cretikos M, et al
Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection.
Vaccine. 2022 Sep 21. pii: S0264-410X(22)01126.
PubMed Abstract available

KIEFER MK, Mehl R, Rood KM, Germann K, et al
Association between social vulnerability and COVID-19 vaccination hesitancy and vaccination in pregnant and postpartum individuals.
Vaccine. 2022 Sep 21. pii: S0264-410X(22)01152.
PubMed Abstract available

SHAPIRO JR, Privor-Dumm L, Rosser EN, Leng SX, et al
The intersection of gender and race in older adults' decision to receive COVID-19 vaccines.
Vaccine. 2022 Sep 20:S0264-410X(22)01151-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

GRAAF A, Petric PP, Sehl-Ewert J, Henritzi D, et al
Cold-passaged isolates and bat-swine influenza a chimeric viruses as modified live-attenuated vaccines against influenza a viruses in pigs.
Vaccine. 2022 Sep 19. pii: S0264-410X(22)01108.
PubMed Abstract available

NTZIORA F, Georgia Kostaki E, Karapanou A, Mylona M, et al
Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers.
Vaccine. 2022 Sep 19. pii: S0264-410X(22)01150.
PubMed Abstract available

CARRENO JM, Singh G, Tcheou J, Srivastava K, et al
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01003.
PubMed Abstract available

FRANKENTHAL D, Zatlawi M, Karni-Efrati Z, Keinan-Boker L, et al
COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01078.
PubMed Abstract available

CREVECOEUR J, Hens N, Neyens T, Lariviere Y, et al
Change in COVID19 outbreak pattern following vaccination in long-term care facilities in Flanders, Belgium.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01124.
PubMed Abstract available

OSEI I, Sarwar G, Hossain I, Sonko K, et al
Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic.
Vaccine. 2022 Sep 13. pii: S0264-410X(22)01125.
PubMed Abstract available

DAY ME, Klein M, Sucharew H, Carol Burkhardt M, et al
Declining influenza vaccination rates in an underserved pediatric primary care center during the COVID-19 pandemic.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01121.
PubMed Abstract available

ZACE D, La Gatta E, Petrella L, Di Pietro ML, et al
The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01118.
PubMed Abstract available

FRIEDMAN-KLABANOFF DJ, Tjaden AH, Santacatterina M, Munawar I, et al
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research Partnership.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01116.
PubMed Abstract available

MONFARED IG
The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01107.
PubMed Abstract available

NAEIM A, Guerin RJ, Baxter-King R, Okun AH, et al
Strategies to increase the intention to get vaccinated against COVID-19: Findings from a nationally representative survey of US adults, October 2020 to October 2021.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01117.
PubMed Abstract available

ISHIGURO C, Mimura W, Murata F, Fukuda H, et al
Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Vaccine. 2022 Sep 9. pii: S0264-410X(22)01077.
PubMed Abstract available

TEPEROWSKI MONRAD J, Quaade S, Powell-Jackson T
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates.
Vaccine. 2022 Sep 8. pii: S0264-410X(22)01041.
PubMed Abstract available

CEANNT R, Vallieres F, Burns H, Murphy J, et al
Covid-19 vaccine hesitancy and resistance amongst parents of children under 18 years of age in Ireland.
Vaccine. 2022 Sep 7. pii: S0264-410X(22)01082.
PubMed Abstract available

MOK CC, Chan KL, Tse SM
Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01067.
PubMed Abstract available

LUBIS TA, Gunardi H, Herqutanto, Soedjatmiko S, et al
Educational videos to address vaccine hesitancy in childhood immunization.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01035.
PubMed Abstract available

HABERSAAT KB, Narayan S, Malue Nielsen S, Scherzer M, et al
How health workers can make a difference in the public COVID-19 vaccination response.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01081.
PubMed

PERRIER Q, Lupo J, Gerster T, Augier C, et al
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01064.
PubMed Abstract available

BOLSEWICZ KT, Steffens MS, Karpish L, Bullivant B, et al
"Every interaction you have ...should be an opportunity to discuss and offer influenza vaccination". Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families living in New South Wales, Australia.
Vaccine. 2022 Sep 1. pii: S0264-410X(22)01047.
PubMed Abstract available

August 2022

HRIN ML, Emmerich VK, Ip EH, Feldman SR, et al
Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States.
Vaccine. 2022 Aug 31. pii: S0264-410X(22)01052.
PubMed Abstract available

FRAIMAN J, Erviti J, Jones M, Greenland S, et al
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.
Vaccine. 2022 Aug 30. pii: S0264-410X(22)01028.
PubMed Abstract available

JACOBSON M, Chang TY, Shah M, Pramanik R, et al
Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial.
Vaccine. 2022 Aug 30. pii: S0264-410X(22)01050.
PubMed Abstract available

SARKAR P, Chandrasekaran V, Gunasekaran D, Chinnakali P, et al
COVID-19 vaccine hesitancy among health care worker-parents (HCWP) in Puducherry, India and its implications on their children: A cross sectional descriptive study.
Vaccine. 2022 Aug 29. pii: S0264-410X(22)01040.
PubMed Abstract available

CAO X, Zai J, Zhao Q, Xie L, et al
Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody.
Vaccine. 2022 Aug 29. pii: S0264-410X(22)01044.
PubMed Abstract available

SANCHEZ-SAEZ F, Peiro S, Cuenca L, Vanaclocha H, et al
Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain.
Vaccine. 2022 Aug 29. pii: S0264-410X(22)01007.
PubMed Abstract available

DOYON-PLOURDE P, Fortin E, Quach C
Evaluation of the 2018-2019 vaccine effectiveness against medically attended influenza-like illness using medical records and claims data.
Vaccine. 2022 Aug 27. pii: S0264-410X(22)00976.
PubMed Abstract available

CHUAN VOO T, Savulescu J, Schaefer O, Ho Zhi Ling A, et al
COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications.
Vaccine. 2022;40:5333-5337.
PubMed Abstract available

PIDIYAR V, Kumraj G, Ahmed K, Ahmed S, et al
COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries.
Vaccine. 2022;40:5302-5312.
PubMed Abstract available

ROSHCHINA Y, Roshchin S, Rozhkova K
Determinants of COVID-19 vaccine hesitancy and resistance in Russia.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01032.
PubMed Abstract available

TERESA VIETRI M, D'Elia G, Caliendo G, Passariello L, et al
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01034.
PubMed Abstract available

HEMMI T, Ainai A, Hashiguchi T, Tobiume M, et al
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01038.
PubMed Abstract available

KIKUT A, Clark D, Jesch E, Hornik R, et al
Strengthened belief in vaccine effectiveness predicted increased COVID-19 vaccination intention and behaviour: Results from a nationally representative longitudinal survey of U.S. adults from July 2020 to April/May 2021.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01036.
PubMed Abstract available

OKUYAMA M, Morino S, Tanaka K, Nakamura-Miwa H, et al
Vasovagal reactions after COVID-19 vaccination in Japan.
Vaccine. 2022 Aug 25. pii: S0264-410X(22)01046.
PubMed Abstract available

LIM AH, Ab Rahman N, Ong SM, Paraja J, et al
Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study.
Vaccine. 2022 Aug 24. pii: S0264-410X(22)01005.
PubMed Abstract available

WILLIS GA, Bloomfield L, Berry M, Bulsara C, et al
The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01026.
PubMed Abstract available

JAFFRY M, Mostafa F, Mandava K, Rosario S, et al
No significant increase in Guillain-Barre syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01025.
PubMed Abstract available

MARRON L, Ferenczi A, O'Brien KM, Cotter S, et al
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01013.
PubMed Abstract available

STIVANELLO E, Beghelli C, Cardoni F, Giansante C, et al
Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01029.
PubMed Abstract available

WANG X, Deng Y, Zhao L, Wang L, et al
Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01030.
PubMed Abstract available

KANOKUDOM S, Assawakosri S, Suntronwong N, Chansaenroj J, et al
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01011.
PubMed Abstract available

DOCHEZ C, Duclos P, MacDonald N, Steffen C, et al
Advanced vaccinology training globally: Update and impact of the COVID-19 crisis.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01006.
PubMed Abstract available

KURASHIMA K, Numano T, Yoshino A, Osawa A, et al
Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01027.
PubMed Abstract available

TOAPANTA-YANCHAPAXI L, Chiquete E, Avila-Rojo E, Lopez-Yanez S, et al
Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01012.
PubMed Abstract available

CLEMENS SAC, Fortaleza CMCB, Crowe M, Pollard A, et al
Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01010.
PubMed Abstract available

MIHIGO RM, Okeibunor JC, Karmal F, O'Malley H, et al
The Addis Declaration on Immunization: A binding reminder of the political support needed to achieve universal immunization in Africa.
Vaccine. 2022;40:5126-5130.
PubMed Abstract available

PSARIDI L, Maltezou HC, Simonidou S, Lialliou I, et al
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection.
Vaccine. 2022 Aug 19. pii: S0264-410X(22)01008.
PubMed Abstract available

STOECKEL F, Stockli S, Phillips J, Lyons B, et al
Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)00965.
PubMed Abstract available

LAFFAN MA, Rees S, Yadavalli M, Ferstenberg LB, et al
Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)00964.
PubMed Abstract available

AMANI A, Ngo Bama S, Dia M, Nguefack Lekelem S, et al
Challenges, best practices, and lessons learned from oral cholera mass vaccination campaign in urban Cameroon during the COVID-19 era.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)01004.
PubMed Abstract available

WYMORE BRAND M, Anderson TK, Kitikoon P, Brian Kimble J, et al
Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease.
Vaccine. 2022 Aug 17. pii: S0264-410X(22)00937.
PubMed Abstract available

LINNANDER E, Ineza L, Mupeta Bobo P, Bechtold K, et al
Improving management of vaccine supply chains: A multi-methods evaluation of vSTEP in Zambia.
Vaccine. 2022 Aug 17. pii: S0264-410X(22)00914.
PubMed Abstract available

MATSUURA T, Fukushima W, Nakagama Y, Kido Y, et al
Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00984.
PubMed Abstract available

ALKETBI LMB, Al Hosani F, Al Memari S, Al Mazrouei S, et al
Parents' views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00954.
PubMed Abstract available

CASEROTTI M, Gavaruzzi T, Girardi P, Sellaro R, et al
People's perspectives about COVID-19 vaccination certificate: Findings from a representative Italian sample.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00980.
PubMed Abstract available

ELLIOTT CBP, Chambers CS
A historical analysis of vaccine mandates in the United States military and its application to the COVID-19 vaccine mandate.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00982.
PubMed Abstract available

VISKUPIC F, Wiltse DL, Badahdah A
Reminders of existing vaccine mandates increase support for a COVID-19 vaccine mandate: Evidence from a survey experiment.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00978.
PubMed Abstract available

OMER SB, O'Leary ST, Bednarczyk RA, Ellingson MK, et al
Multi-tiered intervention to increase maternal immunization coverage: A randomized, controlled trial.
Vaccine. 2022;40:4955-4963.
PubMed Abstract available

SCHMIDTKE KA, Skrybant M, Kudrna L, Russell S, et al
A workshop to co-design messages that may increase uptake of vaccines: A case study.
Vaccine. 2022 Aug 12. pii: S0264-410X(22)00951.
PubMed Abstract available

PROUT A, Rustandi RR, Tubbs C, Winters MA, et al
Functional profiling of Covid 19 vaccine candidate by flow virometry.
Vaccine. 2022 Aug 9. pii: S0264-410X(22)00963.
PubMed Abstract available

PERROUD JM, Soldano S, Avancena ALV, Wagner A, et al
Adult vaccination uptake strategies in low- and middle-income countries: A systematic review.
Vaccine. 2022 Aug 8. pii: S0264-410X(22)00952.
PubMed Abstract available

HU S, Xiong C, Li Q, Wang Z, et al
COVID-19 vaccine hesitancy cannot fully explain disparities in vaccination coverage across the contiguous United States.
Vaccine. 2022 Aug 8. pii: S0264-410X(22)00947.
PubMed Abstract available

DE SWART RL, de Leeuw OS, Oreshkova N, Gerhards NM, et al
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters.
Vaccine. 2022;40:4676-4681.
PubMed Abstract available

ESTRELA M, Magalhaes Silva T, Roque V, Rebelo Gomes E, et al
Unravelling the drivers behind COVID-19 vaccination hesitancy and refusal among teachers: A nationwide study.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00955.
PubMed Abstract available

YEO J, Furr Gudmundsen C, Fazel S, Corrigan A, et al
A behavior change model to address caregiver hesitancy around COVID-19 vaccination in pediatrics.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00949.
PubMed Abstract available

ULRICH AK, Pankratz GK, Bohn B, Yendell S, et al
COVID-19 vaccine confidence and reasons for vaccination among health care workers and household members.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00956.
PubMed Abstract available

SQUIRE JD, Joshi AY
Response to mRNA COVID-19 vaccination in three XLA patients.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00941.
PubMed Abstract available

SNYDER J, Goldenberg M, Crooks VA, Katz R, et al
Crowdfunding narratives and the valuation of vaccines for COVID-19.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00946.
PubMed Abstract available

CIMA MJ, McCormick D, Porter A 3rd, Zohoori N, et al
COVID-19 vaccine uptake among Arkansas public K-12 school teachers and staff.
Vaccine. 2022 Aug 2. pii: S0264-410X(22)00942.
PubMed Abstract available

BAUMER-MOURADIAN SH, Hart RJ, Bone JN, Seiler M, et al
Should COVID-19 vaccines be mandated in schools? - an international caregiver perspective.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00921.
PubMed Abstract available

KORODI M, Horvath I, Rakosi K, Jenei Z, et al
Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00936.
PubMed Abstract available

July 2022

SHINKAI M, Sonoyama T, Kamitani A, Shibata RY, et al
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study.
Vaccine. 2022;40:4328-4333.
PubMed Abstract available

SADOFF J, Le Gars M, Brandenburg B, Cardenas V, et al
Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials.
Vaccine. 2022;40:4403-4411.
PubMed Abstract available

NOWALK MP, D'Agostino H, Dauer K, Stiegler M, et al
Estimating the burden of adult hospitalized RSV infection including special populations.
Vaccine. 2022;40:4121-4127.
PubMed Abstract available

SALMANTON-GARCIA J, Stewart FA, Heringer S, Koniordou M, et al
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.
Vaccine. 2022;40:4090-4097.
PubMed Abstract available

CHEN H, Huang Z, Chang S, Hu M, et al
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiorit
Vaccine. 2022 Jul 29. pii: S0264-410X(22)00919.
PubMed Abstract available

ROSE O, Erzkamp S, Schobel W, Grajeda M, et al
COVID-19 vaccinations in German pharmacies: A survey on patient and provider satisfaction.
Vaccine. 2022 Jul 28. pii: S0264-410X(22)00925.
PubMed Abstract available

RAMMAURO F, Carrion F, Olivero-Deibe N, Flo M, et al
Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2.
Vaccine. 2022 Jul 27. pii: S0264-410X(22)00911.
PubMed Abstract available

SHENYU W, Xiaoqian D, Bo C, Xuan D, et al
Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China.
Vaccine. 2022 Jul 26. pii: S0264-410X(22)00908.
PubMed Abstract available

KRAUSE PR, Arora N, Dowling W, Munoz-Fontela C, et al
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation.
Vaccine. 2022 Jul 26. pii: S0264-410X(22)00916.
PubMed

MCMILLAN CLD, Amarilla AA, Modhiran N, Choo JJY, et al
Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern.
Vaccine. 2022 Jul 18. pii: S0264-410X(22)00888.
PubMed Abstract available

DUGORD C, Franc C
Trajectories and individual determinants of repeated seasonal flu vaccination use over the long term using data from the French E3N cohort.
Vaccine. 2022 Jul 18. pii: S0264-410X(22)00855.
PubMed Abstract available

SETHY G, Chisema M, Sharma L, Joshi K, et al
COVID-19 vaccine express strategy in Malawi: An effort to reach the un-reach.
Vaccine. 2022 Jul 18. pii: S0264-410X(22)00887.
PubMed Abstract available

MIMURA W, Ishiguro C, Fukuda H
Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged>/=75years in Japan: The LIFE-VENUS Study.
Vaccine. 2022 Jul 15. pii: S0264-410X(22)00852.
PubMed Abstract available

VASUDEVAN L, Bruening R, Hung A, Woolson S, et al
COVID-19 vaccination intention and activation among health care system employees: A mixed methods study.
Vaccine. 2022 Jul 13. pii: S0264-410X(22)00884.
PubMed Abstract available

PRIDDY FH, Williams M, Carson S, Lavender B, et al
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults.
Vaccine. 2022 Jul 12. pii: S0264-410X(22)00885.
PubMed Abstract available

ORTQVIST AK, Dahlqwist E, Magnus MC, Ljung R, et al
COVID-19 vaccination in pregnant women in Sweden and Norway.
Vaccine. 2022 Jul 12. pii: S0264-410X(22)00859.
PubMed Abstract available

GODDARD K, Lewis N, Fireman B, Weintraub E, et al
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.
Vaccine. 2022 Jul 12. pii: S0264-410X(22)00860.
PubMed Abstract available

CUFFEL A, Maylin S, Le Buanec H, Delaugerre C, et al
Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients.
Vaccine. 2022 Jul 11. pii: S0264-410X(22)00857.
PubMed Abstract available

PADRON-REGALADO E, Medina-Rivero E
Perspectives for licensing vaccines in Mexico.
Vaccine. 2022 Jul 11. pii: S0264-410X(22)00854.
PubMed Abstract available

WYPLOSZ B, Fernandes J, Sultan A, Roche N, et al
Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00841.
PubMed Abstract available

ZHANG Y, Wang Y, Jia C, Li G, et al
Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects >/=3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00846.
PubMed Abstract available

CHADWICK C, Friede M, Moen A, Nannei C, et al
Technology transfer programme for influenza vaccines - Lessons from the past to inform the future.
Vaccine. 2022 Jul 6. pii: S0264-410X(22)00826.
PubMed

XIRIDOU M, Adam P, Meiberg A, Visser M, et al
The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study.
Vaccine. 2022 Jul 4. pii: S0264-410X(22)00847.
PubMed Abstract available

MCCORMICK DW, Konkle SL, Magleby R, Chakrabarti AK, et al
SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.
Vaccine. 2022 Jul 4. pii: S0264-410X(22)00835.
PubMed Abstract available

HOU Z, Guo J, Lai X, Zhang H, et al
Influenza vaccination hesitancy and its determinants among elderly in China: A national cross-sectional study.
Vaccine. 2022 Jul 1. pii: S0264-410X(22)00832.
PubMed Abstract available

BARRALL AL, Hoff NA, Nkamba DM, Musene K, et al
Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo.
Vaccine. 2022 Jul 1. pii: S0264-410X(22)00842.
PubMed Abstract available

SKIRROW H, Barnett S, Bell S, Mounier-Jack S, et al
Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK.
Vaccine. 2022 Jul 1. pii: S0264-410X(22)00845.
PubMed Abstract available

June 2022

HILLS T, Paterson A, Woodward R, Middleton F, et al
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine.
Vaccine. 2022 Jun 29. pii: S0264-410X(22)00839.
PubMed Abstract available

WONG SC, Chan VW, Lam GKM, Yuen LL, et al
The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00836.
PubMed Abstract available

MEDEIROS MZ, Soares PF, Fialho BC, Gauss L, et al
Vaccine innovation model: A technology transfer perspective in pandemic contexts.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00823.
PubMed Abstract available

LEE JT, Sean Hu S, Zhou T, Bonner KE, et al
Employer requirements and COVID-19 vaccination and attitudes among healthcare personnel in the U.S.: Findings from National Immunization Survey Adult COVID Module, August - September 2021.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00838.
PubMed Abstract available

MOGHNIEH R, Abdallah D, Sayegh MH, Rahman Bizri A, et al
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3987-3988.
PubMed

CIMOLAI N
Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3985-3986.
PubMed

STRAUS W, Rubin H
COVID-19 vaccine safety monitoring in low and middle income countries - Time for a bold new approach.
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00822.
PubMed

SEYRAN M
Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity.
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00821.
PubMed Abstract available

SHIVJI R, Conocchia R, Korakianiti E, Jekerle V, et al
Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA).
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00827.
PubMed Abstract available

WILSON B, Mukundan Geetha K
Nanomedicine to deliver biological macromolecules for treating COVID-19.
Vaccine. 2022;40:3931-3941.
PubMed Abstract available

CARTANYA-HUESO A, Martinez-Sanchez JM, Carlos Martin-Sanchez J, Lidon-Moyano C, et al
Relationship between double COVID-19 vaccine uptake and trust in effectiveness and safety of vaccination in general in 23 Member states of the European Union: an ecological study.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00820.
PubMed Abstract available

AL-MUSTAPHA AI, Okechukwu O, Olayinka A, Muhammed OR, et al
A national survey of COVID-19 vaccine acceptance in Nigeria.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00818.
PubMed Abstract available

LOHMANN S, Albarracin D
Trust in the public health system as a source of information on vaccination matters most when environments are supportive.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00759.
PubMed Abstract available

RONZANI P, Panizza F, Martini C, Savadori L, et al
Countering vaccine hesitancy through medical expert endorsement.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00780.
PubMed Abstract available

KORVES C, Izurieta HS, Smith J, Zwain GM, et al
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00816.
PubMed Abstract available

DIONATO FAV, Jalalizadeh M, Buosi K, Visacri MB, et al
BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial.
Vaccine. 2022 Jun 20. pii: S0264-410X(22)00803.
PubMed Abstract available

ATWELL JE, Lutz CS, Sparrow EG, Feikin DR, et al
Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.
Vaccine. 2022 Jun 17. pii: S0264-410X(22)00783.
PubMed Abstract available

CANADAY LM, Resnick JD, Liu H, Powell H, et al
HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza vaccine infection in human nasal epithelial cell cultures.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00733.
PubMed Abstract available

UWAMINO Y, Kurafuji T, Takato K, Sakai A, et al
Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00763.
PubMed Abstract available

MOUTA NUNES DE OLIVEIRA P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, Crespo Cordeiro C, et al
Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00761.
PubMed Abstract available

REICHERZ F, Golding L, Lavoie PM, Abu-Raya B, et al
Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures.
Vaccine. 2022;40:3746-3751.
PubMed Abstract available

FREW PM, Gonzalez-Casanova I, Otieno NA, Malik FA, et al
Development of effective messages to promote maternal immunization in Kenya.
Vaccine. 2022;40:3761-3770.
PubMed Abstract available

BRAUNFELD JB, Carson HN, Williams SR, Schwartz LM, et al
Clinical endpoints to inform vaccine policy: A systematic review of outcome measures from pediatric influenza vaccine efficacy trials.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00778.
PubMed Abstract available

GAMBRELL A, Sundaram M, Bednarczyk RA
Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00782.
PubMed Abstract available

CHUNG JR, Kim SS, Flannery B, Smith ME, et al
Vaccine-associated attenuation of subjective severity among outpatients with influenza.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00767.
PubMed Abstract available

FOLEGATTI PM, Jenkin D, Morris S, Gilbert S, et al
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00755.
PubMed Abstract available

HERNANDEZ LM, Sumathy K, Sahastrabuddhe S, Excler JL, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00753.
PubMed Abstract available

RAZZAGHI H, Yankey D, Vashist K, Lu PJ, et al
COVID-19 vaccination coverage and intent among women aged 18-49 years by pregnancy status, United States, April-November 2021.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00779.
PubMed Abstract available

PHATARPHEKAR A, Vidyadhar Reddy GEC, Gokhale A, Karanam G, et al
RelCoVax(R), a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00775.
PubMed Abstract available

WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
In response to: JVAC-D-21-02863, detection of a potential error in the results of the manuscript, dementia risk following influenza vaccination in a large veteran cohort, that could call into question the main conclusion.
Vaccine. 2022;40:3529.
PubMed

VUICHARD-GYSIN D, Schoenenberger A
Detection of a potential error in the results of the manuscript "Dementia risk following influenza vaccination in a large veteran cohort" that could eventually call into question the main conclusion.
Vaccine. 2022;40:3528.
PubMed

SCHENK J, Abrams S, Litzroth A, Cornelissen L, et al
Identifying immunity gaps for measles using Belgian serial serology data.
Vaccine. 2022;40:3676-3683.
PubMed Abstract available

POLLET J, Strych U, Chen WH, Versteeg L, et al
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.
Vaccine. 2022;40:3655-3663.
PubMed Abstract available

EVANS S, Holt D, Weil-Olivier C, Finnegan G, et al
Building population and health system resilience: Using lessons learned during the COVID pandemic to implement life-course immunisation policy.
Vaccine. 2022;40:3511-3513.
PubMed

WILLIAMS E, Craig K, Chiu C, Davies H, et al
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.
Vaccine. 2022;40:3484-3489.
PubMed Abstract available

SPARROW E, Adetifa I, Chaiyakunapruk N, Cherian T, et al
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
Vaccine. 2022;40:3506-3510.
PubMed Abstract available

EVANS B, Jombart T
Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic.
Vaccine. 2022;40:3531-3535.
PubMed Abstract available

KUNASEKARAN MP, Chughtai AA, Heslop DJ, Poulos CJ, et al
Influenza cases in nine aged care facilities in Sydney, Australia over a three-year surveillance period, 2018-2020.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00476.
PubMed Abstract available

HALME J, Syrjanen RK, Baum U, Palmu AA, et al
Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00716.
PubMed Abstract available

ZHAO FJ, Liu LT, Wang Z, Wang NX, et al
Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00721.
PubMed Abstract available

LEAV B, Straus W, White P, Leav A, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00752.
PubMed Abstract available

KOBAYASHI T, Nishina Y, Tomoi H, Harada K, et al
Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00754.
PubMed Abstract available

LIN K, Liu M, Bao L, Lv Q, et al
Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00765.
PubMed Abstract available

ZHANG H, Li Y, Peng S, Jiang Y, et al
The effect of health literacy on COVID-19 vaccine hesitancy among community population in China: The moderating role of stress.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00762.
PubMed Abstract available

DIAZ-MENENDEZ M, de la Calle-Prieto F, Montejano R, Arsuaga M, et al
Clinical characteristics and outcome of hospitalized elderly patients with COVID- 19 after vaccine failure.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00751.
PubMed Abstract available

NIESSEN FA, Knol MJ, Hahne SJM, Bonten MJM, et al
Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: A test-negative case-control study.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00758.
PubMed Abstract available

BASS JR, Poland GA
Shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccination.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00750.
PubMed Abstract available

WYNBERG E, Han AX, Boyd A, van Willigen HDG, et al
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00748.
PubMed Abstract available

WALKER JL, Schultze A, Tazare J, Tamborska A, et al
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00757.
PubMed Abstract available

FLYNN JA, Weber T, Cejas PJ, Cox KS, et al
Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00382.
PubMed Abstract available

HASHIMOTO M, Nagata N, Homma T, Maeda H, et al
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00718.
PubMed Abstract available

EUGENIA-TOLEDO-ROMANI M, Verdecia-Sanchez L, Rodriguez-Gonzalez M, Rodriguez-Noda L, et al
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00717.
PubMed Abstract available

DAYTON L, Miller J, Strickland J, Davey-Rothwell M, et al
A socio-ecological perspective on parents' intentions to vaccinate their children against COVID-19.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00736.
PubMed Abstract available

EL-SHESHENY R, El Taweel A, Gomaa MR, Roshdy WH, et al
Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00734.
PubMed Abstract available

SHANMUGARAJ B, Khorattanakulchai N, Panapitakkul C, Malla A, et al
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00735.
PubMed Abstract available

WATANABE A, Nishida S, Burcu T, Shibahara T, et al
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-beta-cyclodextrin: A phase 1 clinical trial.
Vaccine. 2022 Jun 4. pii: S0264-410X(22)00677.
PubMed Abstract available

AB RAHMAN N, Lim MT, Lee FY, Lee SC, et al
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00700.
PubMed Abstract available

STEAD M, Ford A, Eadie D, Biggs H, et al
A "step too far" or "perfect sense"? A qualitative study of British adults' views on mandating COVID-19 vaccination and vaccine passports.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00696.
PubMed Abstract available

May 2022

TOOR J, Li X, Jit M, Trotter CL, et al
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.
Vaccine. 2022 May 30. pii: S0264-410X(22)00698.
PubMed Abstract available

WOO EJ, Dimova RB
Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system.
Vaccine. 2022 May 30. pii: S0264-410X(22)00704.
PubMed Abstract available

MERRICK E, Weissman JP, Patel SJ
Utilizing Google trends to monitor coronavirus vaccine interest and hesitancies.
Vaccine. 2022 May 30. pii: S0264-410X(22)00699.
PubMed Abstract available

FISHMAN J, Salmon MK, Scheitrum D, Aleks Schaefer K, et al
Comparative effectiveness of mandates and financial policies targeting COVID-19 vaccine hesitancy: A randomized, controlled survey experiment.
Vaccine. 2022 May 30. pii: S0264-410X(22)00702.
PubMed Abstract available

SHIOHARA M, Suzuki S, Shichinohe S, Ishigaki H, et al
Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
Vaccine. 2022 May 28. pii: S0264-410X(22)00640.
PubMed Abstract available

SHAPIRO BEN DAVID S, Mizrahi B, Rahamim-Cohen D, Supino-Rosin L, et al
Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study.
Vaccine. 2022 May 28. pii: S0264-410X(22)00668.
PubMed Abstract available

LAI X, Li M, Hou Z, Guo J, et al
Factors associated with caregivers' hesitancy to vaccinate children against influenza: A cross-sectional survey in China.
Vaccine. 2022 May 27. pii: S0264-410X(22)00606.
PubMed Abstract available

PATEL KM, Shafiq M, Malik AA, Cobanoglu A, et al
Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study.
Vaccine. 2022 May 27. pii: S0264-410X(22)00680.
PubMed Abstract available

SOEGIARTO G, Wulandari L, Purnomosari D, Dhia Fahmita K, et al
Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2.
Vaccine. 2022 May 27. pii: S0264-410X(22)00676.
PubMed Abstract available

DUBE C, Paris-Robidas S, Andreani G, Gutzeit C, et al
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines.
Vaccine. 2022 May 27. pii: S0264-410X(22)00641.
PubMed Abstract available

MOSS P, Berenbaum F, Curigliano G, Grupper A, et al
Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.
Vaccine. 2022 May 27. pii: S0264-410X(22)00682.
PubMed Abstract available

HALSTEAD IN, McKay RT, Lewis GJ
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort.
Vaccine. 2022 May 27. pii: S0264-410X(22)00678.
PubMed Abstract available

DUBE E, Gagnon D, MacDonald N
Between persuasion and compulsion: The case of COVID-19 vaccination in Canada.
Vaccine. 2022 May 25. pii: S0264-410X(22)00670.
PubMed

ABRAHAM N, Spruin S, Rossi T, Fireman B, et al
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
Vaccine. 2022 May 25. pii: S0264-410X(22)00667.
PubMed Abstract available

BECK E, Biundo E, Devlin N, Doherty TM, et al
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework.
Vaccine. 2022 May 23. pii: S0264-410X(22)00490.
PubMed Abstract available

FOO D, Sarna M, Pereira G, Moore HC, et al
Maternal influenza vaccination and child mortality: Longitudinal, population-based linked cohort study.
Vaccine. 2022 May 20. pii: S0264-410X(22)00614.
PubMed Abstract available

KITCHEN M, Leierer G, Kistner O, Wodal W, et al
High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
Vaccine. 2022 May 20. pii: S0264-410X(22)00575.
PubMed Abstract available

MCELFISH PA, Selig JP, Scott AJ, Rowland B, et al
Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans.
Vaccine. 2022 May 20. pii: S0264-410X(22)00615.
PubMed Abstract available

SZANYI J, Wilson T, Scott N, Blakely T, et al
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.
Vaccine. 2022 May 20. pii: S0264-410X(22)00634.
PubMed Abstract available

CARSON B, Isaacs J, Carilli T
Jabbing together? The complementarity between social capital, formal public health rules, and COVID-19 vaccine rates in the United States.
Vaccine. 2022 May 19. pii: S0264-410X(22)00612.
PubMed Abstract available

STEELFISHER GK, Caporello H, McIntosh R, Muhammad Safdar R, et al
Preventing erosion of oral polio vaccine acceptance: A role for vaccinator visits and social norms.
Vaccine. 2022 May 19. pii: S0264-410X(22)00567.
PubMed Abstract available

SIQUEIRA PG, Duarte HO, Moura MDC
Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer.
Vaccine. 2022 May 19. pii: S0264-410X(22)00633.
PubMed Abstract available

SALO-TUOMINEN K, Teros-Jaakkola T, Toivonen L, Ollila H, et al
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children.
Vaccine. 2022 May 17. pii: S0264-410X(22)00582.
PubMed Abstract available

ROBERTSON DA, Mohr KS, Barjakova M, Lunn PD, et al
Experimental pre-tests of public health communications on the COVID-19 vaccine: A null finding for medical endorsement, risk and altruism.
Vaccine. 2022 May 16. pii: S0264-410X(22)00613.
PubMed Abstract available

TSAI SY, Yeh TY, Chiu NC, Huang CT, et al
National safety surveillance of quadrivalent recombinant influenza vaccine in Taiwan during NH 20/21.
Vaccine. 2022 May 13. pii: S0264-410X(22)00588.
PubMed Abstract available

IWATA S, Sonoyama T, Kamitani A, Shibata R, et al
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings.
Vaccine. 2022 May 13. pii: S0264-410X(22)00494.
PubMed Abstract available

ALYA WA, Maraqa B, Nazzal Z, Odeh M, et al
COVID-19 vaccine uptake and its associated factors among Palestinian healthcare workers: Expectations beaten by reality.
Vaccine. 2022 May 13. pii: S0264-410X(22)00610.
PubMed Abstract available

KUMAR SURI R, Hayman B, Prasad SD, Makhoana M, et al
Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
Vaccine. 2022 May 13. pii: S0264-410X(22)00576.
PubMed Abstract available

DUC DANG A, Dinh Vu T, Hai Vu H, Thanh Ta V, et al
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Vaccine. 2022 May 13. pii: S0264-410X(22)00526.
PubMed Abstract available

RUSKIN AC, Rice S, O'Connor M, Ruskin KJ, et al
Effects of vaccination status in the United States on willingness to undergo surgery during a pandemic: A prospective survey study.
Vaccine. 2022 May 13. pii: S0264-410X(22)00583.
PubMed Abstract available

MANCARELLA M, Natarelli F, Bertolini C, Zagari A, et al
Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy.
Vaccine. 2022 May 12. pii: S0264-410X(22)00573.
PubMed Abstract available

CHONG-VALBUENA A, De-Jesus-Maria I, Agurto-Ramirez A, Puchades-Gimeno F, et al
Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: Differences between naive and previously infected by SARS-CoV-2.
Vaccine. 2022 May 12. pii: S0264-410X(22)00586.
PubMed Abstract available

TEASDALE CA, Ratzan S, Stuart Lathan H, Rauh L, et al
Acceptability of COVID-19 vaccine mandates among New York City parents, November 2021.
Vaccine. 2022 May 11. pii: S0264-410X(22)00580.
PubMed Abstract available

GUPTA C, Sachdeva A, Khamar J, Bu C, et al
Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis.
Vaccine. 2022 May 10. pii: S0264-410X(22)00468.
PubMed Abstract available

KITRO A, Sirikul W, Thongkum W, Soponpong S, et al
Dynamic of anti-spike receptor binding domain (RBD) levels and short-term adverse events following a heterologous booster dose of BNT162b2 after two doses of CoronaVac in Thai health care workers.
Vaccine. 2022;40:2915-2924.
PubMed Abstract available

PERUMAL N, Steffen A, Ullrich A, Siedler A, et al
Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021.
Vaccine. 2022;40:2910-2914.
PubMed Abstract available

YI S, Choe YJ, Lim DS, Lee HR, et al
Impact of national Covid-19 vaccination Campaign, South Korea.
Vaccine. 2022 May 8. pii: S0264-410X(22)00572.
PubMed Abstract available

BIFULCO M, Di Zazzo E, Pisanti S, Martini M, et al
The nineteenth-century experience of the kingdom of the two Sicilies on mandatory vaccination: An Italian phenomenon?
Vaccine. 2022 May 6. pii: S0264-410X(22)00492.
PubMed Abstract available

LUMBRERAS ARETA M, Valiton A, Diana A, Morales M, et al
Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study.
Vaccine. 2022 May 6. pii: S0264-410X(22)00533.
PubMed Abstract available

YU Y, Ma YL, Luo S, Wang S, et al
Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China.
Vaccine. 2022 May 5. pii: S0264-410X(22)00532.
PubMed Abstract available

BELLIZZI S, Panu Napodano CM, Pinto S, Pichierri G, et al
COVID-19 and seasonal influenza: The potential 2021-22 "Twindemic".
Vaccine. 2022 May 5. pii: S0264-410X(22)00531.
PubMed

GASTEIGER N, Gasteiger C, Vedhara K, Broadbent E, et al
Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach.
Vaccine. 2022 May 5. pii: S0264-410X(22)00547.
PubMed Abstract available

NAULT L, Marchitto L, Goyette G, Tremblay-Sher D, et al
Covid-19 vaccine immunogenicity in people living with HIV-1.
Vaccine. 2022 May 5. pii: S0264-410X(22)00543.
PubMed Abstract available

REES F, Geiger M, Lilleholt L, Zettler I, et al
Measuring parents' readiness to vaccinate themselves and their children against COVID-19.
Vaccine. 2022 May 5. pii: S0264-410X(22)00549.
PubMed Abstract available

LEIGH JP, Moss SJ, White TM, Picchio CA, et al
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries.
Vaccine. 2022 May 5. pii: S0264-410X(22)00545.
PubMed Abstract available

LIU W, Lien YH, Lee PI, Chan TC, et al
Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
Vaccine. 2022 May 4. pii: S0264-410X(22)00358.
PubMed Abstract available

PERSSON U, Olofsson S, Althin R, Palmborg A, et al
Acceptance and application of a broad population health perspective when evaluating vaccine.
Vaccine. 2022 May 4. pii: S0264-410X(22)00425.
PubMed Abstract available

BOSE AS, Rai P, Gupta BP, Pradhan R, et al
Nepal measles outbreak response immunization during COVID-19: A risk-based intervention strategy.
Vaccine. 2022;40:2884-2893.
PubMed Abstract available

BOTHUN LS, Feeder SE, Poland GA
Readability of COVID-19 vaccine information for the general public.
Vaccine. 2022 May 3. pii: S0264-410X(22)00546.
PubMed Abstract available

NANTANEE R, Aikphaibul P, Jaru-Ampornpan P, Sodsai P, et al
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac.
Vaccine. 2022 May 2. pii: S0264-410X(22)00521.
PubMed Abstract available

FEIKIN DR, Abu-Raddad LJ, Andrews N, Davies MA, et al
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization.
Vaccine. 2022 May 2. pii: S0264-410X(22)00523.
PubMed Abstract available

April 2022

MASUDA T, Murakami K, Sugiura K, Sakui S, et al
Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00463.
PubMed Abstract available

HUSSAIN B, Latif A, Timmons S, Nkhoma K, et al
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies.
Vaccine. 2022 Apr 28. pii: S0264-410X(22)00446.
PubMed Abstract available

NASREEN S, Calzavara A, Buchan SA, Thampi N, et al
Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00520.
PubMed Abstract available

DEMIR E, Dheir H, Safak S, Serra Artan A, et al
Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00519.
PubMed Abstract available

KULCZYCKI A, Shewchuk R
Back to Basics: A general approach to improving Covid and adult immunization delivery focused on Pharmacy-Based immunization services.
Vaccine. 2022;40:2647-2649.
PubMed

MARKOVITZ NH, Strome AL, Patel PK
Commentary: "The vaccine Selfie" and its influence on COVID-19 vaccine acceptance.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00503.
PubMed

KRUPP K, Galea J, Madhivanan P, Gerald L, et al
Conversational artificial intelligence: A new approach for increasing influenza vaccination rates in children with asthma?
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00496.
PubMed

MCCOSKER LK, El-Heneidy A, Seale H, Ware RS, et al
Strategies to improve vaccination rates in people who are homeless: A systematic review.
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00436.
PubMed Abstract available

BEYER WEP, Palache AM, Boulfich M, Osterhaus ADME, et al
Clinical relevance of increased antibody titres in older adults upon vaccination with squalene-adjuvanted versus non-adjuvanted influenza vaccines.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00489.
PubMed Abstract available

STRECKENBACH B, Baldt J, Heidler F, Frahm N, et al
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00428.
PubMed Abstract available

SALO H, Lehtonen T, Auranen K, Baum U, et al
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00495.
PubMed Abstract available

TAMANG ST, Dorji T
COVID-19 vaccinations in Bhutan - Mix-and-Match to Boosters: An experience.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00499.
PubMed Abstract available

ANTONOPOULOU T, Athanassakis I
SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00501.
PubMed

SHEA LL, Becker A, Lee BK, Miller KK, et al
Self-reported COVID-19 vaccination acceptance and hesitancy among autistic adults.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00500.
PubMed Abstract available

ORTIZ JR, Spearman PW, Goepfert PA, Cross K, et al
Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial.
Vaccine. 2022 Apr 21. pii: S0264-410X(22)00366.
PubMed Abstract available

CAN G, Acar HC, Aydin SN, Balkan II, et al
Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers.
Vaccine. 2022;40:2574-2579.
PubMed Abstract available

GARTNER BC, Weinke T, Wahle K, Kwetkat A, et al
Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective - A systematic review of recently published literature on real-world data.
Vaccine. 2022 Apr 19. pii: S0264-410X(22)00440.
PubMed Abstract available

SINGH BK, Walker J, Paul P, Reddy S, et al
De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in US nursing homes amidst rising community vaccination coverage: A modeling study.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00467.
PubMed Abstract available

LI L, Honda-Okubo Y, Baldwin J, Bowen R, et al
Covax-19/Spikogen(R) vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00469.
PubMed Abstract available

WANLAPAKORN N, Suntronwong N, Phowatthanasathian H, Yorsaeng R, et al
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00471.
PubMed Abstract available

SAADE A, Cha L, Tadie E, Jurado B, et al
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00473.
PubMed Abstract available

CHRISSIAN AA, Oyoyo UE, Patel P, Lawrence Beeson W, et al
Impact of COVID-19 vaccine-associated side effects on health care worker absenteeism and future booster vaccination.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00474.
PubMed Abstract available

XU S, Hong V, Sy LS, Glenn SC, et al
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00464.
PubMed Abstract available

MACINTYRE CR, Heslop DJ, Nguyen P, Adam D, et al
Pacific Eclipse - A tabletop exercise on smallpox pandemic response.
Vaccine. 2022;40:2478-2483.
PubMed Abstract available

BRAEYE T, Catteau L, Brondeel R, van Loenhout JAF, et al
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00441.
PubMed Abstract available

FENOLLAR F, Thomas L, Raoult D, Gautret P, et al
Screening for SARS-CoV-2 antibodies to save vaccine doses.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00444.
PubMed

MORO PL, Olson CK, Clark E, Marquez P, et al
Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00447.
PubMed Abstract available

YAN Y, Naito T, Tabe Y, Ito K, et al
Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00445.
PubMed Abstract available

SHINJOH M, Furuichi M, Kobayashi H, Yamaguchi Y, et al
Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00449.
PubMed Abstract available

CEYLAN ME, Onen Unsalver B, Donmez A, Kaya Yertutanol FD, et al
A case of myocarditis and isolated hypopotassemia after Biontech-Pfizer vaccine for Covid-19.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00432.
PubMed

LJUNG R, Feychting M, Burstrom B, Moller J, et al
Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00431.
PubMed Abstract available

BENINGER P
Need for a contingency dimension when planning vaccine development in a pandemic environment.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00401.
PubMed

ZHU XM, Yan W, Sun J, Liu L, et al
Patterns and influencing factors of COVID-19 vaccination willingness among college students in China.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00433.
PubMed Abstract available

SPRINGER S, Kaatz M, Zieger M
Evaluation of weekly COVID-19 vaccination and case data supports negative correlation between incidence and vaccination in German federal states and cities during 4th wave.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00430.
PubMed Abstract available

PARK SJ, Kang YM, Cho HK, Kim DY, et al
Corrigendum to 'Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice' [Vaccine 39 (2021) 6213-6220].
Vaccine. 2022 Apr 9. pii: S0264-410X(22)00221.
PubMed

AINSLIE KEC, Riley S
Is annual vaccination best? A modelling study of influenza vaccination strategies in children.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00384.
PubMed Abstract available

MAYFIELD HJ, Lau CL, Sinclair JE, Brown SJ, et al
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00418.
PubMed Abstract available

BELDA F, Mora O, Lopez Martinez M, Torres N, et al
Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00419.
PubMed Abstract available

ERFANI P, Sandoval RS, Rich KM, Ojo A, et al
Ask Me Anything": Lessons learned in implementing a COVID-19 vaccine information initiative in Massachusetts jails.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00439.
PubMed Abstract available

KENIGSBERG TA, Hause AM, McNeil MM, Nelson JC, et al
Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the vaccine safety datalink.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00426.
PubMed Abstract available

LINKINS LA, Iorio A, Little J, Lavis J, et al
Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19.
Vaccine. 2022 Apr 7. pii: S0264-410X(22)00422.
PubMed

DE-LOS-RIOS-PINTO A, Fernandez-Guzman D, Soriano-Moreno DR, Sangster-Carrasco L, et al
Factors associated with the intention to participate in COVID-19 vaccine clinical trials: A cross-sectional study in Peru.
Vaccine. 2022 Apr 7. pii: S0264-410X(22)00421.
PubMed Abstract available

SHAH S, Gui H, Chua PEY, Tan JB, et al
Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong.
Vaccine. 2022 Apr 5. pii: S0264-410X(22)00381.
PubMed Abstract available

WALTERS JN, Schouest B, Patel A, Reuschel EL, et al
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00368.
PubMed Abstract available

HASSAN PM, Ali T, Saber E, Asghar A, et al
Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00385.
PubMed Abstract available

MA C, Sun W, Tang T, Jia M, et al
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00386.
PubMed Abstract available

SUGHAYER MA, Souan L, Abu Alhowr MM, Al Rimawi D, et al
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00387.
PubMed Abstract available

FRISE R, Baillon L, Zhou J, Kugathasan R, et al
A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00383.
PubMed Abstract available

March 2022

VANDOORN E, Parys A, Chepkwony S, Chiers K, et al
Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00362.
PubMed Abstract available

MCRAE J, Blyth CC, Cheng AC, Quinn HE, et al
Preventing severe influenza in Australian infants: Maternal influenza vaccine effectiveness in the PAEDS-FluCAN networks using the test-negative design.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00353.
PubMed

LI K, Yu T, Seabury SA, Dor A, et al
Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00370.
PubMed Abstract available

KATO H, Miyakawa K, Ohtake N, Yamaoka Y, et al
Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00369.
PubMed Abstract available

ISITT C, Sjoholm D, Hergens MP, Granath F, et al
The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00372.
PubMed Abstract available

FUNK PR, Yogurtcu ON, Forshee RA, Anderson SA, et al
Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 years.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00329.
PubMed Abstract available

JUDDOO V, Juddoo S, Megarbane B
Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00363.
PubMed

WELLS K, Moore KL, Bednarczyk R
Supporting immunization programs to address COVID-19 vaccine hesitancy: Recommendations for national and community-based stakeholders.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00339.
PubMed

SIMMONS LA, Whipps MDM, Phipps JE, Satish NS, et al
Understanding COVID-19 vaccine uptake during pregnancy: 'Hesitance', knowledge, and evidence-based decision-making.
Vaccine. 2022 Mar 25. pii: S0264-410X(22)00355.
PubMed Abstract available

FARAH W, Breeher L, Shah V, Hainy C, et al
Disparities in COVID-19 vaccine uptake among health care workers.
Vaccine. 2022 Mar 25. pii: S0264-410X(22)00356.
PubMed Abstract available

NANTHAPISAL S, Puthanakit T, Jaru-Ampornpan P, Nantanee R, et al
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00336.
PubMed Abstract available

ABDEL-QADER DH, Hazza Alkhatatbeh I, Hayajneh W, Annab H, et al
IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00265.
PubMed

MALTEZOU HC, Medic S, Cassimos DC, Effraimidou E, et al
Decreasing routine vaccination rates in children in the COVID-19 era.
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00333.
PubMed

FANO V, Crielesi A, Coviello E, Fabiani M, et al
Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy).
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00208.
PubMed Abstract available

SNIDER CJ, Boualam L, Tallis G, Takashima Y, et al
Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021.
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00145.
PubMed Abstract available

FERDINANDS JM, Patel M
Influence of disease attenuation on relative influenza vaccine effectiveness by vaccine type.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00274.
PubMed Abstract available

YUEN WLP, Loh SYJ, Wang DB
SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00337.
PubMed Abstract available

JIAN-BIN L, Lau EYH, Chan DKC
Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? testing health belief model and theory of planned behavior in a large-scale survey.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00340.
PubMed Abstract available

PI-ESTOPINAN F, Perez MT, Fraga A, Bergado G, et al
A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies.
Vaccine. 2022;40:1958-1967.
PubMed Abstract available

ESPOSITO S, Nauta J, Lapini G, Montomoli E, et al
Efficacy and safety of a quadrivalent influenza vaccine in children aged 6-35 months: A global, multiseasonal, controlled, randomized Phase III study.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00263.
PubMed Abstract available

BILGIN H, Marku M, Yilmaz SS, Karahasan Yagci A, et al
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-gamma release by natural killer cells.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00264.
PubMed Abstract available

CALLAGHAN T, Washburn D, Goidel K, Nuzhath T, et al
Imperfect messengers? An analysis of vaccine confidence among primary care physicians.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00302.
PubMed Abstract available

JI C, Piche-Renaud PP, Apajee J, Stephenson E, et al
Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: A retrospective cohort study.
Vaccine. 2022;40:1790-1798.
PubMed Abstract available

CAMARA J, Gonzalez-Diaz A, Barrabeig I, Fernandez-Huerta M, et al
SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: A role for the quantification of circulating antibodies.
Vaccine. 2022 Mar 15. pii: S0264-410X(22)00303.
PubMed Abstract available

ROTOLO B, Dube E, Vivion M, MacDonald SE, et al
Hesitancy towards COVID-19 vaccines on social media in Canada.
Vaccine. 2022 Mar 15. pii: S0264-410X(22)00301.
PubMed Abstract available

MOSCARDINO U, Musso P, Inguglia C, Ceccon C, et al
Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy.
Vaccine. 2022 Mar 14. pii: S0264-410X(22)00293.
PubMed Abstract available

VAN DEN HOOGEN LL, Smits G, van Hagen CCE, Wong D, et al
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
Vaccine. 2022 Mar 9. pii: S0264-410X(22)00272.
PubMed Abstract available

THOMAS CM, Searle K, Galvan A, Liebman AK, et al
Healthcare worker perspectives on COVID-19 vaccines: Implications for increasing vaccine acceptance among healthcare workers and patients.
Vaccine. 2022 Mar 9. pii: S0264-410X(22)00276.
PubMed Abstract available

YUEN VWH
Political attitudes and efficacy of health expert communication on the support for COVID-19 vaccination program: Findings from a survey in Hong Kong.
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00261.
PubMed Abstract available

BANSAL P, Raj A, Mani Shukla D, Sunder N, et al
COVID-19 vaccine preferences in India.
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00241.
PubMed Abstract available

MASCHERINI M, Nivakoski S
Social media use and vaccine hesitancy in the European Union.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00206.
PubMed Abstract available

KLUMPP M, Monfared IG, Vollmer S
Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00259.
PubMed Abstract available

COULAUD PJ, Ablona A, Bolduc N, Fast D, et al
COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00260.
PubMed Abstract available

ROBERTSON LJ, Price R, Moore JS, Curry G, et al
IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00262.
PubMed Abstract available

YU M, Yao X, Liu G, Wu J, et al
Barriers and facilitators to uptake and promotion of influenza vaccination among health care workers in the community in Beijing, China: A qualitative study.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00207.
PubMed Abstract available

POINTON L, Howe AS, Hobbs M, Paynter J, et al
Evidence of suboptimal maternal vaccination coverage in pregnant New Zealand women and increasing inequity over time: A nationwide retrospective cohort study.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00243.
PubMed Abstract available

KREPS SE, Kriner DL
How do COVID-19 vaccine mandates affect attitudes toward the vaccine and participation in mandate-affected activities? Evidence from the United States.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00258.
PubMed Abstract available

LAI FTT, Leung MTY, Chan EWW, Huang L, et al
Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring.
Vaccine. 2022;40:1390-1396.
PubMed Abstract available

LILLVIS DF, Miller CR, Kuo DZ
Pediatric primary care immunization policies in New York State.
Vaccine. 2022;40:1458-1463.
PubMed Abstract available

MOURA C, Truche P, Sousa Salgado L, Meireles T, et al
The impact of COVID-19 on routine pediatric vaccination delivery in Brazil.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00242.
PubMed Abstract available

February 2022

SINGH JA, Kochhar S, Wolff J, Atuire C, et al
WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations.
Vaccine. 2022 Feb 28. pii: S0264-410X(22)00175.
PubMed Abstract available

MCANDREW T, Cambeiro J, Besiroglu T
Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine.
Vaccine. 2022 Feb 28. pii: S0264-410X(22)00200.
PubMed Abstract available

SALIOU P, Duteil Q, Plotkin SA, Gentilini M, et al
The scourge of vaccine falsification.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00119.
PubMed Abstract available

MULLER KE, Dohos D, Sipos Z, Kiss S, et al
Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients.
Vaccine. 2022 Feb 25. pii: S0264-410X(22)00163.
PubMed Abstract available

KAGEYAMA T, Tanaka S, Etori K, Hattori K, et al
Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2.
Vaccine. 2022 Feb 25. pii: S0264-410X(22)00192.
PubMed Abstract available

MCGOLDRICK M, Gastineau T, Wilkinson D, Campa C, et al
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation.
Vaccine. 2022;40:1223-1230.
PubMed Abstract available

MCGOLDRICK M, Gastineau T, Wilkinson D, Campa C, et al
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation.
Vaccine. 2022;40:1215-1222.
PubMed Abstract available

HAO F, Shao W
Understanding the influence of political orientation, social network, and economic recovery on COVID-19 vaccine uptake among Americans.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00219.
PubMed Abstract available

ABBATECOLA AM, Incalzi RA, Malara A, Palmieri A, et al
Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00217.
PubMed Abstract available

EL-HENEIDY A, Grimwood K, Lambert SB, Sarna M, et al
Association between vaccination status, symptom identification and healthcare use: Implications for test negative design observational studies.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00198.
PubMed Abstract available

TAWINPRAI K, Siripongboonsitti T, Porntharukchareon T, Wittayasak K, et al
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial
Vaccine. 2022 Feb 21. pii: S0264-410X(22)00143.
PubMed Abstract available

ISMAIL ALHOSANI F, Eduardo Stanciole A, Aden B, Timoshkin A, et al
Impact of the Sinopharm's BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE).
Vaccine. 2022 Feb 19. pii: S0264-410X(22)00174.
PubMed Abstract available

WINTER T, Riordan BC, Scarf D, Jose PE, et al
Conspiracy beliefs and distrust of science predicts reluctance of vaccine uptake of politically right-wing citizens.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00074.
PubMed Abstract available

SCHMALING KB
Couples and COVID-19 vaccination: Frequency and reasons for discordance.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00202.
PubMed Abstract available

MERKLEY E, Loewen PJ
The correlates and dynamics of COVID-19 vaccine-specific hesitancy.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00168.
PubMed Abstract available

KASSTAN B, Mounier-Jack S, Letley L, Gaskell KM, et al
Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00201.
PubMed Abstract available

LAZO L, Bequet-Romero M, Lemos G, Musacchio A, et al
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice.
Vaccine. 2022;40:1162-1169.
PubMed Abstract available

JOG P, Memon IA, Thisyakorn U, Hozbor D, et al
Pertussis in Asia: Recent country-specific data and recommendations.
Vaccine. 2022;40:1170-1179.
PubMed Abstract available

STEFANIZZI P, Larocca AMV, Martinelli A, Soldano S, et al
Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00124.
PubMed Abstract available

KALASKA B, Miklosz J, Swieton J, Jakimczuk A, et al
The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00173.
PubMed Abstract available

SALEH OA, Halperin O
Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00160.
PubMed Abstract available

QUITIAN LM, Rodriguez-Martinez CE, Sossa-Briceno MP, Cortes JA, et al
Disease burden and vaccination priorities in Colombia.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00029.
PubMed Abstract available

AMMETER T, Lang P, Czock A
Overview of the influenza vaccination activities and legal frameworks in 26 Swiss cantons during the influenza season 2019/20.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00132.
PubMed Abstract available

GAFFNEY KK, Jana Broadhurst M, Brett-Major DM
Mumps to COVID-19: Vaccinated persons remain vulnerable when community uptake is low.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00193.
PubMed Abstract available

CHAN IL, Mowson R, Alonso JP, Roberti J, et al
Promoting immunization equity in Latin America and the Caribbean: Case studies, lessons learned, and their implication for COVID-19 vaccine equity.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00197.
PubMed Abstract available

MUCHIRI SK, Muthee R, Kiarie H, Sitienei J, et al
Unmet need for COVID-19 vaccination coverage in Kenya.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00167.
PubMed Abstract available

UWAMINO Y, Yokoyama T, Shimura T, Nishimura T, et al
The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00191.
PubMed Abstract available

YAMAMOTO S, Fukunaga A, Tanaka A, Takeuchi JS, et al
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00196.
PubMed Abstract available

TANI N, Chong Y, Kurata Y, Gondo K, et al
Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00158.
PubMed Abstract available

GAO F, An C, Bian L, Wang Y, et al
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00194.
PubMed Abstract available

CHRYSI P, Stella M, Marios K, Despo C, et al
Exploring vaccination coverage and attitudes of health care workers towards influenza vaccine in Cyprus.
Vaccine. 2022 Feb 12. pii: S0264-410X(22)00141.
PubMed Abstract available

TIBBELS NJ, Dosso A, Fordham C, Benie W, et al
"On the last day of the last month, I will go": A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00166.
PubMed Abstract available

HELLER O, Chun Y, Shlomo Y, Gewirtz-Meydan A, et al
Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00165.
PubMed Abstract available

DIETRICH LG, Luthy A, Lucas Ramanathan P, Baldesberger N, et al
Healthcare professional and professional stakeholders' perspectives on vaccine mandates in Switzerland: A mixed-methods study.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00007.
PubMed Abstract available

ABHILASH KPP, Mathiyalagan P, Krishnaraj VRK, Selvan S, et al
Impact of prior vaccination with Covishield(TM) and Covaxin(R) on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00157.
PubMed Abstract available

DREYER N, Reynolds MW, Albert L, Brinkley E, et al
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00103.
PubMed Abstract available

PRAMOD S, Govindan D, Ramasubramani P, Kar SS, et al
Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative case-control study.
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00138.
PubMed Abstract available

MASUDA T, Murakami K, Sugiura K, Sakui S, et al
A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report.
Vaccine. 2022 Feb 8. pii: S0264-410X(22)00164.
PubMed Abstract available

PEREZ-RODRIGUEZ S, de la Caridad Rodriguez-Gonzalez M, Ochoa-Azze R, Climent-Ruiz Y, et al
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity.
Vaccine. 2022 Feb 8. pii: S0264-410X(22)00161.
PubMed Abstract available

WALKER B, Anderson A, Stoecker C, Shao Y, et al
COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid.
Vaccine. 2022;40:837-840.
PubMed Abstract available

DOMNICH A, Orsi A, Sticchi L, Panatto D, et al
Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00137.
PubMed Abstract available

CRUVINEL E, P Richter K, S Scheuermann T, M Machado N, et al
The impact of COVID-19 on income and employment and willingness to become vaccinated among African Americans enrolled in a smoking cessation randomized trial.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00120.
PubMed Abstract available

MEWHIRTER J, Sagir M, Sanders R
Towards a predictive model of COVID-19 vaccine hesitancy among American adults.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00134.
PubMed Abstract available

BELLOS I, Karageorgiou V, Viskin D
Myocarditis following mRNA Covid-19 vaccination: A pooled analysis.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00140.
PubMed Abstract available

WONODI C, Obi-Jeff C, Adewumi F, Keluo-Udeke SC, et al
Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00126.
PubMed Abstract available

WALKER J, Paul P, Dooling K, Oliver S, et al
Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00136.
PubMed Abstract available

SPRENGHOLZ P, Korn L, Eitze S, Felgendreff L, et al
Attitude toward a mandatory COVID-19 vaccination policy and its determinants: Evidence from serial cross-sectional surveys conducted throughout the pandemic in Germany.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00130.
PubMed Abstract available

NONVIGNON J, Owusu R, Asare B, Adjagba A, et al
Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool.
Vaccine. 2022 Feb 4. pii: S0264-410X(22)00070.
PubMed Abstract available

AKGUN O, Kayaalp GK, Demirkan FG, Cakmak F, et al
Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey.
Vaccine. 2022 Feb 4. pii: S0264-410X(22)00117.
PubMed Abstract available

GORSE GJ, Grimes S, Buck H, Mulla H, et al
MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00059.
PubMed Abstract available

GORSE GJ, Grimes S, Buck H, Mulla H, et al
A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00058.
PubMed Abstract available

OLIANI F, Savoia A, Gallo G, Tiwana N, et al
Italy's rollout of COVID-19 vaccinations: The crucial contribution of the first experimental mass vaccination site in Lombardy.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00115.
PubMed Abstract available

IRVING SA, Groom HC, Dandamudi P, Daley MF, et al
A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00091.
PubMed Abstract available

ELLITHORPE ME, Alade F, Adams RB, Nowak GJ, et al
Looking ahead: Caregivers' COVID-19 vaccination intention for children 5 years old and younger using the health belief model.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00097.
PubMed Abstract available

HEYERDAHL LW, Vray M, Lana B, Tvardik N, et al
Conditionality of COVID-19 vaccine acceptance in European countries.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00099.
PubMed Abstract available

SHAW J, Anderson KB, Fabi RE, Thompson CA, et al
COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00100.
PubMed Abstract available

YOUSAF M, Hassan Raza S, Mahmood N, Core R, et al
Immunity debt or vaccination crisis? A multi-method evidence on vaccine acceptance and media framing for emerging COVID-19 variants.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00101.
PubMed Abstract available

January 2022

SANDMANN FG, van Leeuwen E, Bernard-Stoecklin S, Casado I, et al
Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00039.
PubMed Abstract available

JANSSEN YF, Feitsma EA, Boersma HH, Alleva DG, et al
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00077.
PubMed Abstract available

PAGET J, Danielle Iuliano A, Taylor RJ, Simonsen L, et al
Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project.
Vaccine. 2022 Jan 28. pii: S0264-410X(21)01561.
PubMed Abstract available

DING H, Huang J, Ngai CH, Sun Q, et al
The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00057.
PubMed Abstract available

KALNIN KV, Plitnik T, Kishko M, Huang D, et al
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00045.
PubMed Abstract available

JAFFE AE, Graupensperger S, Blayney JA, Duckworth JC, et al
The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies.
Vaccine. 2022 Jan 26. pii: S0264-410X(22)00073.
PubMed Abstract available

BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein.
Vaccine. 2022;40:536-543.
PubMed Abstract available

TANGUAY M, Boutin M, Laumaea A, Salaciak M, et al
B-cell cytopenia and time to last B-cell-depleting therapy predict response to SARS-COV-2 vaccines in patients with lymphoproliferative disorders.
Vaccine. 2022 Jan 24. pii: S0264-410X(22)00071.
PubMed Abstract available

TRENT MJ, Salmon DA, MacIntyre CR
Predictors of pneumococcal vaccination among Australian adults at high risk of pneumococcal disease.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00026.
PubMed Abstract available

STEBBINGS R, Armour G, Pettis V, Goodman J, et al
AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice.
Vaccine. 2022;40:192-195.
PubMed Abstract available

LIAO Q, Cowling BJ, Xiao J, Yuan J, et al
Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00055.
PubMed Abstract available

LIU F, Feng C, Xu S, Wu Q, et al
An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00054.
PubMed Abstract available

ZHU D, Lv M, Bai Y, Wu J, et al
Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in Beijing: A modeling analysis.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00024.
PubMed Abstract available

LI LL, Zheng C, La J, Do NV, et al
Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00051.
PubMed Abstract available

PITCOVSKI J, Gruzdev N, Abzach A, Katz C, et al
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00050.
PubMed Abstract available

PASSARETTI CL, Priem JS, Agner TG, McCurdy L, et al
Reducing the rates of household transmission: The impact of COVID-19 vaccination in healthcare workers with a known household exposure.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00044.
PubMed Abstract available

ROLFES L, Harmark L, Kant A, van Balveren L, et al
COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes.
Vaccine. 2022 Jan 17. pii: S0264-410X(22)00028.
PubMed Abstract available

BEDSTON S, Akbari A, Jarvis CI, Lowthian E, et al
COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales.
Vaccine. 2022 Jan 15. pii: S0264-410X(21)01535.
PubMed Abstract available

MOYO P, Bosco E, Bardenheier BH, Rivera-Hernandez M, et al
Variation in influenza vaccine assessment, receipt, and refusal by the concentration of Medicare Advantage enrollees in U.S. nursing homes.
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01688.
PubMed Abstract available

WONG WHS, Leung D, Chua GT, Duque JSR, et al
Adolescents' attitudes to the COVID-19 vaccination.
Vaccine. 2022 Jan 12. pii: S0264-410X(22)00025.
PubMed Abstract available

WOO EJ, Moro PL
Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
Vaccine. 2022 Jan 11. pii: S0264-410X(22)00001.
PubMed Abstract available

SHIMIZU S, Tanaka R, Itoh E, Maekawa-Matsuura M, et al
Performance and usability evaluation of novel intradermal injection device Immucise and reanalysis of intradermal administration trials of influenza vaccine for the elderly.
Vaccine. 2022 Jan 11. pii: S0264-410X(21)01669.
PubMed Abstract available

BLYTH DM, Liang Z, Williams M, Murray CK, et al
Immune interference revisited: Impact of live-attenuated influenza vaccine prior to yellow fever vaccination.
Vaccine. 2022 Jan 11. pii: S0264-410X(21)01637.
PubMed Abstract available

DANIEL CL, Williams J, Legg R, McGowen C, et al
Factors associated with COVID-19 vaccination intentions among adults in the deep South.
Vaccine. 2022 Jan 10. pii: S0264-410X(21)01667.
PubMed Abstract available

PENG KW, Carey T, Lech P, Vandergaast R, et al
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.
Vaccine. 2022 Jan 10. pii: S0264-410X(21)01671.
PubMed Abstract available

OMER I, Rosenberg A, Sefty H, Pando R, et al
Lineage-matched versus mismatched influenza B vaccine effectiveness following seasons of marginal influenza B circulation.
Vaccine. 2022 Jan 8. pii: S0264-410X(21)01664.
PubMed Abstract available

FOO D, Sarna M, Pereira G, Moore HC, et al
Longitudinal, population-based cohort study of prenatal influenza vaccination and influenza infection in childhood.
Vaccine. 2022 Jan 7. pii: S0264-410X(21)01556.
PubMed Abstract available

UWAMINO Y, Kurafuji T, Sato Y, Tomita Y, et al
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and universit
Vaccine. 2022 Jan 7. pii: S0264-410X(22)00002.
PubMed Abstract available

HSIAO A, Hansen J, Nunley KV, Lewis N, et al
Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational study.
Vaccine. 2022 Jan 6. pii: S0264-410X(21)01641.
PubMed Abstract available

EUSER S, Kroese FM, Derks M, de Bruin M, et al
Understanding COVID-19 vaccination willingness among youth: A survey study in the Netherlands.
Vaccine. 2022 Jan 5. pii: S0264-410X(21)01670.
PubMed Abstract available

THOMAS S, Durrheim D, Islam F, Higgins H, et al
Improved childhood immunization coverage using the World Health Organization's Tailoring Immunization Programmes guide (TIP) in a regional centre in Australia.
Vaccine. 2022;40:18-20.
PubMed Abstract available

KUJAWSKI SA, Yao L, Wang HE, Carias C, et al
Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis.
Vaccine. 2022 Jan 1. pii: S0264-410X(21)01672.
PubMed Abstract available

December 2021

GROOM HC, Crane B, Naleway AL, Weintraub E, et al
Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems.
Vaccine. 2021 Dec 31. pii: S0264-410X(21)01656.
PubMed Abstract available

PASCHALL AV, Ozdilek A, Briner SL, Brindley MA, et al
Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice.
Vaccine. 2021 Dec 31. pii: S0264-410X(21)01666.
PubMed Abstract available

SAELAND E, van der Fits L, Bolder R, Heemskerk-van der Meer M, et al
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.
Vaccine. 2021 Dec 29. pii: S0264-410X(21)01651.
PubMed Abstract available

SHUKLA S, Fressin F, Un M, Coetzer H, et al
Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01657.
PubMed Abstract available

RIBEIRO SP, De Moura Mattaraia VG, Almeida RR, Valentine EJG, et al
A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01550.
PubMed Abstract available

JUNE CHOE Y, Yi S, Hwang I, Kim J, et al
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01654.
PubMed Abstract available

THOMAS SJ, Perez JL, Lockhart SP, Hariharan S, et al
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01652.
PubMed Abstract available

KIM HJ, Yun HJ, Kim J, Kym S, et al
Antibody response to second dose of the BNT162b2 mRNA vaccine in the first 12 weeks in South Korea: A prospective longitudinal study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01620.
PubMed Abstract available

ROMAIN-SCELLE N, Elias C, Vanhems P
COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhone-Alpes region (France): An ecological study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01644.
PubMed Abstract available

MANOMAIPIBOON A, Phumisantiphong U, Maneerit J, Chalearmchai Y, et al
Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01632.
PubMed Abstract available

TADAKUMA K, Maruyama T, Mori K, Fujiki N, et al
Effectiveness of seasonal influenza vaccine in adult Japanese workers, 2017-2020.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01624.
PubMed Abstract available

WILLIAMS KV, Zhai B, Alcorn JF, Patricia Nowalk M, et al
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01643.
PubMed Abstract available

PETERSEN MB, Jorgensen F, Lindholt MF
Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic?
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01631.
PubMed Abstract available

SHAPIRO GK, Gottfredson N, Leask J, Wiley K, et al
COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01649.
PubMed Abstract available

BLANCO S, Salome Konigheim B, Diaz A, Spinsanti L, et al
Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort.
Vaccine. 2021 Dec 20. pii: S0264-410X(21)01634.
PubMed Abstract available

POUKKA E, Baum U, Palmu AA, Lehtonen TO, et al
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01640.
PubMed Abstract available

HERRING WL, Zhang Y, Shinde V, Stoddard J, et al
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01609.
PubMed Abstract available

CHUNG NH, Chen YC, Yang SJ, Lin YC, et al
Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein.
Vaccine. 2021 Dec 17. pii: S0264-410X(21)01635.
PubMed Abstract available

CARLSON SJ, McKenzie L, Roberts L, Blyth CC, et al
Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation.
Vaccine. 2021 Dec 16. pii: S0264-410X(21)01629.
PubMed Abstract available

GOLDBLATT D, Fiore-Gartland A, Johnson M, Hunt A, et al
Towards a population-based threshold of protection for COVID-19 vaccines.
Vaccine. 2021 Dec 15. pii: S0264-410X(21)01615.
PubMed Abstract available

YU Y, Jia W, Lau MMC, Lau JTF, et al
Levels and factors derived from the Health Action Process Approach of behavioral intentions to take up COVID-19 vaccination: A random population-based study.
Vaccine. 2021 Dec 15. pii: S0264-410X(21)01628.
PubMed Abstract available

CHEN X, Wang H
On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine.
Vaccine. 2021 Dec 14. pii: S0264-410X(21)01596.
PubMed Abstract available

ALMOHAYA AM, Alsubie H, Alqarni B, Alzayad B, et al
Acute unsolicited adverse events following BNT162b2 vaccine in Saudi Arabia, a real-world data.
Vaccine. 2021 Dec 13. pii: S0264-410X(21)01610.
PubMed Abstract available

BOTTON J, Dray-Spira R, Baricault B, Drouin J, et al
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01617.
PubMed Abstract available

LUTRICK K, Groom H, Fowlkes AL, Groover KD, et al
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01593.
PubMed Abstract available

HSIEH YL, Rak S, SteelFisher GK, Bauhoff S, et al
Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01559.
PubMed Abstract available

OLIVEIRA-SILVA J, Reis T, Lopes C, Batista-Silva R, et al
Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01621.
PubMed Abstract available

ZHAO AR, Bishai DM
Public health spending, primary care, and perceived risk promoted vaccination against H1N1.
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01538.
PubMed Abstract available

KATZ MA, Harlev EB, Chazan B, Chowers M, et al
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01580.
PubMed Abstract available

KADKHODA K
Post RNA-based COVID vaccines myocarditis: Proposed mechanisms.
Vaccine. 2021 Dec 9. pii: S0264-410X(21)01594.
PubMed

ZHAO H, Li Y, Wang Z
Adverse event of Sinovac Coronavirus vaccine: Deafness.
Vaccine. 2021 Dec 9. pii: S0264-410X(21)01576.
PubMed Abstract available

PEPIN J, Labbe AC, Carignan A, Parent ME, et al
Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, Canada.
Vaccine. 2021;39:7300-7307.
PubMed Abstract available

HOOK SA, Hansen AP, Niesobecki SA, Meek JI, et al
Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States.
Vaccine. 2021 Dec 8. pii: S0264-410X(21)01540.
PubMed Abstract available

LENNON RP, Block R Jr, Schneider EC, Zephrin L, et al
Underserved population acceptance of combination influenza-COVID-19 booster vaccines.
Vaccine. 2021 Dec 7. pii: S0264-410X(21)01597.
PubMed Abstract available

SULIS G, Basta NE, Wolfson C, Kirkland SA, et al
Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA).
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01579.
PubMed Abstract available

RAW RK, Rees J, Kelly CA, Wroe C, et al
Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01577.
PubMed Abstract available

BRONSTEIN MV, Kummerfeld E, MacDonald A 3rd, Vinogradov S, et al
Willingness to vaccinate against SARS-CoV-2: The role of reasoning biases and conspiracist ideation.
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01553.
PubMed Abstract available

NGUYEN AT, Arnold BF, Kennedy CJ, Mishra K, et al
Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01547.
PubMed Abstract available

HILL R
COVID-19 from a polio perspective.
Vaccine. 2021;39:7117-7118.
PubMed

IZAK M, Stoyanov E, Dezuraev K, Shinar E, et al
Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01557.
PubMed Abstract available

HERZBERG J, Vollmer T, Fischer B, Becher H, et al
SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01555.
PubMed Abstract available

YORSAENG R, Suntronwong N, Phowatthanasathian H, Assawakosri S, et al
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01560.
PubMed Abstract available

HELLE F, Moyet J, Demey B, Francois C, et al
Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01558.
PubMed Abstract available

VALCKX S, Crevecoeur J, Verelst F, Vranckx M, et al
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020).
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01414.
PubMed Abstract available

November 2021

ATTWELL K, Rizzi M, McKenzie L, Carlson SJ, et al
COVID-19 vaccine Mandates: An Australian attitudinal study.
Vaccine. 2021 Nov 30. pii: S0264-410X(21)01530.
PubMed Abstract available

SUGISHITA Y, Sugawara T
Effectiveness and cost-effectiveness of influenza vaccination for elderly people.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01257.
PubMed Abstract available

CASTRO F, Pascale JM, Slocum Hewitt I, Calvo A, et al
Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01504.
PubMed

SCHMITZ M, Luminet O, Klein O, Morbee S, et al
Predicting vaccine uptake during COVID-19 crisis: A motivational approach.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01542.
PubMed Abstract available

MALTEZOU HC, Anastassopoulou C, Hatziantoniou S, Poland GA, et al
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01539.
PubMed Abstract available

GULPINAR G, Uzun MB
Examining community pharmacists' intention to provide pharmacist-driven vaccination services: A structural equation modelling.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01499.
PubMed Abstract available

ROBERTSON JS, Loizides U, Adisa A, Lopez de la Rica Manjavacas A, et al
International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01528.
PubMed Abstract available

BUCHMAN TG, Simpson SQ, Sciarretta KL, Finne KP, et al
Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries().
Vaccine. 2021 Nov 23. pii: S0264-410X(21)01461.
PubMed Abstract available

LENTZEN MP, Huebenthal V, Kaiser R, Kreppel M, et al
A retrospective analysis of social media posts pertaining to COVID-19 vaccination side effects.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01526.
PubMed Abstract available

DINC HO, Saltoglu N, Can G, Balkan II, et al
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01507.
PubMed Abstract available

LIN C, Tu P, Terry TC
Moving the needle on racial disparity: COVID-19 vaccine trust and hesitancy.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01444.
PubMed Abstract available

MUSCATELLO DJ, Nazareno AL, Turner RM, Newall AT, et al
Influenza-associated mortality in Australia, 2010 through 2019: High modelled estimates in 2017.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01464.
PubMed Abstract available

CHEN T, Dai M, Xia S
Perceived facilitators and barriers to intentions of receiving the COVID-19 vaccines among elderly Chinese adults.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01484.
PubMed Abstract available

CAMBON L, Schwarzinger M, Alla F
Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01467.
PubMed Abstract available

ORTEGA-SANCHEZ IR, Mott JA, Kittikraisak W, Khanthamaly V, et al
Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01445.
PubMed Abstract available

IRVING SA, Ball SW, Booth SM, Regan AK, et al
A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01463.
PubMed Abstract available

NGUYEN KH, Anneser E, Toppo A, Allen JD, et al
Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults >/= 18 years, United States.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01485.
PubMed Abstract available

BELLIZZI S, Aidyralieva C, Al-Shaikh A, Muthu N, et al
Inclusiveness of prisons in COVID-19 vaccination deployment: Evidence from Jordan.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01468.
PubMed

KITRO A, Sirikul W, Piankusol C, Rirermsoonthorn P, et al
Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand.
Vaccine. 2021 Nov 17. pii: S0264-410X(21)01476.
PubMed Abstract available

VOSS G, Jacquet JM, Tornieporth N, Kampmann B, et al
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01382.
PubMed Abstract available

BRAKEL KA, Binjawadagi B, French-Kim K, Watts M, et al
Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model.
Vaccine. 2021;39:6817-6828.
PubMed Abstract available

MURPHY RP, Taaffe C, Ahern E, McMahon G, et al
A meta-analysis of influenza vaccination following correspondence: Considerations for COVID-19.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01470.
PubMed Abstract available

ROGERS JH, Cox SN, Hughes JP, Link AC, et al
Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 - King County, Washington.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01471.
PubMed Abstract available

SILAS J, Jones A, Weiss-Cohen L, Ayton P, et al
The seductive allure of technical language and its effect on covid-19 vaccine beliefs and intentions.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01472.
PubMed Abstract available

ROSENTHAL S, Cummings CL
Influence of rapid COVID-19 vaccine development on vaccine hesitancy.
Vaccine. 2021 Nov 13. pii: S0264-410X(21)01448.
PubMed Abstract available

VIZCARRA P, Haemmerle J, Velasco H, Velasco T, et al
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity.
Vaccine. 2021 Nov 11. pii: S0264-410X(21)01417.
PubMed Abstract available

CHHABRIA S, Stanford FC
A long shot: The importance of needle length in vaccinating patients with obesity against COVID-19.
Vaccine. 2021 Nov 11. pii: S0264-410X(21)01442.
PubMed

MCLEAN HQ, Levine MZ, King JP, Flannery B, et al
Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01415.
PubMed Abstract available

RODRIGUES CMC, Plotkin SA
The influence of interval between doses on response to vaccines.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01381.
PubMed

WU K, Choi A, Koch M, Elbashir S, et al
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01435.
PubMed Abstract available

MCKINNON B, Quach C, Dube E, Tuong Nguyen C, et al
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01426.
PubMed Abstract available

SHARUN K, Tiwari R, Saied AA, Dhama K, et al
SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01386.
PubMed Abstract available

GOODE JR, Cook P, Cuttino S, Gatewood SBS, et al
Early experience with COVID-19 vaccine in a Federally-Qualified Healthcare Center for the homeless.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01388.
PubMed

DE HAAS TDJ, Yeung KHT, Hutubessy R, van der Putten IM, et al
Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
Vaccine. 2021;39:6762-6780.
PubMed Abstract available

LAU CL, Mayfield HJ, Sinclair JE, Brown SJ, et al
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
Vaccine. 2021 Nov 4. pii: S0264-410X(21)01428.
PubMed Abstract available

SANZ-ROJO S, Jimenez-Garcia R, Lopez-de-Andres A, de Miguel-Diez J, et al
Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01392.
PubMed Abstract available

RIBERA-CANO A, Dupont M, Houze-Cerfon CH, Houze-Cerfon V, et al
Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01429.
PubMed Abstract available

MALTEZOU HC
Vaccination of healthcare personnel in the COVID-19 era: A call for actions.
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01427.
PubMed

CASSONE A, Cauda R
Multicomponent vaccines to fight SARS-CoV-2 variants of concern.
Vaccine. 2021 Nov 1. pii: S0264-410X(21)01402.
PubMed

WAGNER A, Jasinska J, Tomosel E, Zielinski CC, et al
Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments.
Vaccine. 2021 Nov 1. pii: S0264-410X(21)01401.
PubMed Abstract available

October 2021

KHOURY J, Najjar-Debbiny R, Hanna A, Jabbour A, et al
COVID-19 vaccine - Long term immune decline and breakthrough infections.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01370.
PubMed Abstract available

LIU H, Zhou C, An J, Song Y, et al
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01399.
PubMed Abstract available

MALTEZOU HC, Panagopoulos P, Sourri F, Giannouchos TV, et al
COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01387.
PubMed Abstract available

GORDON SF, Clothier HJ, Morgan H, Buttery JP, et al
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
Vaccine. 2021 Oct 29. pii: S0264-410X(21)01350.
PubMed Abstract available

GARCIA-GRIMSHAW M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
Vaccine. 2021 Oct 29. pii: S0264-410X(21)01391.
PubMed Abstract available

MAZUR A, Benitez S, Chuffart-Finsterwald S, La Rotta R, et al
COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries.
Vaccine. 2021 Oct 28. pii: S0264-410X(21)01380.
PubMed

MARTIN S, Vanderslott S
"Any idea how fast 'It's just a mask!' can turn into 'It's just a vaccine!'": From mask mandates to vaccine mandates during the COVID-19 pandemic.
Vaccine. 2021 Oct 28. pii: S0264-410X(21)01351.
PubMed Abstract available

NOWALK MP, D'Agostino HEA, Zimmerman RK, Saul SG, et al
Agreement among sources of adult influenza vaccination in the age of immunization information systems.
Vaccine. 2021 Oct 26. pii: S0264-410X(21)01372.
PubMed Abstract available

CHANTHAVANICH P, Versage E, Van Twuijver E, Hohenboken M, et al
Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01317.
PubMed Abstract available

OLANIPEKUN T, Abe T, Effoe V, Westney G, et al
Changes in COVID-19 vaccine acceptance rate among recovered critically Ill patients: A 12-month follow-up study.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01324.
PubMed Abstract available

LOEB M, Russell ML, Kelly-Stradiotto C, Fuller N, et al
Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01355.
PubMed Abstract available

SHACHOR-MEYOUHAS Y, Hussein K, Szwarcwort-Cohen M, Weissman A, et al
Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01327.
PubMed Abstract available

TRAN VN, Nguyen HA, Le TTA, Truong TT, et al
Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
Vaccine. 2021;39:6485-6491.
PubMed Abstract available

ANDRADE G
Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01371.
PubMed Abstract available

MAKOVITZKI A, Lerer E, Kafri Y, Adar Y, et al
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01376.
PubMed Abstract available

FAN S, Li D, Zhao H, Yu L, et al
Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01375.
PubMed Abstract available

JAMES EK, Bokemper SE, Gerber AS, Omer SB, et al
Persuasive messaging to increase COVID-19 vaccine uptake intentions.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01368.
PubMed Abstract available

WANG J, Wagner AL, Chen Y, Jaime E, et al
Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01340.
PubMed Abstract available

DANG TKNS, Rivero Cabrera R, Yeung KHT, van der Putten IM, et al
Feasibility of age- and gestation-based routine universal influenza vaccines schedules for children aged 6 months - 2 years and pregnant women.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01291.
PubMed Abstract available

CHEN AT, Stacey HD, Marzok A, Singh P, et al
Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01341.
PubMed Abstract available

KIM D, Pekgun P, Yildirim I, Keskinocak P, et al
Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01346.
PubMed Abstract available

CHAPIN-BARDALES J, Myers T, Gee J, Shay DK, et al
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
Vaccine. 2021 Oct 16. pii: S0264-410X(21)01339.
PubMed Abstract available

ALI SAHRAIAN M, Ghadiri F, Azimi A, Naser Moghadasi A, et al
Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV.
Vaccine. 2021;39:6347-6350.
PubMed Abstract available

YAMAMOTO N, Takahashi Y, Hayashi S
Legal and regulatory processes for Japan's COVID-19 immunization program.
Vaccine. 2021;39:6449-6450.
PubMed

AYAZ S, Dibben O, Chapman D
Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness.
Vaccine. 2021 Oct 15. pii: S0264-410X(21)01320.
PubMed Abstract available

MOGHNIEH R, Mekdashi R, El-Hassan S, Abdallah D, et al
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01314.
PubMed Abstract available

MCNAY LA, Arnoczy G, Martell M, Mock P, et al
Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies.
Vaccine. 2021;39:6183-6185.
PubMed Abstract available

HART P, Farrar J
The influenza vaccines roadmap - A better future through improved influenza vaccines.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01286.
PubMed

MOTTELSON A, Vandeweerdt C, Atchapero M, Luong T, et al
A self-administered virtual reality intervention increases COVID-19 vaccination intention.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01311.
PubMed Abstract available

BYRNE T, Patel P, Shrotri M, Beale S, et al
Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and Wales (Virus Watch).
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01281.
PubMed Abstract available

HUMBLE RM, Sell H, Dube E, MacDonald NE, et al
Canadian parents' perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01309.
PubMed Abstract available

MULLER-PEBODY B, Sinnathamby MA, Warburton F, Rooney G, et al
Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01284.
PubMed Abstract available

REIDENBERG BE, Hirsch K, Costello CM, Russo M, et al
Drive through COVID19 vaccination for developmentally disabled persons.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01279.
PubMed

ALLEVA DG, Delpero AR, Scully MM, Murikipudi S, et al
Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01294.
PubMed Abstract available

LAZAROS G, Anastassopoulou C, Hatziantoniou S, Kalos T, et al
A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01295.
PubMed Abstract available

CORCORAN KE, Scheitle CP, DiGregorio BD
Christian nationalism and COVID-19 vaccine hesitancy and uptake.
Vaccine. 2021 Oct 2. pii: S0264-410X(21)01289.
PubMed Abstract available

PALLIKKUTH S, Williams E, Pahwa R, Hoffer M, et al
Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers.
Vaccine. 2021;39:6019-6024.
PubMed Abstract available

BOZORGI A, Fahimnia B
Micro array patch (MAP) for the delivery of thermostable vaccines in Australia: A cost/benefit analysis.
Vaccine. 2021;39:6166-6173.
PubMed Abstract available

BOZORGI A, Fahimnia B
Transforming the vaccine supply chain in Australia: Opportunities and challenges.
Vaccine. 2021;39:6157-6165.
PubMed Abstract available

September 2021

ROMANO CJ, Hall C, Khodr ZG, Bukowinski AT, et al
History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01171.
PubMed Abstract available

FRANCIS-OLIVIERO F, Bozoki S, Micsik A, Kieny MP, et al
Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination).
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01224.
PubMed Abstract available

YACOUB MR, Cucca V, Asperti C, Ramirez GA, et al
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01239.
PubMed Abstract available

VIEIRA REZENDE RP, Braz AS, Guimaraes MFB, Ribeiro SLE, et al
Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01260.
PubMed Abstract available

BLEICHER I, Kadour-Peero E, Sagi-Dain L, Sagi S, et al
Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01234.
PubMed Abstract available

SHEVZOV-ZEBRUN N, Caplan A
Parental consent for vaccination of minors against COVID-19.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01250.
PubMed

FISHER KA, Nguyen N, Crawford S, Fouayzi H, et al
Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01261.
PubMed Abstract available

MOLODECKY NA, Jafari H, Safdar RM, Ahmed JA, et al
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01228.
PubMed Abstract available

LAW JLM, Logan M, Joyce MA, Landi A, et al
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1.
Vaccine. 2021;39:5769-5779.
PubMed Abstract available

LI L, Honda-Okubo Y, Huang Y, Jang H, et al
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection.
Vaccine. 2021;39:5940-5953.
PubMed Abstract available

FADLYANA E, Rusmil K, Tarigan R, Rahmadi AR, et al
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01255.
PubMed Abstract available

SINGH AK, Phatak SR, Singh R, Bhattacharjee K, et al
Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield(TM)(R)) and BBV-152 (Covaxin(TM)(R)) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01258.
PubMed Abstract available

MOORE KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, et al
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.
Vaccine. 2021 Sep 23. pii: S0264-410X(21)01028.
PubMed Abstract available

PARK SJ, Kang YM, Cho HK, Kim DY, et al
Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice.
Vaccine. 2021 Sep 20. pii: S0264-410X(21)01207.
PubMed Abstract available

MANSUY JM, Sagna AS, Laurent M, Izopet J, et al
COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination?
Vaccine. 2021 Sep 17. pii: S0264-410X(21)01227.
PubMed

RAINA MACINTYRE C, Costantino V, Chanmugam A
The use of face masks during vaccine roll-out in New YorkCity and impact on epidemic control.
Vaccine. 2021 Sep 16. pii: S0264-410X(21)01164.
PubMed Abstract available

MOSINA L, Kulper-Schiek W, Jacques-Carroll L, Earnshaw A, et al
Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform.
Vaccine. 2021 Sep 16. pii: S0264-410X(21)01225.
PubMed Abstract available

SELL H, Assi A, Driedger SM, Dube E, et al
Continuity of routine immunization programs in Canada during the COVID-19 pandemic.
Vaccine. 2021;39:5532-5537.
PubMed Abstract available

SULIMAN S, Pelzer PT, Shaku M, Rozot V, et al
Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021.
Vaccine. 2021 Sep 15. pii: S0264-410X(21)01154.
PubMed Abstract available

LIU D, Leung K, Jit M, Wu JT, et al
Cost-effectiveness of strategies for preventing paediatric lower respiratory infections associated with respiratory syncytial virus in eight Chinese cities.
Vaccine. 2021;39:5490-5498.
PubMed Abstract available

KOHL-HECKL WK, Schroter M, Dobos G, Cramer H, et al
Complementary medicine use and flu vaccination - A nationally representative survey of US adults.
Vaccine. 2021;39:5635-5640.
PubMed Abstract available

KIM DY, Kang YM, Cho HK, Park SJ, et al
Development of a recombinant H9N2 influenza vaccine candidate against the Y280 lineage field virus and its protective efficacy.
Vaccine. 2021 Sep 14. pii: S0264-410X(21)01149.
PubMed Abstract available

VAN HOOSTE WLC
Influenza vaccination at the workplace.
Vaccine. 2021 Sep 14. pii: S0264-410X(21)01188.
PubMed

BENJAMIN-CHUNG J, Arnold BF, Mishra K, Kennedy CJ, et al
City-wide school-located influenza vaccination: A retrospective cohort study.
Vaccine. 2021 Sep 14. pii: S0264-410X(21)01161.
PubMed Abstract available

PALACHE A, Rockman S, Taylor B, Akcay M, et al
Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
Vaccine. 2021 Sep 11. pii: S0264-410X(21)01157.
PubMed Abstract available

THOMPSON MG, Soto G, Perez A, Newes-Adeyim G, et al
Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.
Vaccine. 2021 Sep 8. pii: S0264-410X(21)00982.
PubMed Abstract available

PERRY M, Akbari A, Cottrell S, Gravenor MB, et al
Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK.
Vaccine. 2021 Sep 8. pii: S0264-410X(21)01198.
PubMed Abstract available

JOGI P, Soeorg H, Ingerainen D, Soots M, et al
Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study).
Vaccine. 2021;39:5376-5384.
PubMed Abstract available

WAINSTOCK T, Yoles I, Sergienko R, Sheiner E, et al
Prenatal maternal COVID-19 vaccination and pregnancy outcomes.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01191.
PubMed Abstract available

MOORE DCBC, Nehab MF, Camacho KG, Reis AT, et al
Low COVID-19 vaccine hesitancy in Brazil.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01192.
PubMed Abstract available

EBERHARDT J, Ling J
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01189.
PubMed Abstract available

SULIMAN DM, Nawaz FA, Mohanan P, Modber MAKA, et al
UAE efforts in promoting COVID-19 vaccination and building vaccine confidence.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01194.
PubMed Abstract available

JACOBI CJ, Vaidyanathan B
Racial differences in anticipated COVID-19 vaccine acceptance among religious populations in the US.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01184.
PubMed Abstract available

SCHLEISS MR, John CC, Permar SR
Children are the key to the Endgame: A case for routine pediatric COVID vaccination.
Vaccine. 2021;39:5333-5336.
PubMed

LEVIN D, Shimon G, Fadlon-Derai M, Gershovitz L, et al
Myocarditis following COVID-19 vaccination - A case series.
Vaccine. 2021 Sep 4. pii: S0264-410X(21)01172.
PubMed Abstract available

ZHOU Z, Zhang X, Li Q, Fu L, et al
Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19.
Vaccine. 2021 Sep 3. pii: S0264-410X(21)01165.
PubMed Abstract available

ALI A, Dwyer D, Wu Q, Wang Q, et al
Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies.
Vaccine. 2021 Sep 2. pii: S0264-410X(21)01126.
PubMed Abstract available

DRUEDAHL LC, Minssen T, Price WN
Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships.
Vaccine. 2021 Sep 2. pii: S0264-410X(21)01163.
PubMed Abstract available

BARRY M, Temsah MH, Aljamaan F, Saddik B, et al
COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout.
Vaccine. 2021 Sep 1. pii: S0264-410X(21)01131.
PubMed Abstract available

August 2021

PRIVOR-DUMM LA, Poland GA, Barratt J, Durrheim DN, et al
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action.
Vaccine. 2021;39:5240-5250.
PubMed Abstract available

CANTARELLI P, Belle N, Quattrone F
Nudging influenza vaccination among health care workers.
Vaccine. 2021 Aug 31. pii: S0264-410X(21)01073.
PubMed Abstract available

TROGSTAD L, Robertson AH, Mjaaland S, Magnus P, et al
Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study.
Vaccine. 2021 Aug 31. pii: S0264-410X(21)01103.
PubMed Abstract available

ALBANI VVL, Loria J, Massad E, Zubelli JP, et al
The impact of COVID-19 vaccination delay: A data-driven modeling analysis for Chicago and New York City.
Vaccine. 2021 Aug 31. pii: S0264-410X(21)01158.
PubMed Abstract available

DRISCOLL AJ, Ortiz JR, Hartert TV, Riddell CA, et al
Recalibrating public health expectations of respiratory syncytial virus lower respiratory tract illness prevention on chronic respiratory disease.
Vaccine. 2021;39:5257-5258.
PubMed

BROSH-NISSIMOV T, Sorek N, Yeshayahu M, Zherebovich I, et al
Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19.
Vaccine. 2021 Aug 30. pii: S0264-410X(21)01148.
PubMed Abstract available

O'LORCAIN P, Cotter S, Walsh C
Influenza vaccine uptake among healthcare workers and residents in public health care facilities in Ireland over nine influenza seasons (2011-2012 to 2019-2020).
Vaccine. 2021 Aug 27. pii: S0264-410X(21)00987.
PubMed Abstract available

XU X, Rodgers MD, Guo WG
A hub-and-spoke design for ultra-cold COVID-19 vaccine distribution.
Vaccine. 2021 Aug 25. pii: S0264-410X(21)01117.
PubMed Abstract available

HARPAZ R
COVID-19 vaccine safety monitoring: Might differential healthcare seeking introduce detection bias into rates of medical events and cause false safety signals?
Vaccine. 2021 Aug 25. pii: S0264-410X(21)00712.
PubMed

ROTENBERG S, Downer MB, Cooper J
Making COVID-19 vaccinations accessible for people with disabilities.
Vaccine. 2021 Aug 24. pii: S0264-410X(21)01110.
PubMed

PIERCE-RUIZ C, Santana WI, Sutton WJH, Fischler DA, et al
Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry.
Vaccine. 2021;39:5106-5115.
PubMed Abstract available

WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
Dementia risk following influenza vaccination in a large veteran cohort running head: Influenza vaccination and dementia.
Vaccine. 2021 Aug 19. pii: S0264-410X(21)01079.
PubMed Abstract available

BRAEYE T, Cornelissen L, Catteau L, Haarhuis F, et al
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
Vaccine. 2021 Aug 19. pii: S0264-410X(21)01108.
PubMed Abstract available

DUDLEY MZ, Bernier R, Brewer J, Salmon DA, et al
Walking the Tightrope: Reevaluating science communication in the era of COVID-19 vaccines.
Vaccine. 2021 Aug 19. pii: S0264-410X(21)01070.
PubMed Abstract available

PENG HK, Dombkowski KJ, Freed GL, Creary SE, et al
Influenza immunization coverage of children with sickle cell disease.
Vaccine. 2021 Aug 17. pii: S0264-410X(21)01072.
PubMed Abstract available

LIU S, Liu J
Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis.
Vaccine. 2021 Aug 17. pii: S0264-410X(21)01106.
PubMed Abstract available

LAUFER RS, Driscoll AJ, Baral R, Buchwald AG, et al
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions.
Vaccine. 2021;39:5037-5045.
PubMed Abstract available

HAGAN LM, Dusseau C, Crockett M, Rodriguez T, et al
COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.
Vaccine. 2021 Aug 14. pii: S0264-410X(21)01078.
PubMed Abstract available

LAIGLE V, Postma MJ, Pavlovic M, Cadeddu C, et al
Vaccine market access pathways in the EU27 and the United Kingdom-analysis and recommendations for improvements.
Vaccine. 2021 Aug 14. pii: S0264-410X(21)00918.
PubMed Abstract available

CIAPPONI A, Bardach A, Mazzoni A, Alconada T, et al
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.
Vaccine. 2021 Aug 13. pii: S0264-410X(21)01067.
PubMed Abstract available

PALLADINO G, Ferrari A, Music N, Settembre EC, et al
Improved immunologic responses to heterologous influenza strains in children with low preexisting antibody response vaccinated with MF59-adjuvanted influenza vaccine.
Vaccine. 2021 Aug 12. pii: S0264-410X(21)01041.
PubMed Abstract available

STINSON JA, Boopathy AV, Cieslewicz BM, Zhang Y, et al
Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles.
Vaccine. 2021 Aug 11. pii: S0264-410X(21)00957.
PubMed Abstract available

GRUPEL D, Gazit S, Schreiber L, Nadler V, et al
Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination.
Vaccine. 2021 Aug 11. pii: S0264-410X(21)01045.
PubMed Abstract available

KANJI JN, Bailey A, Fenton J, Ling SH, et al
Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests.
Vaccine. 2021 Aug 11. pii: S0264-410X(21)01042.
PubMed Abstract available

OKAMURA S, Ebina H
Could live attenuated vaccines better control COVID-19?
Vaccine. 2021 Aug 11. pii: S0264-410X(21)01038.
PubMed Abstract available

RIZK JG, Barr CE, Rizk Y, Lewin JC, et al
The next frontier in vaccine safety and VAERS: Lessons from COVID-19 and ten recommendations for action.
Vaccine. 2021 Aug 10. pii: S0264-410X(21)01006.
PubMed

PETRIE JG, Fligiel H, Lamerato L, Martin ET, et al
Agreement between state registry, health record, and self-report of influenza vaccination.
Vaccine. 2021 Aug 9. pii: S0264-410X(21)00995.
PubMed Abstract available

LYTLE KL, Collins SP, Feldstein LR, Baughman AH, et al
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.
Vaccine. 2021 Aug 7. pii: S0264-410X(21)00948.
PubMed Abstract available

YOSHIKAWA T
Implementing vaccination policies based upon scientific evidence in Japan.
Vaccine. 2021 Aug 7. pii: S0264-410X(21)00968.
PubMed Abstract available

PHILLIPS A, Carlson S, Danchin M, Beard F, et al
From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years.
Vaccine. 2021 Aug 7. pii: S0264-410X(21)00950.
PubMed Abstract available

FENG J, Li Q
How to ensure vaccine safety: An evaluation of China's vaccine regulation system.
Vaccine. 2021 Aug 6. pii: S0264-410X(21)00986.
PubMed Abstract available

TAYLOR SC, Hurst B, Martiszus I, Hausman MS, et al
Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination.
Vaccine. 2021 Aug 6. pii: S0264-410X(21)01013.
PubMed Abstract available

D'SOUZA MP, Palin AC, Calder T, Golding H, et al
Mind the gap from research laboratory to clinic: Challenges and opportunities for next-generation assays in human diseases.
Vaccine. 2021 Aug 5. pii: S0264-410X(21)00964.
PubMed Abstract available

FRIEDENSOHN L, Zur M, Timofeyev M, Burshtein S, et al
Sub-cutaneous Pfizer/BioNTech COVID-19 vaccine administration results in seroconversion among young adults.
Vaccine. 2021 Aug 5. pii: S0264-410X(21)01010.
PubMed Abstract available

DODD RH, Pickles K, Cvejic E, Cornell S, et al
Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia.
Vaccine. 2021 Aug 5. pii: S0264-410X(21)01008.
PubMed Abstract available

HAUPT RE, Harberts EM, Kitz RJ, Strohmeier S, et al
Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection.
Vaccine. 2021 Aug 3. pii: S0264-410X(21)00847.
PubMed Abstract available

SAKALA IG, Honda-Okubo Y, Li L, Baldwin J, et al
A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization.
Vaccine. 2021 Aug 3. pii: S0264-410X(21)00914.
PubMed Abstract available

HAYMAN B, Dennehy M
Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization.
Vaccine. 2021 Aug 3. pii: S0264-410X(21)00922.
PubMed Abstract available

July 2021

REDONDO E, Drago G, Lopez-Belmonte JL, Guillen JM, et al
Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine.
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00926.
PubMed Abstract available

KONTOPOULOU K, Ainatzoglou A, Nakas CT, Ifantidou A, et al
Second dose of the BNT162b2 mRNA vaccine: Value of timely administration but questionable necessity among the seropositive.
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00958.
PubMed Abstract available

SIDDIQUI A, Ahmed A, Tanveer M, Saqlain M, et al
An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan.
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00965.
PubMed

MAHAJAN A, Kaur J, Sidana C, Shivam S, et al
Geo-prioritization framework for COVID-19 vaccine allocation in India.
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00989.
PubMed Abstract available

RAGHUNANDAN R, Higgins D, Hosken N
RSV neutralization assays - Use in immune response assessment.
Vaccine. 2021;39:4591-4597.
PubMed Abstract available

DIACO M, Yin K, Seet B, Samson S, et al
Author response to a Letter to the Editor on "Introductory paper: High dose influenza vaccine".
Vaccine. 2021 Jul 28. pii: S0264-410X(21)00917.
PubMed

YU VG, Lasco G, David CC
Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines.
Vaccine. 2021 Jul 27. pii: S0264-410X(21)00929.
PubMed Abstract available

GEORGIADIS GP, Georgiadis MC
Optimal planning of the COVID-19 vaccine supply chain.
Vaccine. 2021 Jul 27. pii: S0264-410X(21)00961.
PubMed Abstract available

RAJAN S, Akhtar N, Sharma S, Chakrabarti D, et al
COVID-19 vaccination for cancer patients: Evidence, priority, and practice.
Vaccine. 2021 Jul 24. pii: S0264-410X(21)00956.
PubMed

MICHOS A, Tatsi EB, Filippatos F, Dellis C, et al
Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1(st) and 2(nd) doses of the BNT162b2 vaccine.
Vaccine. 2021 Jul 24. pii: S0264-410X(21)00960.
PubMed Abstract available

CALLAHAN AG, Coleman-Cowger VH, Schulkin J, Power ML, et al
Racial disparities in influenza immunization during pregnancy in the United States: A narrative review of the evidence for disparities and potential interventions.
Vaccine. 2021 Jul 23. pii: S0264-410X(21)00905.
PubMed Abstract available

BURKE PF, Masters D, Massey G
Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions.
Vaccine. 2021 Jul 23. pii: S0264-410X(21)00947.
PubMed Abstract available

TEASDALE CA, Borrell LN, Shen Y, Kimball S, et al
Parental plans to vaccinate children for COVID-19 in New York city.
Vaccine. 2021 Jul 23. pii: S0264-410X(21)00949.
PubMed Abstract available

SUNDARAM M, Nasreen S, Calzavara A, He S, et al
Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments.
Vaccine. 2021 Jul 23. pii: S0264-410X(21)00951.
PubMed Abstract available

SCHEIBLHOFER S, Drothler S, Braun W, Braun R, et al
Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.
Vaccine. 2021;39:4399-4403.
PubMed Abstract available

ARIAS-FERNANDEZ L, San-Roman Montero J, Gil-Prieto R, Walter S, et al
Burden of pneumonia in patients with viral and bacterial coinfection in Spain during six consecutive influenza seasons, from 2009-10 to 2014-15.
Vaccine. 2021 Jul 22. pii: S0264-410X(21)00912.
PubMed Abstract available

HERVE PL, Dhelft V, Zuniga A, Ghasparian A, et al
Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.
Vaccine. 2021;39:4555-4563.
PubMed Abstract available

MATHIVATHANAN K
Will COVID-19 vaccine equity be possible in India?
Vaccine. 2021 Jul 22. pii: S0264-410X(21)00927.
PubMed

TISSOT N, Brunel AS, Bozon F, Rosolen B, et al
Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine.
Vaccine. 2021 Jul 22. pii: S0264-410X(21)00925.
PubMed Abstract available

CHUA H, Kwan MYW, Chan ELY, Wong JSC, et al
Influenza vaccine effectiveness against influenza-associated hospitalization in children in Hong Kong, 2010-2020.
Vaccine. 2021 Jul 20. pii: S0264-410X(21)00873.
PubMed Abstract available

INGROLE RSJ, Tao W, Joshi G, Gill HS, et al
M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets.
Vaccine. 2021 Jul 20. pii: S0264-410X(21)00909.
PubMed Abstract available

PAUL E, Brown GW, Kalk A, Ridde V, et al
Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager.
Vaccine. 2021 Jul 20. pii: S0264-410X(21)00923.
PubMed

HANLY M, Churches T, Fitzgerald O, MacIntyre CR, et al
Vaccinating Australia: How long will it take?
Vaccine. 2021 Jul 17. pii: S0264-410X(21)00865.
PubMed Abstract available

FLUCKIGER AC, Ontsouka B, Bozic J, Diress A, et al
An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.
Vaccine. 2021 Jul 16. pii: S0264-410X(21)00911.
PubMed Abstract available

INSERRA F, Tajer C, Antonietti L, Mariani J, et al
Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
Vaccine. 2021 Jul 16. pii: S0264-410X(21)00908.
PubMed

JAIN R, Chopra A, Falezan C, Patel M, et al
COVID-19 related immunization disruptions in Rajasthan, India: A retrospective observational study.
Vaccine. 2021;39:4343-4350.
PubMed Abstract available

PICHE-RENAUD PP, Ji C, Farrar DS, Friedman JN, et al
Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada.
Vaccine. 2021;39:4373-4382.
PubMed Abstract available

MOGAJI E
Marketing the COVID-19 vaccine and the implications for public health.
Vaccine. 2021 Jul 13. pii: S0264-410X(21)00874.
PubMed Abstract available

HAYMAN B, Suri R, Prasad SD
COVID-19 vaccine capacity: Challenges and mitigation - The DCVMN perspective.
Vaccine. 2021 Jul 13. pii: S0264-410X(21)00866.
PubMed Abstract available

LAZAROS G, Klein AL, Hatziantoniou S, Tsioufis C, et al
The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism.
Vaccine. 2021 Jul 13. pii: S0264-410X(21)00875.
PubMed

CLARKE M, Goodchild LM, Evans S, Giles LC, et al
Body mass index and vaccine responses following influenza vaccination during pregnancy.
Vaccine. 2021 Jul 12. pii: S0264-410X(21)00826.
PubMed Abstract available

MACINTYRE CR, Veness B, Berger D, Hamad N, et al
Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
Vaccine. 2021 Jul 10. pii: S0264-410X(21)00872.
PubMed Abstract available

MATEO-URDIALES A, Del Manso M, Andrianou X, Spuri M, et al
Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
Vaccine. 2021 Jul 7. pii: S0264-410X(21)00862.
PubMed Abstract available

BELLIER L, Petitjean A, Sarazu T, Tresierra J, et al
Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
Vaccine. 2021;39:4144-4152.
PubMed Abstract available

LO CY, Misplon JA, Li X, Price GE, et al
Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.
Vaccine. 2021 Jul 2. pii: S0264-410X(21)00833.
PubMed Abstract available

RAHAMIMOV N, Baturov V, Shani A, Ben Zoor I, et al
Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification.
Vaccine. 2021 Jul 2. pii: S0264-410X(21)00843.
PubMed Abstract available

June 2021

HINES AM, Murphy N, Mullin C, Barillas J, et al
Henoch-Schonlein purpura presenting post COVID-19 vaccination.
Vaccine. 2021 Jun 30. pii: S0264-410X(21)00841.
PubMed

YOUSSEF Y, Chmaisse A, Boutros C, Chamseddine S, et al
The burden of Respiratory Syncytial Virus (RSV) infection in the Middle East and North Africa (MENA) region across age groups: A systematic review.
Vaccine. 2021;39:3803-3813.
PubMed Abstract available

AL-SHAIKH A, Muthu N, Aidyralieva C, Profili MC, et al
COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience.
Vaccine. 2021 Jun 29. pii: S0264-410X(21)00840.
PubMed

BANKS C, Portnoy A, Moi F, Boonstoppel L, et al
Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic.
Vaccine. 2021 Jun 29. pii: S0264-410X(21)00838.
PubMed Abstract available

FUJIMOTO AB, Keskinocak P, Yildirim I
Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation.
Vaccine. 2021 Jun 26. pii: S0264-410X(21)00828.
PubMed Abstract available

MYLES IA, Vinciguerra JS, Premus RT
Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.
Vaccine. 2021 Jun 25. pii: S0264-410X(21)00811.
PubMed Abstract available

GUAN L, Yu Y, Wu X, Nie J, et al
The first Chinese national standards for SARS-CoV-2 neutralizing antibody.
Vaccine. 2021;39:3724-3730.
PubMed Abstract available

DESAI AP, Desai AP, Loomis GJ
Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00808.
PubMed Abstract available

BALDOLLI A, Michon J, Appia F, Galimard C, et al
Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00804.
PubMed Abstract available

GOOCH KE, Smith TRF, Salguero FJ, Fotheringham SA, et al
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00807.
PubMed Abstract available

TRENT M, Seale H, Chughtai AA, Salmon D, et al
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00798.
PubMed Abstract available

CHEN IH, Ahorsu DK, Ko NY, Yen CF, et al
Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.
Vaccine. 2021 Jun 22. pii: S0264-410X(21)00794.
PubMed Abstract available

LUNDBERG L, Bygdell M, Stukat von Feilitzen G, Woxenius S, et al
Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
Vaccine. 2021 Jun 22. pii: S0264-410X(21)00795.
PubMed Abstract available

SMITH KJ, Wateska AR, Nowalk MP, Lin CJ, et al
Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.
Vaccine. 2021 Jun 21. pii: S0264-410X(21)00773.
PubMed Abstract available

FOGEL B, Schaefer EW, Hicks SD
Early influenza vaccination rates decline in children during the COVID-19 pandemic.
Vaccine. 2021 Jun 17. pii: S0264-410X(21)00777.
PubMed Abstract available

BROWN CC, Young SG, Pro GC
COVID-19 vaccination rates vary by community vulnerability: A county-level analysis.
Vaccine. 2021 Jun 17. pii: S0264-410X(21)00774.
PubMed Abstract available

BIFULCO M, Pisanti S, Fusco I
Lessons from the 1656 Neapolitan Plague: Something to learn for the current coronavirus Pandemic?
Vaccine. 2021;39:3641-3643.
PubMed Abstract available

JETHWA H, Wong R, Abraham S
Covid-19 vaccine trials: Ethnic diversity and immunogenicity.
Vaccine. 2021;39:3541-3543.
PubMed

PRASAD N, Read JM, Jewell C, Waite B, et al
Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
Vaccine. 2021 Jun 16. pii: S0264-410X(21)00708.
PubMed Abstract available

ZIMMERMAN RK
Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines.
Vaccine. 2021 Jun 15. pii: S0264-410X(21)00763.
PubMed Abstract available

POLAND GA, Ovsyannikova IG, Kennedy RB
The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.
Vaccine. 2021 Jun 14. pii: S0264-410X(21)00764.
PubMed

IVANOV V, Oomens AGP, Papin JF, Staats R, et al
Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection.
Vaccine. 2021 Jun 14. pii: S0264-410X(21)00737.
PubMed Abstract available

FERRARI D, Di Resta C, Tomaiuolo R, Sabetta E, et al
Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects.
Vaccine. 2021 Jun 12. pii: S0264-410X(21)00756.
PubMed Abstract available

LIPSITCH M, Kahn R
Interpreting vaccine efficacy trial results for infection and transmission.
Vaccine. 2021 Jun 12. pii: S0264-410X(21)00735.
PubMed Abstract available

MCFADDEN K, Heywood A, Dyda A, Kaufman J, et al
Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution?
Vaccine. 2021;39:3467-3472.
PubMed Abstract available

BEAU RENEER Z, Abreu RB, Jamal US, Corn MR, et al
Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00659.
PubMed Abstract available

HSIA J, Zhao G, Lu PJ, Town M, et al
Estimating bias from internet non-use for a hybrid web vaccination survey - 2013-2017 Behavioral Risk Factor Surveillance System.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00675.
PubMed Abstract available

ODITA CI, Conan A, Smith-Antony M, Battice J, et al
Non-specific effects of rabies vaccine on the incidence of self-reported common infectious disease episodes: A randomized controlled trial.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00719.
PubMed Abstract available

LUTZ CS, Biggerstaff M, Rolfes MA, Lafond KE, et al
Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries.
Vaccine. 2021 Jun 9. pii: S0264-410X(21)00557.
PubMed Abstract available

GUNTUKU SC, Buttenheim AM, Sherman G, Merchant RM, et al
Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States.
Vaccine. 2021 Jun 9. pii: S0264-410X(21)00738.
PubMed Abstract available

IKILEZI G, Bachmeier SD, Cogswell IE, Maddison ER, et al
Tracking government spending on immunization: The joint reporting forms, national health accounts, comprehensive multi-year plans and co-financing data.
Vaccine. 2021;39:3410-3418.
PubMed Abstract available

NUZHATH T, Ajayi KV, Fan Q, Hotez P, et al
Childhood immunization during the COVID-19 pandemic in Texas.
Vaccine. 2021;39:3333-3337.
PubMed Abstract available

SILVEIRA MF, Tonial CT, Goretti K Maranhao A, Teixeira AMS, et al
Missed childhood immunizations during the COVID-19 pandemic in Brazil: Analyses of routine statistics and of a national household survey.
Vaccine. 2021;39:3404-3409.
PubMed Abstract available

JENSEN A, A F Simoes E, Bohn Christiansen C, Graff Stensballe L, et al
Respiratory syncytial virus and influenza hospitalizations in Danish children 2010-2016.
Vaccine. 2021 Jun 8. pii: S0264-410X(21)00705.
PubMed Abstract available

HOEHL S, Ciesek S, Graf J, Wicker S, et al
A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated.
Vaccine. 2021 Jun 8. pii: S0264-410X(21)00736.
PubMed

ANDAYI F, Emukule GO, Osoro E, Ndegwa LK, et al
Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic.
Vaccine. 2021 Jun 7. pii: S0264-410X(21)00643.
PubMed Abstract available

RAZ A, Keshet Y, Popper-Giveon A, Karkabi MS, et al
One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy.
Vaccine. 2021 Jun 5. pii: S0264-410X(21)00714.
PubMed

DAL-RE R, Launay O
Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label.
Vaccine. 2021 Jun 4. pii: S0264-410X(21)00703.
PubMed

STUURMAN AL, Biccler J, Carmona A, Descamps A, et al
Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
Vaccine. 2021 Jun 3. pii: S0264-410X(21)00654.
PubMed Abstract available

GATES A, Rahman S, Sim S, Pillay J, et al
Health inequities related to vaccination: An evidence map of potentially influential factors and systematic review of interventions.
Vaccine. 2021 Jun 3. pii: S0264-410X(21)00640.
PubMed Abstract available

FERDINANDS JM, Thompson MG, Blanton L, Spencer S, et al
Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.
Vaccine. 2021 Jun 2. pii: S0264-410X(21)00562.
PubMed Abstract available

SHINGAI M, Nomura N, Sekiya T, Ohno M, et al
Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
Vaccine. 2021 Jun 2. pii: S0264-410X(21)00660.
PubMed Abstract available

LASKY T, McMahon AW, Hua W, Forshee R, et al
Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
Vaccine. 2021 Jun 2. pii: S0264-410X(21)00666.
PubMed Abstract available

WANG Y, Zhang Y, Wu H, Huang L, et al
Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00665.
PubMed Abstract available

DEY A, Chozhavel Rajanathan TM, Chandra H, Pericherla HPR, et al
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00706.
PubMed Abstract available

PATEL MK, Bergeri I, Bresee JS, Cowling BJ, et al
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00707.
PubMed Abstract available

May 2021

ZIPFEL CM, Colizza V, Bansal S
The missing season: The impacts of the COVID-19 pandemic on influenza.
Vaccine. 2021 May 30. pii: S0264-410X(21)00635.
PubMed Abstract available

LEWIS NS, Banyard AC, Essen S, Whittard E, et al
Antigenic evolution of contemporary clade 2.3.4.4 HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control.
Vaccine. 2021 May 29. pii: S0264-410X(21)00655.
PubMed Abstract available

BARDENHEIER BH, Gravenstein S, Blackman C, Gutman R, et al
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.
Vaccine. 2021 May 28. pii: S0264-410X(21)00683.
PubMed Abstract available

ABU MOUCH S, Roguin A, Hellou E, Ishai A, et al
Myocarditis following COVID-19 mRNA vaccination.
Vaccine. 2021 May 28. pii: S0264-410X(21)00682.
PubMed Abstract available

GURWITZ D
COVID-19 vaccine hesitancy: Lessons from Israel.
Vaccine. 2021 May 27. pii: S0264-410X(21)00680.
PubMed

KESSELS R, Luyten J, Tubeuf S
Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general.
Vaccine. 2021 May 26. pii: S0264-410X(21)00664.
PubMed Abstract available

VANHEMS P
A breath of humanity in the era of Covid-19 vaccine.
Vaccine. 2021 May 24. pii: S0264-410X(21)00638.
PubMed

EARLE KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, et al
Evidence for antibody as a protective correlate for COVID-19 vaccines.
Vaccine. 2021 May 24. pii: S0264-410X(21)00658.
PubMed Abstract available

SAM IC, Ahmad Jaafar N, Wong LP, Nathan AM, et al
Socioeconomic costs of children <5 years hospitalised with acute respiratory infections in Kuala Lumpur, Malaysia.
Vaccine. 2021;39:2983-2988.
PubMed Abstract available

VOGEL TP, Top KA, Karatzios C, Hilmers DC, et al
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2021;39:3037-3049.
PubMed Abstract available

SERAZIN NA, Edem B, Williams SR, Ortiz JR, et al
Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2021;39:3028-3036.
PubMed Abstract available

AIZAWA Y, Katsuta T, Sakiyama H, Tanaka-Taya K, et al
Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan.
Vaccine. 2021 May 21. pii: S0264-410X(21)00636.
PubMed Abstract available

NICHOLLS LAB, Gallant AJ, Cogan N, Rasmussen S, et al
Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.
Vaccine. 2021 May 19. pii: S0264-410X(21)00544.
PubMed Abstract available

KIM S, Williams TC, Viboud C, Campbell H, et al
RSV genomic diversity and the development of a globally effective RSV intervention.
Vaccine. 2021;39:2811-2820.
PubMed Abstract available

NAG K, Chandra Baray J, Rahman Khan M, Mahmud A, et al
An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose.
Vaccine. 2021 May 18. pii: S0264-410X(21)00607.
PubMed Abstract available

LUK TT, Zhao S, Wu Y, Wong JY, et al
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.
Vaccine. 2021 May 18. pii: S0264-410X(21)00608.
PubMed Abstract available

CHAN YW, Wong ML, Kwok FY, Au AK, et al
The effect of seasonal influenza vaccine on medically-attended influenza and non-influenza respiratory viruses infections at primary care level, Hong Kong SAR, 2017/18 to 2019/20.
Vaccine. 2021 May 17. pii: S0264-410X(21)00541.
PubMed Abstract available

GUBERNOT D, Jazwa A, Niu M, Baumblatt J, et al
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.
Vaccine. 2021 May 14. pii: S0264-410X(21)00578.
PubMed Abstract available

WOOD RM, Murch BJ, Moss SJ, Tyler JMB, et al
Operational research for the safe and effective design of COVID-19 mass vaccination centres.
Vaccine. 2021 May 14. pii: S0264-410X(21)00588.
PubMed

CHUNG JR, Flannery B, Kim SS, Gaglani M, et al
Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States.
Vaccine. 2021 May 13. pii: S0264-410X(21)00555.
PubMed Abstract available

KIM TH, Choi JH, Park SH, Yoo JH, et al
Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged >/= 65 years.
Vaccine. 2021 May 12. pii: S0264-410X(21)00551.
PubMed Abstract available

KRAIGSLEY AM, Moore KA, Bolster A, Peters M, et al
Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
Vaccine. 2021 May 12. pii: S0264-410X(21)00502.
PubMed Abstract available

AFIFI TO, Salmon S, Taillieu T, Stewart-Tufescu A, et al
Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies.
Vaccine. 2021 May 12. pii: S0264-410X(21)00590.
PubMed Abstract available

LONGCHAMPS C, Ducarroz S, Crouzet L, Vignier N, et al
COVID-19 vaccine hesitancy among persons living in homeless shelters in France.
Vaccine. 2021 May 12. pii: S0264-410X(21)00563.
PubMed Abstract available

LEUNG VKY, Fox A, Carolan LA, Aban M, et al
Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016.
Vaccine. 2021 May 10. pii: S0264-410X(21)00483.
PubMed Abstract available

POWELL H, Liu H, Pekosz A
Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.
Vaccine. 2021 May 10. pii: S0264-410X(21)00535.
PubMed Abstract available

PASTORINO R, Villani L, La Milia DI, Ieraci R, et al
Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital.
Vaccine. 2021 May 9. pii: S0264-410X(21)00566.
PubMed Abstract available

HUANG JM, Wang SY, Lai MR, Tseng YK, et al
Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity.
Vaccine. 2021 May 7. pii: S0264-410X(21)00485.
PubMed Abstract available

CORREIA R, Meneses L, Richheimer C, Alves PM, et al
Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.
Vaccine. 2021 May 6. pii: S0264-410X(21)00480.
PubMed Abstract available

SOMIYA M, Mine S, Yasukawa K, Ikeda S, et al
Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines.
Vaccine. 2021 May 6. pii: S0264-410X(21)00548.
PubMed

April 2021

EYAL N, Gerhard T, Strom BL
Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.
Vaccine. 2021 Apr 30. pii: S0264-410X(21)00526.
PubMed

WELSH KJ, Baumblatt J, Chege W, Goud R, et al
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
Vaccine. 2021 Apr 30. pii: S0264-410X(21)00524.
PubMed Abstract available

KINI A, Morgan R, Kuo H, Shea P, et al
Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race.
Vaccine. 2021 Apr 28. pii: S0264-410X(21)00448.
PubMed Abstract available

SAITOH A, Okabe N
Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap.
Vaccine. 2021 Apr 27. pii: S0264-410X(21)00460.
PubMed Abstract available

KWON JH, Criado MF, Killmaster L, Ali MZ, et al
Efficacy of two vaccines against recent emergent antigenic variants of clade 2.3.2.1a highly pathogenic avian influenza viruses in Bangladesh.
Vaccine. 2021 Apr 25. pii: S0264-410X(21)00459.
PubMed Abstract available

KREPS SE, Kriner DL
Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment.
Vaccine. 2021 Apr 24. pii: S0264-410X(21)00503.
PubMed Abstract available

MACINTYRE CR, Costantino V, Trent M
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
Vaccine. 2021 Apr 24. pii: S0264-410X(21)00501.
PubMed Abstract available

OLATUNJI EA, Ogunsola AS, Khodakarami N, Callaghan T, et al
Who receives influenza vaccinations at the Pharmacy? An analysis of the Texas Behavioral Risk Factor Surveillance System.
Vaccine. 2021 Apr 22. pii: S0264-410X(21)00451.
PubMed Abstract available

DADARI I, Higgins-Steele A, Sharkey A, Charlet D, et al
Pro-equity immunization and health systems strengthening strategies in select Gavi-supported countries.
Vaccine. 2021;39:2434-2444.
PubMed Abstract available

WANG C, Han B, Zhao T, Liu H, et al
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study.
Vaccine. 2021 Apr 13. pii: S0264-410X(21)00455.
PubMed Abstract available

LEVIN Y, Balakirski NM, Caraco Y, Ben-Ami E, et al
Ethics and execution of developing a 2nd wave COVID vaccine - Our interim phase I/II VSV-SARS-CoV2 vaccine experience.
Vaccine. 2021 Apr 13. pii: S0264-410X(21)00452.
PubMed

HAMILTON RA, Krockow EM, Vekria P
Attitudes towards influenza and uptake of the flu vaccine: A survey of pharmacy staff working in English hospitals.
Vaccine. 2021 Apr 9. pii: S0264-410X(21)00407.
PubMed Abstract available

PU J, Yu Q, Yin Z, Zhang Y, et al
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.
Vaccine. 2021 Apr 9. pii: S0264-410X(21)00431.
PubMed Abstract available

POLUEKTOV Y, George M, Daftarian P, Delcommenne MC, et al
Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.
Vaccine. 2021;39:2110-2116.
PubMed Abstract available

HOGAN AB, Winskill P, Watson OJ, Walker PGT, et al
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.
Vaccine. 2021 Apr 8. pii: S0264-410X(21)00427.
PubMed Abstract available

PAGLIUSI S, Hayman B, Jarrett S
Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
Vaccine. 2021 Apr 7. pii: S0264-410X(21)00293.
PubMed Abstract available

DANIELS V, Saxena K, Roberts C, Kothari S, et al
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis.
Vaccine. 2021 Apr 6. pii: S0264-410X(21)00428.
PubMed Abstract available

GRAMACHO WG, Turgeon M
When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil.
Vaccine. 2021 Apr 6. pii: S0264-410X(21)00396.
PubMed Abstract available

HATZIANTONIOU S, Maltezou HC, Tsakris A, Poland GA, et al
Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study.
Vaccine. 2021 Apr 6. pii: S0264-410X(21)00377.
PubMed

March 2021

PELTON SI, Divino V, Postma MJ, Shah D, et al
A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
Vaccine. 2021 Mar 30. pii: S0264-410X(21)00347.
PubMed Abstract available

GUR-ARIE R, Katz MA, Hirsch A, Greenberg D, et al
"You Have to Die Not to Come to Work": A Mixed Methods Study of Attitudes and Behaviors regarding Presenteeism, Absenteeism and Influenza Vaccination among Healthcare Personnel with Respiratory Illness in Israel, 2016-2019.
Vaccine. 2021 Mar 29. pii: S0264-410X(21)00361.
PubMed Abstract available

KUTER BJ, Offit PA, Poland GA
The development of COVID-19 vaccines in the United States: Why and how so fast?
Vaccine. 2021 Mar 26. pii: S0264-410X(21)00383.
PubMed

RUSSO AG, Decarli A, Valsecchi MG
Strategy to identify priority groups for COVID-19 vaccination: A population based cohort study.
Vaccine. 2021 Mar 26. pii: S0264-410X(21)00382.
PubMed Abstract available

GKENTZI D, Aggelopoulos K, Karatza A, Sinopidis X, et al
Influenza vaccination among caregivers and household contacts of children with asthma.
Vaccine. 2021 Mar 25. pii: S0264-410X(21)00325.
PubMed Abstract available

SALMON DA, Dudley MZ, Brewer J, Kan L, et al
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization.
Vaccine. 2021 Mar 24. pii: S0264-410X(21)00315.
PubMed Abstract available

ROSA SS, Prazeres DMF, Azevedo AM, Marques MPC, et al
mRNA vaccines manufacturing: Challenges and bottlenecks.
Vaccine. 2021 Mar 23. pii: S0264-410X(21)00319.
PubMed Abstract available

HAEDER SF
Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic.
Vaccine. 2021 Mar 23. pii: S0264-410X(21)00348.
PubMed Abstract available

KOCHHAR S, Dube E, Graham J, Jee Y, et al
COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER).
Vaccine. 2021 Mar 22. pii: S0264-410X(21)00364.
PubMed

ZHANG Y, Li D, Zhao H, Wang L, et al
The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response.
Vaccine. 2021 Mar 22. pii: S0264-410X(21)00371.
PubMed

ANTONELLI INCALZI R, Trevisan C, Del Signore S, Volpato S, et al
Are vaccines against COVID-19 tailored to the most vulnerable people?
Vaccine. 2021 Mar 22. pii: S0264-410X(21)00370.
PubMed

ANGELIS A, Darrow J
Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines.
Vaccine. 2021 Mar 22. pii: S0264-410X(21)00346.
PubMed

KENDAL A
Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs.
Vaccine. 2021 Mar 20. pii: S0264-410X(21)00283.
PubMed

CHEN D, Ye Z, Pi Z, Mizukami S, et al
Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China.
Vaccine. 2021 Mar 20. pii: S0264-410X(21)00324.
PubMed Abstract available

VILCHES TN, Zhang K, Van Exan R, Langley JM, et al
Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada.
Vaccine. 2021 Mar 20. pii: S0264-410X(21)00362.
PubMed Abstract available

CAMBOU MC, Copeland TP, Nielsen-Saines K, Macinko J, et al
Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00294.
PubMed Abstract available

GRAUPENSPERGER S PHD, Abdallah DA, Lee CM
Social norms and vaccine uptake: College students' COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00286.
PubMed Abstract available

SZIGETI R, Kellermayer R
Natural unblinding of BCG vaccination trials.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00320.
PubMed Abstract available

ALLINGTON D, McAndrew S, Moxham-Hall VL, Duffy B, et al
Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK.
Vaccine. 2021 Mar 16. pii: S0264-410X(21)00234.
PubMed Abstract available

CHOI UY, Kim KH, Lee KY, Kim JH, et al
Active-controlled phase III study of an egg-cultivated quadrivalent inactivated split-virion influenza vaccine (GC3110A) in healthy Korean children aged 6-35 months.
Vaccine. 2021 Mar 15. pii: S0264-410X(21)00273.
PubMed Abstract available

NET P, Colrat F, Nascimento Costa M, Bianic F, et al
Estimating public health and economic benefits along 10 years of Fluzone(R) High Dose in the United States.
Vaccine. 2021;39 Suppl 1:A56-A69.
PubMed Abstract available

BUTTERY JP
Developing standard safety outcomes for COVID-19 vaccines.
Vaccine. 2021 Mar 12. pii: S0264-410X(21)00272.
PubMed

LEE J, Li Y, Li Y, Cino-Ozuna AG, et al
Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge.
Vaccine. 2021 Mar 11. pii: S0264-410X(21)00268.
PubMed Abstract available

BERTRAN K, Kassa A, Criado MF, Nunez IA, et al
Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
Vaccine. 2021 Mar 11. pii: S0264-410X(21)00266.
PubMed Abstract available

EBAMA MS, Chu SY, Azziz-Baumgartner E, Lafond KE, et al
Ancillary benefits of seasonal influenza vaccination in middle-income countries.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00228.
PubMed Abstract available

LATKIN C, Dayton LA, Yi G, Konstantopoulos A, et al
COVID-19 vaccine intentions in the United States, a social-ecological framework.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00238.
PubMed Abstract available

REPERANT LA, Osterhaus ADME
COVID-19 vaccination and critical care capacity: Perilous months ahead.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00316.
PubMed

WENTZELL E, Racila AM
The social experience of participation in a COVID-19 vaccine trial: Subjects' motivations, others' concerns, and insights for vaccine promotion.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00317.
PubMed Abstract available

GUIDRY JPD, Perrin PB, Laestadius LI, Vraga EK, et al
U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic.
Vaccine. 2021 Mar 9. pii: S0264-410X(21)00306.
PubMed Abstract available

SADARANGANI M, Abu Raya B, Conway JM, Iyaniwura SA, et al
Importance of COVID-19 vaccine efficacy in older age groups.
Vaccine. 2021 Mar 8. pii: S0264-410X(21)00288.
PubMed Abstract available

KISZEWSKI AE, Cleary EG, Jackson MJ, Ledley FD, et al
NIH funding for vaccine readiness before the COVID-19 pandemic.
Vaccine. 2021 Mar 8. pii: S0264-410X(21)00290.
PubMed Abstract available

PULLAN S, Dey M
Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis.
Vaccine. 2021 Mar 6. pii: S0264-410X(21)00287.
PubMed Abstract available

BLACK SB, Law B, Chen RT, Dekker CL, et al
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
Vaccine. 2021 Mar 6. pii: S0264-410X(21)00284.
PubMed Abstract available

GASPAR EB, De Gaspari E
Avidity assay to test functionality of anti-SARS-Cov-2 antibodies.
Vaccine. 2021;39:1473-1475.
PubMed

YOKOMICHI H, Kojima R, Horiuchi S, Ooka T, et al
Effectiveness of influenza vaccination in infants and toddlers with and without prior infection history: The Japan Environment and Children's Study.
Vaccine. 2021 Mar 5. pii: S0264-410X(21)00224.
PubMed Abstract available

DU Y, Xu Y, Feng J, Hu L, et al
Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse.
Vaccine. 2021 Mar 5. pii: S0264-410X(21)00274.
PubMed Abstract available

KUO H, Shapiro JR, Dhakal S, Morgan R, et al
Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers.
Vaccine. 2021 Mar 4. pii: S0264-410X(21)00227.
PubMed Abstract available

WOO EJ, Moro PL
Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.
Vaccine. 2021 Mar 4. pii: S0264-410X(21)00232.
PubMed Abstract available

STURM L, Kasting ML, Head KJ, Hartsock JA, et al
Influenza vaccination in the time of COVID-19: A national U.S. survey of adults.
Vaccine. 2021 Mar 4. pii: S0264-410X(21)00271.
PubMed Abstract available

HELMKAMP LJ, Szilagyi PG, Zimet G, Saville AW, et al
A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines.
Vaccine. 2021 Mar 3. pii: S0264-410X(21)00206.
PubMed Abstract available

FELL DB, Dimitris MC, Hutcheon JA, Ortiz JR, et al
Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy.
Vaccine. 2021 Mar 2. pii: S0264-410X(21)00261.
PubMed Abstract available

February 2021

WANG J, Lyu Y, Zhang H, Jing R, et al
Willingness to pay and financing preferences for COVID-19 vaccination in China.
Vaccine. 2021 Feb 27. pii: S0264-410X(21)00240.
PubMed Abstract available

SHEN M, Zu J, Fairley CK, Pagan JA, et al
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.
Vaccine. 2021 Feb 27. pii: S0264-410X(21)00236.
PubMed Abstract available

SANDBRINK JB, Koblentz GD
Biosecurity risks associated with vaccine platform technologies.
Vaccine. 2021 Feb 25. pii: S0264-410X(21)00171.
PubMed Abstract available

SELL TK, Gastfriend D, Watson M, Watson C, et al
Building the global vaccine manufacturing capacity needed to respond to pandemics.
Vaccine. 2021 Feb 24. pii: S0264-410X(21)00165.
PubMed

MUNOZ FM, Cramer JP, Dekker CL, Dudley MZ, et al
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2021 Feb 23. pii: S0264-410X(21)00094.
PubMed Abstract available

VERELST F, Beutels P, Hens N, Willem L, et al
Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective.
Vaccine. 2021 Feb 22. pii: S0264-410X(21)00168.
PubMed Abstract available

SU QD, Zou YN, Yi Y, Shen LP, et al
Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.
Vaccine. 2021;39:1241-1247.
PubMed Abstract available

BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
Vaccine. 2021;39:1248-1256.
PubMed Abstract available

ELSENPETER HMS
How COVID exposed the hypocrisy within me.
Vaccine. 2021;39:1178-1179.
PubMed

ORTIZ JR, Robertson J, Hsu JS, Yu SL, et al
The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
Vaccine. 2021 Feb 19. pii: S0264-410X(21)00204.
PubMed Abstract available

CHANG LJ, Anderson EJ, Jeanfreau R, He Y, et al
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6months through<18years of age: A randomized controlled phase II dose-finding trial.
Vaccine. 2021 Feb 18. pii: S0264-410X(21)00162.
PubMed Abstract available

KUTER BJ, Browne S, Momplaisir FM, Feemster KA, et al
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia.
Vaccine. 2021 Feb 16. pii: S0264-410X(21)00185.
PubMed Abstract available

WU MJ, Chung JR, Kim SS, Jackson ML, et al
Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019.
Vaccine. 2021 Feb 15. pii: S0264-410X(21)00106.
PubMed Abstract available

GURWITZ D
Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries.
Vaccine. 2021;39:1027.
PubMed

RID A, Shah SK, Miller FG, Danis M, et al
Ethical trade-offs in vaccine development and distribution-Response to Gurwitz.
Vaccine. 2021;39:1028-1029.
PubMed

WARD BJ, Seguin A, Couillard J, Trepanier S, et al
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age.
Vaccine. 2021 Feb 10. pii: S0264-410X(21)00004.
PubMed Abstract available

POLAND CM, Matthews AKS, Poland GA
Improving COVID-19 vaccine acceptance: Including insights from human decision-making under conditions of uncertainty and human-centered design.
Vaccine. 2021 Feb 10. pii: S0264-410X(21)00154.
PubMed

BRUCE-STASKAL PJ, Woods RM, Borisov OV, Massare MJ, et al
Corrigendum to "Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance" [Vaccine 38(43) (2020) 6757-6765].
Vaccine. 2021 Feb 9. pii: S0264-410X(21)00105.
PubMed

CHU L, McPhee R, Huang W, Bennett H, et al
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
Vaccine. 2021 Feb 9. pii: S0264-410X(21)00153.
PubMed Abstract available

ROBINSON E, Jones A, Lesser I, Daly M, et al
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples.
Vaccine. 2021 Feb 6. pii: S0264-410X(21)00140.
PubMed Abstract available

KUMAR N, Bhartiya S, Singh T
Duration of anti-SARS-CoV-2 antibodies much shorter in India.
Vaccine. 2021;39:886-888.
PubMed Abstract available

DIACO M, Chang LJ, Seet B, Robertson CA, et al
Introductory paper: High dose influenza vaccine.
Vaccine. 2021 Feb 3. pii: S0264-410X(20)31147.
PubMed Abstract available

WILCK MB, Jin Xu Z, Stek JE, Goveia MG, et al
Protective immune responses against Haemophilus influenza type B elicited by a fully-liquid DTaP-IPV-Hib-HepB vaccine (VAXELIS).
Vaccine. 2021 Feb 1. pii: S0264-410X(21)00073.
PubMed Abstract available

January 2021

AXELSEN PH, Poland GA
Vaccines, masks, distancing and credibility: An urgent warning for pandemic management.
Vaccine. 2021 Jan 31. pii: S0264-410X(21)00079.
PubMed

COLRAT F, Thommes E, Largeron N, Alvarez FP, et al
Economic evaluation of high-dose inactivated influenza vaccine in adults aged >/=65 years: A systematic literature review.
Vaccine. 2021 Jan 29. pii: S0264-410X(20)31603.
PubMed Abstract available

HAMPTON LM, Aggarwal R, Evans SJW, Law B, et al
General determination of causation between Covid-19 vaccines and possible adverse events.
Vaccine. 2021 Jan 29. pii: S0264-410X(21)00096.
PubMed

BERMAN L, Riedel M
Coping with COVID.
Vaccine. 2021;39:777-778.
PubMed

KIM SH, Paldurai A, Xiao S, Collins PL, et al
Retraction notice to "Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens" [Vaccine 32(35) (2014) 4428-4435].
Vaccine. 2021;39:775.
PubMed

WANG Y, Chen L, Cheng F, Biggerstaff M, et al
Economic burden of influenza illness among children under 5 years in Suzhou, China: Report from the cost surveys during 2011/12 to 2016/17 influenza seasons.
Vaccine. 2021 Jan 22. pii: S0264-410X(20)31672.
PubMed Abstract available

OKOLI GN, Racovitan F, Abdulwahid T, Righolt CH, et al
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studie
Vaccine. 2021 Jan 22. pii: S0264-410X(21)00048.
PubMed Abstract available

BHUIYAN MU, Stiboy E, Hassan MZ, Chan M, et al
Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis.
Vaccine. 2021;39:667-677.
PubMed Abstract available

JAMROZIK E, Littler K, Bull S, Emerson C, et al
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
Vaccine. 2021;39:633-640.
PubMed Abstract available

BALASUBRAMANI GK, Zimmerman RK, Eng H, Lyons J, et al
Comparison of local influenza vaccine effectiveness using two methods.
Vaccine. 2021 Jan 20. pii: S0264-410X(21)00017.
PubMed Abstract available

DAL-RE R
US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
Vaccine. 2021 Jan 20. pii: S0264-410X(21)00077.
PubMed

POLAND EG, McGuire DK, Ratishvili T, Poland GA, et al
The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice?
Vaccine. 2021 Jan 20. pii: S0264-410X(20)31694.
PubMed

WINOKUR P, El Sahly HM, Mulligan MJ, Frey SE, et al
Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.
Vaccine. 2021 Jan 20. pii: S0264-410X(20)31504.
PubMed Abstract available

CAO L, Lou J, Zhao S, Chan RWY, et al
In silico prediction of influenza vaccine effectiveness by sequence analysis.
Vaccine. 2021 Jan 19. pii: S0264-410X(21)00006.
PubMed Abstract available

REEMERS S, Verstegen I, Basten S, Hubers W, et al
A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity.
Vaccine. 2021 Jan 19. pii: S0264-410X(21)00022.
PubMed Abstract available

FATOBA AJ, Maharaj L, Adeleke VT, Okpeku M, et al
Immunoinformatics prediction of overlapping CD8(+) T-cell, IFN-gamma and IL-4 inducer CD4(+) T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2).
Vaccine. 2021 Jan 18. pii: S0264-410X(21)00003.
PubMed Abstract available

SCOTT EM, Stein R, Brown MF, Hershberger J, et al
Vaccination patterns of the northeast Ohio Amish revisited.
Vaccine. 2021 Jan 18. pii: S0264-410X(21)00026.
PubMed Abstract available

WHITAKER JA, Parikh SA, Shanafelt TD, Kay NE, et al
The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).
Vaccine. 2021 Jan 15. pii: S0264-410X(21)00001.
PubMed Abstract available

GUALANO MR, Corradi A, Voglino G, Catozzi D, et al
Healthcare Workers' (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis.
Vaccine. 2021 Jan 12. pii: S0264-410X(20)31655.
PubMed Abstract available

AKMATOV MK, Holstiege J, Steffen A, Batzing J, et al
Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis.
Vaccine. 2021 Jan 12. pii: S0264-410X(20)31693.
PubMed Abstract available

BURGER AE, Reither EN, Mamelund SE, Lim S, et al
Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic.
Vaccine. 2021 Jan 11. pii: S0264-410X(20)31666.
PubMed Abstract available

WIEMKEN TL, Rutschman AS
Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic.
Vaccine. 2021 Jan 9. pii: S0264-410X(21)00018.
PubMed

SINGH J, Malik D, Raina A
Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
Vaccine. 2021 Jan 9. pii: S0264-410X(21)00015.
PubMed Abstract available

RUIZ JB, Bell RA
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey.
Vaccine. 2021 Jan 9. pii: S0264-410X(21)00014.
PubMed Abstract available

BEIGI RH, Krubiner C, Jamieson DJ, Lyerly AD, et al
The need for inclusion of pregnant women in COVID-19 vaccine trials.
Vaccine. 2021 Jan 8. pii: S0264-410X(20)31671.
PubMed

GOLD MS, Lincoln G, Cashman P, Braunack-Mayer A, et al
Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial.
Vaccine. 2021;39:332-342.
PubMed Abstract available

CALDERA F, Mercer M, Samson SI, Pitt JM, et al
Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity.
Vaccine. 2021 Jan 7. pii: S0264-410X(20)31490.
PubMed Abstract available

WILLIAMS J, Degeling C, McVernon J, Dawson A, et al
How should we conduct pandemic vaccination?
Vaccine. 2021 Jan 7. pii: S0264-410X(20)31639.
PubMed Abstract available

KELSO JM
Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31696.
PubMed

KOHLI M, Maschio M, Becker D, Weinstein MC, et al
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31690.
PubMed Abstract available

MIDDELDORP M, van Lier A, van der Maas N, Veldhuijzen I, et al
Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31692.
PubMed Abstract available

WONG MCS, Wong ELY, Huang J, Cheung AWL, et al
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31695.
PubMed Abstract available

SU JR, McNeil MM, Welsh KJ, Marquez PL, et al
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31614.
PubMed Abstract available

GODINOT LD, Sicsic J, Lachatre M, Bouvet E, et al
Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers.
Vaccine. 2021 Jan 5. pii: S0264-410X(20)31637.
PubMed Abstract available

December 2020

JIANG X, Shang X, Lin J, Zhao Y, et al
Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study.
Vaccine. 2020 Dec 31. pii: S0264-410X(20)31608.
PubMed Abstract available

DAMJANOVSKA S, Smith C, Sayin I, Burant CJ, et al
Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines.
Vaccine. 2020 Dec 31. pii: S0264-410X(20)31631.
PubMed Abstract available

ZHONG Y, Clapham HE, Aishworiya R, Chua YX, et al
Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore.
Vaccine. 2020 Dec 26. pii: S0264-410X(20)31634.
PubMed Abstract available

MORO PL, Marquez P
Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020.
Vaccine. 2020 Dec 24. pii: S0264-410X(20)31613.
PubMed Abstract available

THANGARAJAH D, Malo JA, Field E, Andrews R, et al
Effectiveness of quadrivalent influenza vaccination in the first year of a funded childhood program in Queensland, Australia, 2018.
Vaccine. 2020 Dec 23. pii: S0264-410X(20)31579.
PubMed Abstract available

MCFADDEN K, Seale H
A review of hospital-based interventions to improve inpatient influenza vaccination uptake for high-risk adults.
Vaccine. 2020 Dec 21. pii: S0264-410X(20)31610.
PubMed Abstract available

SCHMIT T, Kuntz M, Patel D, Nadeem Khan M, et al
Anti-capsular immunity to Streptococcus pneumoniae serotype 22F prevents bacterial transmission in murine colonization and influenza virus co-infection models.
Vaccine. 2020 Dec 18. pii: S0264-410X(20)31558.
PubMed Abstract available

SPARROW E, Wood JG, Chadwick C, Newall AT, et al
Global production capacity of seasonal and pandemic influenza vaccines in 2019.
Vaccine. 2020 Dec 16. pii: S0264-410X(20)31585.
PubMed Abstract available

FULVINI AA, Tuteja A, Le J, Pokorny BA, et al
HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC.
Vaccine. 2020 Dec 16. pii: S0264-410X(20)31563.
PubMed Abstract available

BORRIELLO A, Master D, Pellegrini A, Rose JM, et al
Preferences for a COVID-19 vaccine in Australia.
Vaccine. 2020 Dec 16. pii: S0264-410X(20)31599.
PubMed Abstract available

BOKEMPER SE, Huber GA, Gerber AS, James EK, et al
Timing of COVID-19 vaccine approval and endorsement by public figures.
Vaccine. 2020 Dec 16. pii: S0264-410X(20)31616.
PubMed Abstract available

SANFTENBERG L, Kuehne F, Anraad C, Jung-Sievers C, et al
Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis.
Vaccine. 2020 Dec 14. pii: S0264-410X(20)31581.
PubMed Abstract available

BROOCKMAN D, Kalla J, Guerrero A, Budolfson M, et al
Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
Vaccine. 2020 Dec 14. pii: S0264-410X(20)31555.
PubMed Abstract available

BRAVO-GRANDE JL, Asuncion Blanco-Gonzalez M, de la Torre-Robles JM, Asmat-Inostrosa MP, et al
Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines.
Vaccine. 2020 Dec 14. pii: S0264-410X(20)31571.
PubMed Abstract available

SARINHO E, Goudouris E, Sole D
BCG vaccine: Worrying proposal for COVID-19.
Vaccine. 2020 Dec 13. pii: S0264-410X(20)31593.
PubMed Abstract available

DEGELING C, Williams J, Carter SM, Moss R, et al
Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.
Vaccine. 2020 Dec 11. pii: S0264-410X(20)31577.
PubMed Abstract available

RASTEGAR M, Tavana M, Meraj A, Mina H, et al
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.
Vaccine. 2020 Dec 9. pii: S0264-410X(20)31589.
PubMed Abstract available

HOLM MR, Poland GA
Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy.
Vaccine. 2020 Dec 9. pii: S0264-410X(20)31584.
PubMed

CARIAS C, Pawaskar M, Nyaku M, Conway JH, et al
Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US).
Vaccine. 2020 Dec 9. pii: S0264-410X(20)31557.
PubMed Abstract available

DHAKAL S, Deshpande S, McMahon M, Strohmeier S, et al
Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice.
Vaccine. 2020 Dec 5. pii: S0264-410X(20)31510.
PubMed Abstract available

LENG A, Maitland E, Wang S, Nicholas S, et al
Individual preferences for COVID-19 vaccination in China.
Vaccine. 2020 Dec 5. pii: S0264-410X(20)31576.
PubMed Abstract available

GHIGA I, Richardson S, Alvarez AMR, Kato M, et al
PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness.
Vaccine. 2020 Dec 5. pii: S0264-410X(20)31500.
PubMed Abstract available

WENZEL NS, Atkins KE, van Leeuwen E, Halloran ME, et al
Cost-effectiveness of live-attenuated influenza vaccination among school-age children.
Vaccine. 2020 Dec 4. pii: S0264-410X(20)31282.
PubMed Abstract available

MAYKIN MM, Heuser C, Feltovich H
Pregnant people deserve the protection offered by SARS-CoV-2 vaccines.
Vaccine. 2020 Dec 4. pii: S0264-410X(20)31572.
PubMed

BOTHUN LS
COVID-19: The worst date to the senior dance.
Vaccine. 2020;38:8066-8067.
PubMed

November 2020

EDOKA I, Kohli-Lynch C, Fraser H, Hofman K, et al
A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
Vaccine. 2020 Nov 30. pii: S0264-410X(20)31468.
PubMed Abstract available

HAVERI A, Ikonen N, Savolainen-Kopra C, Julkunen I, et al
Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines.
Vaccine. 2020 Nov 24. pii: S0264-410X(20)31494.
PubMed Abstract available

VANDER STICHELE RH, Hay C, Fladvad M, Sturkenboom MCJM, et al
How to ensure we can track and trace global use of COVID-19 vaccines?
Vaccine. 2020 Nov 24. pii: S0264-410X(20)31508.
PubMed

KITANO T, Aoki H
A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan.
Vaccine. 2020 Nov 24. pii: S0264-410X(20)31506.
PubMed Abstract available

URA T, Yamashita A, Mizuki N, Okuda K, et al
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Vaccine. 2020 Nov 24. pii: S0264-410X(20)31507.
PubMed Abstract available

KITTIKRAISAK W, Phadungkiatwatana P, Ditsungnoen D, Kaoiean S, et al
Comparison of influenza antibody titers among women who were vaccinated in the 2(nd) and the 3(rd) trimesters of pregnancy.
Vaccine. 2020 Nov 23. pii: S0264-410X(20)31472.
PubMed Abstract available

DRORI Y, Pando R, Sefty H, Rosenberg A, et al
Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season.
Vaccine. 2020 Nov 23. pii: S0264-410X(20)31394.
PubMed Abstract available

GANGULY M, Yeolekar L, Tyagi P, Sagar U, et al
Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform.
Vaccine. 2020 Nov 20. pii: S0264-410X(20)31424.
PubMed Abstract available

TUCKERMAN JL, Kaufman J, Danchin M, Marshall HS, et al
Influenza vaccination: A qualitative study of practice level barriers from medical practitioners caring for children with special risk medical conditions.
Vaccine. 2020;38:7806-7814.
PubMed Abstract available

GARCIA LY, Cerda AA
Acceptance of a COVID-19 vaccine: A multifactorial consideration.
Vaccine. 2020;38:7587.
PubMed

GRAFFIGNA G, Palamenghi L, Barello S, Stefania B, et al
"Cultivating" acceptance of a COVID-19 vaccination program: Lessons from Italy.
Vaccine. 2020;38:7585-7586.
PubMed

COUDEVILLE L, Gomez GB, Jollivet O, Harris RC, et al
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
Vaccine. 2020;38:7588-7595.
PubMed

ZHANG W, Gao J, Chen L, Tian J, et al
Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6-59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons.
Vaccine. 2020 Nov 8. pii: S0264-410X(20)31389.
PubMed Abstract available

CHIU SS, Chua H, Kwan MYW, Chan ELY, et al
Influenza vaccination effectiveness in preventing influenza hospitalization in children, Hong Kong, winter 2019/20.
Vaccine. 2020 Nov 6. pii: S0264-410X(20)31401.
PubMed Abstract available

SARASTY O, Carpio CE, Hudson D, Guerrero-Ochoa PA, et al
The demand for a COVID-19 vaccine in Ecuador.
Vaccine. 2020 Nov 6. pii: S0264-410X(20)31439.
PubMed Abstract available

KESKE S, Mutters NT, Tsioutis C, Ergonul O, et al
Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic.
Vaccine. 2020 Nov 5. pii: S0264-410X(20)31427.
PubMed Abstract available

CHEN WH, Tao X, Agrawal AS, Algaissi A, et al
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
Vaccine. 2020;38:7533-7541.
PubMed Abstract available

October 2020

VESIKARI T, Ramsey K, Pitisuttithum P, Capeding R, et al
Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies.
Vaccine. 2020 Oct 30. pii: S0264-410X(20)31330.
PubMed Abstract available

BONANNI P, Angelillo IF, Villani A, Biasci P, et al
Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic: Appeal from the Board of the Vaccination Calendar for Life in Italy: Maintain and increase coverage also by r
Vaccine. 2020 Oct 30. pii: S0264-410X(20)31318.
PubMed Abstract available

CARCELEN AC, Vilajeliu A, Malik F, Gilman RH, et al
Perceptions and attitudes towards vaccination during pregnancy in a peri urban area of Lima, Peru.
Vaccine. 2020 Oct 30. pii: S0264-410X(20)31325.
PubMed Abstract available

LIU B, Shi P, Wang T, Zhao Y, et al
Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus.
Vaccine. 2020 Oct 29. pii: S0264-410X(20)31370.
PubMed Abstract available

SCHNEIKART G, Tavarini S, Sammicheli C, Torricelli G, et al
The respiratory syncytial virus fusion protein-specific B cell receptor repertoire reshaped by post-fusion subunit vaccination.
Vaccine. 2020 Oct 29. pii: S0264-410X(20)31371.
PubMed Abstract available

SCHOCH-SPANA M, Brunson EK, Long R, Ruth A, et al
The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States.
Vaccine. 2020 Oct 29. pii: S0264-410X(20)31368.
PubMed Abstract available

LIU X, Drelich A, Li W, Chen C, et al
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.
Vaccine. 2020;38:7205-7212.
PubMed Abstract available

GUEBRE-XABIER M, Patel N, Tian JH, Zhou B, et al
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.
Vaccine. 2020 Oct 23. pii: S0264-410X(20)31373.
PubMed Abstract available

CHANDIR S, Siddiqi DA, Mehmood M, Setayesh H, et al
Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data.
Vaccine. 2020;38:7146-7155.
PubMed Abstract available

RUSCIO BA, Hotez P
Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response.
Vaccine. 2020 Oct 21. pii: S0264-410X(20)31364.
PubMed

BELL S, Clarke R, Mounier-Jack S, Walker JL, et al
Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England.
Vaccine. 2020 Oct 19. pii: S0264-410X(20)31321.
PubMed Abstract available

ZHAI Y, Santibanez TA, Kahn KE, Srivastav A, et al
Rural, urban, and suburban differences in influenza vaccination coverage among children.
Vaccine. 2020 Oct 15. pii: S0264-410X(20)31324.
PubMed Abstract available

GARCIA PJ, George PE, Romero C, Soto G, et al
"The flu... is a little more complicated than a cold": Knowledge, beliefs, and practices related to influenza and influenza vaccination among at-risk populations and health professionals in Peru.
Vaccine. 2020 Oct 15. pii: S0264-410X(20)31236.
PubMed Abstract available

VERGKIZI S, Nikolakakis I
Bacillus Calmette-Guerin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally.
Vaccine. 2020 Oct 15. pii: S0264-410X(20)31284.
PubMed Abstract available

MALTEZOU HC, Theodoridou K, Tseroni M, Raftopoulos V, et al
Influenza vaccination policies for health workers in low-income and middle-income countries: A cross-sectional survey, January-March 2020.
Vaccine. 2020 Oct 12. pii: S0264-410X(20)31276.
PubMed Abstract available

MO Y, Zeng J, Xiao C, Zhang, et al
Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis.
Vaccine. 2020 Oct 12. pii: S0264-410X(20)31262.
PubMed Abstract available

GOLDMAN RD, Yan TD, Seiler M, Parra Cotanda C, et al
Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey.
Vaccine. 2020 Oct 10. pii: S0264-410X(20)31317.
PubMed Abstract available

SAFAVI A, Kefayat A, Mahdevar E, Abiri A, et al
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Vaccine. 2020 Oct 9. pii: S0264-410X(20)31307.
PubMed Abstract available

RONCATI L, Vadala M, Corazzari V, Palmieri B, et al
COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
Vaccine. 2020 Oct 9. pii: S0264-410X(20)31303.
PubMed Abstract available

SINGH JA
COVID-19 vaccine trials: Duty of care and standard of prevention considerations.
Vaccine. 2020 Oct 9. pii: S0264-410X(20)31302.
PubMed

MACIAS AE, McElhaney JE, Chaves SS, Nealon J, et al
The disease burden of influenza beyond respiratory illness.
Vaccine. 2020 Oct 8. pii: S0264-410X(20)31209.
PubMed Abstract available

GUILFOYLE K, Major D, Skeldon S, James H, et al
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.
Vaccine. 2020 Oct 6. pii: S0264-410X(20)31233.
PubMed Abstract available

LEE JKH, Lam GKL, Shin T, Samson SI, et al
Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.
Vaccine. 2020 Oct 6. pii: S0264-410X(20)31146.
PubMed Abstract available

WOLF J, Hansen R, Hassis K, Lapps W, et al
The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.
Vaccine. 2020 Oct 5. pii: S0264-410X(20)31228.
PubMed

CUSTERS J, Kim D, Leyssen M, Gurwith M, et al
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment.
Vaccine. 2020 Oct 3. pii: S0264-410X(20)31160.
PubMed Abstract available

HOSHI SL, Shono A, Seposo X, Okubo I, et al
Cost-effectiveness analysis of influenza vaccination during pregnancy in Japan.
Vaccine. 2020 Oct 2. pii: S0264-410X(20)31180.
PubMed Abstract available

NIANG M, Deming ME, Goudiaby D, Diop OM, et al
Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial.
Vaccine. 2020 Oct 1. pii: S0264-410X(20)31230.
PubMed Abstract available

September 2020

TEMPIA S, Moyes J, Cohen AL, Walaza S, et al
Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015.
Vaccine. 2020 Sep 23. pii: S0264-410X(20)31193.
PubMed Abstract available

DETOC M, Bruel S, Frappe P, Tardy B, et al
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic.
Vaccine. 2020 Sep 17. pii: S0264-410X(20)31201.
PubMed Abstract available

DEAN NE, Pastore Y Piontti A, Madewell ZJ, Cummings DAT, et al
Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials.
Vaccine. 2020 Sep 15. pii: S0264-410X(20)31191.
PubMed Abstract available

WANG K, Wong ELY, Ho KF, Cheung AWL, et al
Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey.
Vaccine. 2020 Sep 10. pii: S0264-410X(20)31175.
PubMed Abstract available

August 2020

TOMITA Y, Sato R, Ikeda T, Sakagami T, et al
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
Vaccine. 2020 Aug 20. pii: S0264-410X(20)31086.
PubMed Abstract available

REITER PL, Pennell ML, Katz ML
Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
Vaccine. 2020 Aug 20. pii: S0264-410X(20)31084.
PubMed Abstract available

GALILI U
Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present alpha-gal epitopes.
Vaccine. 2020 Aug 19. pii: S0264-410X(20)31073.
PubMed Abstract available

GRADY C, Shah S, Miller F, Danis M, et al
So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.
Vaccine. 2020 Aug 11. pii: S0264-410X(20)31048.
PubMed Abstract available

YITBAREK K, Abraham G, Girma T, Tilahun T, et al
The effect of Bacillus Calmette-Guerin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
Vaccine. 2020 Aug 10. pii: S0264-410X(20)31049.
PubMed Abstract available

MARELLAPUDI A, King AR, Bednarczyk RA
Presentation of caregiver-specific vaccine-related information on National Cancer Institute designated cancer center websites.
Vaccine. 2020 Aug 1. pii: S0264-410X(20)30983.
PubMed Abstract available

July 2020

VERDIJK P, van der Plas JL, van Brummelen EMJ, Jeeninga RE, et al
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
Vaccine. 2020 Jul 25. pii: S0264-410X(20)30947.
PubMed Abstract available

June 2020

BALZARINI F, Frascella B, Oradini-Alacreu A, Gaetti G, et al
Does the use of personal electronic health records increase vaccine uptake? A systematic review.
Vaccine. 2020 Jun 30. pii: S0264-410X(20)30738.
PubMed Abstract available

GUIDRY JPD, Coman IA, Vraga EK, O'Donnell NH, et al
(S)pin the flu vaccine: Recipes for concern.
Vaccine. 2020 Jun 24. pii: S0264-410X(20)30773.
PubMed Abstract available

BARAL R, Li X, Willem L, Antillon M, et al
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.
Vaccine. 2020 Jun 22. pii: S0264-410X(20)30822.
PubMed Abstract available

WOLFF GG
Letter to the Editor.
Vaccine. 2020;38:4651.
PubMed

May 2020

PLOTKIN SA, Caplan A
Extraordinary diseases require extraordinary solutions.
Vaccine. 2020;38:3987-3988.
PubMed

BELL S, Chantler T, Paterson P, Mounier-Jack S, et al
Is flu vaccination opt-out feasible? Evidence from vaccination programme implementers and managers in the English National Health Service.
Vaccine. 2020 May 4. pii: S0264-410X(20)30506.
PubMed Abstract available

April 2020

KAUFMAN J, Attwell K, Tuckerman J, O'Sullivan J, et al
Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study.
Vaccine. 2020 Apr 19. pii: S0264-410X(20)30469.
PubMed Abstract available

March 2020

DRISCOLL AJ, Arshad SH, Bont L, Brunwasser SM, et al
Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting.
Vaccine. 2020;38:2435-2448.
PubMed Abstract available

February 2020

MUELLER S, Stauft CB, Kalkeri R, Koidei F, et al
A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
Vaccine. 2020 Feb 24. pii: S0264-410X(20)30279.
PubMed Abstract available

HOSCHLER K, Maharjan S, Whitaker H, Southern J, et al
Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
Vaccine. 2020 Feb 15. pii: S0264-410X(20)30221.
PubMed Abstract available

SAMY N, Reichhardt D, Schmidt D, Chen LM, et al
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial.
Vaccine. 2020 Feb 11. pii: S0264-410X(20)30081.
PubMed Abstract available

January 2020

MCDONALD JU, Rigsby P, Atkinson E, Engelhardt OG, et al
Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study.
Vaccine. 2020;38:800-807.
PubMed Abstract available

RAINISCH G, Adhikari B, Meltzer MI, Langley G, et al
Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.
Vaccine. 2020;38:251-257.
PubMed Abstract available

December 2019

GIESE H, Neth H, Moussaid M, Betsch C, et al
The echo in flu-vaccination echo chambers: Selective attention trumps social influence.
Vaccine. 2019 Dec 18. pii: S0264-410X(19)31563.
PubMed Abstract available

WILSON R, Zaytseva A, Bocquier A, Nokri A, et al
Vaccine hesitancy and self-vaccination behaviors among nurses in southeastern France.
Vaccine. 2019 Dec 3. pii: S0264-410X(19)31541.
PubMed Abstract available

November 2019

WELLIVER RC, Papin JF, Preno A, Ivanov V, et al
Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge.
Vaccine. 2019 Nov 21. pii: S0264-410X(19)31510.
PubMed Abstract available

NUNEZ IA, Ross TM
Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses.
Vaccine. 2019 Nov 13. pii: S0264-410X(19)31497.
PubMed Abstract available

BROWNE SK, Beeler JA, Roberts JN
Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naive infants.
Vaccine. 2019 Nov 6. pii: S0264-410X(19)31428.
PubMed Abstract available

October 2019

STURKENBOOM M, Bahri P, Chiucchiuini A, Grove Krause T, et al
Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.
Vaccine. 2019 Oct 31. pii: S0264-410X(19)31002.
PubMed Abstract available

KOLB EA, Buterbaugh RE, Rinehart CL, Ensley D, et al
Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
Vaccine. 2019 Oct 24. pii: S0264-410X(19)31378.
PubMed Abstract available

ROBERTS NJ JR
Respiratory syncytial virus suppression of the antiviral immune response: Implications for evaluation of candidate vaccines.
Vaccine. 2019 Oct 10. pii: S0264-410X(19)31339.
PubMed Abstract available

September 2019

GILES ML, Buttery J, Davey MA, Wallace E, et al
Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines.
Vaccine. 2019 Sep 17. pii: S0264-410X(19)31173.
PubMed Abstract available

August 2019

PATEL N, Massare MJ, Tian JH, Guebre-Xabier M, et al
Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
Vaccine. 2019 Aug 12. pii: S0264-410X(19)31010.
PubMed Abstract available

May 2019

TORCEL-PAGNON L, Bauchau V, Mahy P, Tin Tin Htar M, et al
Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
Vaccine. 2019 May 6. pii: S0264-410X(19)30561.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: